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ABSTRACT 
 
 
 BACKGROUND: Medicaid coverage among adults is often characterized by 
discontinuity – loss of Medicaid coverage, and churning, or entering and exiting 
Medicaid – over short durations. Little is known about the impact of having 
discontinuous Medicaid coverage on access to care, preventive care, pharmacotherapy, 
primary care, and hospitalizations, among non-elderly adults with cardiovascular disease 
(CVD) or high-risk conditions. 
 
 OBJECTIVES: This dissertation employed a three empirical research papers 
approach to pursue the following aims: (1) characterize the adult subpopulations with 
CVD or conditions placing them at high risk for CVD who lack continuous Medicaid 
coverage, and examine the characteristics associated with Medicaid discontinuity, (2) 
examine associations between Medicaid discontinuity, medication adherence and 
medication utilization, and (3) examine the associations between Medicaid discontinuity, 
access to care, preventive care, primary care visits, and hospitalizations. 
 
METHODS: This was a retrospective comparative analysis of the 2002–2011 
Medical Expenditure Panel Survey employing a repeated cross-sectional study design. 
Study sample included adults aged 18–64 years diagnosed with ≥1 CVD (defined as 
acute myocardial infarction, coronary artery disease, congestive heart failure, peripheral 
and visceral atherosclerosis, or stroke) or high-risk conditions for CVD (defined as 
hypertension, lipid disorders, diabetes, or chronic kidney disease) who reported having 
Medicaid coverage any time during survey year. Individuals having continuous, full-year 
Medicaid coverage (Continuous Medicaid) were compared to those with <12 months of 
Medicaid coverage with no other insurance reported during the year (Discontinuous–
Uninsured), and separately to those with <12months of Medicaid along with other 
sources of health insurance during the year (Discontinuous–Insured). Associations 
between Medicaid discontinuity, access to care, and preventive care were estimated using 
multivariate logistic regression. Medication adherence, measured as medication 
possession ratio (MPR) with adequate adherence being considered at MPR>0.8, was 
estimated using multivariate logistic regression. Medication utilization, measured as the 
number of all-cause, and disease-specific prescription drug fills, was estimated using 
multivariate negative binomial regression. Four health care services utilization outcomes 
– inpatient, emergency room (ER), hospital outpatient, and office-based physician visits – 
measured as both, number of all-cause and number of disease-specific visits, were 
estimated using either zero-inflated negative binomial regression or negative binomial 
regression depending on the distribution of the outcome of interest. 
 
RESULTS: Overall, 31.8% of adults with CVD or high-risk conditions for CVD 
had <12 months of Medicaid coverage, majority of whom (23.5%) belonged to the 
Discontinuous–Uninsured group. Of those who had Medicaid at the beginning of the 
year, only 21.9% of the Discontinuous–Uninsured, and 8% of the Discontinuous–Insured 
still had Medicaid by the year end. Male gender, minority race/ethnicity, receiving 
disability benefits or participating in a federal assistance program, Medicaid managed 
 vi 
care enrollment, and diagnosis of respiratory illnesses were the characteristics associated 
with lower odds of Medicaid discontinuity, whereas being married, residing in the South, 
having higher income, or education, being employed, and having fair to poor perceived 
health status were associated with higher odds of Medicaid discontinuity. Overall 
adherence to commonly prescribed therapeutic medication classes, measured as average 
MPR, was not significantly different between the Continuous Medicaid and the two 
discontinuous coverage groups, whereas examination of class-specific adherence yielded 
mixed results. Discontinuous Medicaid coverage was associated with significantly lower 
all-cause and disease-specific prescription drug utilization among both the discontinuous 
Medicaid groups. Medicaid discontinuity was associated with poor access to care, and 
higher disease-specific inpatient and ER hospitalizations among both the discontinuous 
Medicaid coverage groups. Additionally, among the Discontinuous–Uninsured, Medicaid 
discontinuity was associated with lower odds of routine medical checkup, lower all-cause 
primary care office visits, and higher disease-specific hospital outpatient visits. 
 
CONCLUSION: Among non-elderly adults with CVD or high-risk conditions, 
for CVD having discontinuous Medicaid coverage was found to be associated with poor 
access to care and preventive care, poor adherence to certain medication classes and 
lower utilization of prescription medications, higher hospitalizations for CVD or 
associated conditions, and lower primary care office visits. Disruptions in and loss of 
Medicaid coverage among adults with CVD or high-risk conditions may lead to negative 
health outcomes due to the disruptions in continuity of care and inability to appropriately 
manage these disease conditions. This research provides strong support for 
implementation of policies to stabilize Medicaid coverage and reduce Medicaid 
discontinuity among individuals with CVD or high-risk conditions for CVD, such as the 
12 month continuous Medicaid eligibility provisions currently in place for low-income 
children. Such policies will greatly improve some of the adverse access to care, 
preventive care, pharmacotherapy, and medical care outcomes observed in this study. 
Vulnerable populations with chronic, debilitating conditions may benefit from such 
policies to a greater extent compared to the overall low-income adult population. 
Simultaneously, reenrollment and outreach strategies may need to be more efficiently 
implemented to ensure individuals who are eligible for Medicaid, continue to remain 
enrolled in Medicaid. Such enabling strategies employed by Medicaid managed care 
organizations may be adopted by State Medicaid agencies to ensure greater continuity in 
Medicaid coverage for low-income vulnerable populations with chronic and debilitating 
diseases. 
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CHAPTER 1.    INTRODUCTION 
 
 
INSTABILITY IN HEALTH INSURANCE 
 
 The health care system in the United States (U.S.) has widely recognized to be 
“fragmented”.1 The systemic misalignment of incentives, and lack of coordination 
between physician, and hospitals, leading to poor care coordination, inefficient allocation 
of resources, contribute to this narrative. This in turn greatly hampers the quality of care 
that patients receive. Likewise, the health insurance system in the U.S. too is fragmented 
with most individuals covered by employer-sponsored private health insurance (48%), 
and the poor, elderly, and disabled population groups being covered by government-
sponsored public health insurance (roughly 31%), with the remaining either purchasing 
individual private health plans (just 5% of the total population), or remaining uninsured, 
which estimates peg at 15% of the total population, roughly the same as those on 
Medicaid and Medicare.2 Rules and regulations are set separately for both private health 
insurance by employers, and for public health insurance by government, regarding 
eligibility for the insurance plans paid for, the specific covered benefits and cost sharing. 
 
The principal requirement for employer-sponsored insurance is employment. 
Losing employment, changing jobs, moving to different geographic regions, and starting 
one’s own venture, are circumstances that can lead to losing employer-sponsored 
insurance coverage or gaps in insurance coverage. The number of individuals that lose 
insurance resulting from loss of employment increased significantly during times of 
economic recession.3,4 As a cost-cutting measure, employers may change the benefit 
structure of the plans by requiring their employees to pay more through higher premiums, 
deductibles or co-pays, and also by cutting the numbers and/or types of services covered.  
Such measures may make health insurance expensive for low-income employees and 
those who cannot afford such plan structures. When an individual employee receives 
employment-sponsored coverage, his/her entire family is covered under the insurance 
plan. Thus, employee spouses and children of may also experience insurance instability 
as well due to circumstances such as changes in benefit structure where spouse coverage 
is dropped, loss of coverage or employment, retirement, death or other circumstances. 
 
Government-sponsored public health insurance too has its own set of eligibility 
criteria and enrollment procedures, and requires individuals to be aware of them to 
determine whether they are eligible or not, and if they are, to provide the appropriate 
documentation to enroll for these insurance plans, and maintain eligibility; this is 
especially true for Medicaid and Children’s Health Insurance Plan (CHIP) that are also 
referred to as means-tested public health insurance programs.5 The eligibility 
requirements and enrollment procedures for Medicaid and CHIP differ from state-to-
state, and so any change in residence across states may lead to loss of insurance coverage 
resulting from either ineligibility or failure to enroll successfully. Traditionally, before 
the passage of the 2010 Patient Protection and Affordable Care Act (PPACA), not only 
did the income eligibility thresholds vary greatly between the states, but they were also 
different for different population groups, such as more generous coverage limits for 
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children and pregnant women, less generous coverage limits for non-elderly adults with 
children, and no coverage for non-elderly adults without any children.6 Small fluctuations 
in income levels for covered non-elderly adults would end up disqualifying individuals 
with incomes at or near eligibility thresholds. As with employer-sponsored health 
insurance, changes or loss in Medicaid coverage for one member of the family impacted 
the continuity in Medicaid for the entire family. Also, changes in family size and 
compositions would also impact eligibility for these public insurance programs, since 
yearly poverty levels that are established take into account these factors. The rules and 
regulations for eligibility and enrollment between public and private health insurance are 
different, and therefore, individuals who have to transition between one system to another 
also experience gaps in insurance coverage, either due to failure to follow enrollment 
procedures, or being unaware of such an option, or even due to the stigma of enrolling for 
Medicaid or other low-income public programs.6 It is broadly due to these diverse factors 
in this fragmented health insurance system, that individuals and families experience 
insurance instability and continue to swing into and out of various types of health 
insurance coverage. 
 
 
INSTABILITY IN MEDICAID AMONG LOW-INCOME ADULT POPULATION 
 
Medicaid, the nation’s primary public health insurance program for the low-
income population, provides much-needed health insurance coverage to an estimated 67 
million individuals who meet the eligibility criteria, which include having incomes and 
assets below a certain threshold level determined by each State.7 These include low-
income children, adults, elderly, and disabled who do not have access to private health 
insurance, and many of whom are not eligible for any other source of coverage. Medicaid 
however, has been described as a leaky sieve. Inefficient administrative hurdles and 
ponderous periodic paperwork requirements, result in discontinuity in Medicaid 
coverage, characterized by either loss of coverage or “churning” – frequent transitions 
into and out of various sources of coverage.8,9 Such instability often plagues Medicaid-
eligible individuals, leading to both gaps in coverage and interruptions in the continuity 
of care. Families may have to find new providers or change their existing health 
treatments due to different provider networks or different services covered in their new 
health plans, or may end up forgoing needed care after becoming uninsured. Some 
research has been conducted to examine Medicaid instability and its impact on various 
outcomes, although the research in this area is not exhaustive. 
 
Harman and colleagues examined Utah Medicaid claims data from 1990-1994 to 
study the impact of Medicaid interruptions on inpatient psychiatric services use. They 
found that interruptions in Medicaid were associated with an average of 0.63 more 
psychiatric hospitalizations per beneficiary, and 8.3 more psychiatric hospitalization days 
over the study period.10 Using the Ohio Medicaid claims from 1992-1999 Koroukian 
examined the impact of length of enrollment in Medicaid on use of screening 
mammography among women aged 40-64 years. They found that with each additional 
year of Medicaid enrollment, the proportion of women receiving screening 
mammography increased significantly, and [Odds Ratio (OR): 1.59; 95% Confidence 
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Interval (CI): 1.57–1.60], and the mean number of annual mammography exams 
increased from 0.08/year among women enrolled for less than a year to 0.26/year among 
women enrolled for more than 7 years.11 Continuous Medicaid enrollment also was 
shown to have a positive impact on cervical cancer prevention.12 Harman and colleagues 
analyzed Florida Medicaid claims data from 1999-2002 to examine the impact of 
Medicaid interruption on depressed beneficiaries’ health care utilization and 
expenditures. They found that inpatient episodes, the length of inpatient stay, number of 
emergency department (ED) visits, and total Medicaid expenditures increased 
significantly (P<0.001) in the three-month period after an interruption in coverage of 
more than one month, indicating a significant negative impact of Medicaid instability 
among low-income elderly with mental illness.13 More recently, studies that have 
examined the impact of interruptions in Medicaid using state-specific data have found 
that instability in Medicaid is associated with higher risk for hospitalization for 
ambulatory care-sensitive conditions, and increase in overall program expenditures due to 
higher inpatient and ED utilization.14 In the only study using nationally representative 
data, Banerjee and colleagues (2010) examined the Medical Expenditure Panel Survey 
(MEPS) 2000-2004 to study the impact of Medicaid instability on health care utilization, 
and found that individuals with discontinuous Medicaid coverage had higher inpatient 
and ED utilization, but lower prescription drug utilization annually.15 
 
The literature examining the impact of lack of insurance on health care outcomes 
in general, and disease-specific outcomes in particular is exhaustive with studies 
highlighting the adverse impact of lacking health insurance. The literature examining the 
impact of gaps in health insurance is less comprehensive, however, for the most part this 
literature has established that even short gaps in insurance coverage may lead to negative 
outcomes among individuals with chronic conditions. Although these studies have 
assessed the impact of insurance gaps on patients with numerous conditions including 
cancer, depression/anxiety and schizophrenia, and diabetes, fewer studies have focused 
on patient with cardiovascular disease (CVD) and CVD-associated conditions. Studies 
using more advanced statistical analyses such as zero-inflated linear models, difference-
in-differences analyses, and instrumental variable regression analyses need to be 
conducted more to account for endogeneity problems that may confound the association 
between continuation and discontinuation in Medicaid and other insurance programs and 
major clinical outcomes. Studies examining Medicaid instability have mostly been 
conducted using data on a single state’s Medicaid program, and there is a paucity of 
studies (could also be due to lack of national data) that examine nationally representative 
estimates of churning in Medicaid and its impact on health care outcomes, especially 
among individuals diagnosed with chronic disease conditions. Although medication 
adherence/compliance as an area of research has been thoroughly examined with several 
high-quality robust analyses of adherence, and its impact of health care utilization, 
research examining the impact of churning in insurance in general and Medicaid in 
particular is lacking. It is imperative therefore, to examine the impact of Medicaid 
discontinuity on pharmacotherapy outcomes, such as medication adherence and 
medication utilization. 
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CARDIOVASCULAR DISEASE OR ASSOCIATED HIGH-RISK CONDITIONS 
AMONG LOW-INCOME POPULATIONS 
 
 CVD is the leading cause of death in the U.S. accounting for approximately 1 in 
every 4 deaths being attributed to them.16 Cardiovascular complications resulting from 
high blood pressure, lipid disorders, and other risk factors have been known to exert a 
substantial burden leading to disability, morbidity, and mortality.17,18 The economic 
burden due to CVD has been estimated to exceed $300 billion.19 Estimates peg the 
prevalence of cardiovascular disease (CVD), including heart failure and stroke, among 
low-income adult population at 28%.20 Additionally, many individuals with CVD that 
have resulted from worsening of other chronic conditions such as hypertension, diabetes, 
and hyperlipidemia. High blood pressure (24%), high cholesterol (17%), and high blood 
sugar level (9%) are some of the prevalent risk factors or high-risk conditions for 
CVD.21,22 For instance, 82% of low-income diabetic adults, and 74% of low-income 
adults with CVD reported one or more additional chronic condition, which indicates the 
complex disease burden and health care needs in the CVD or high risk population. 
Additionally, spending for nonelderly adult Medicaid enrollees with CVD and many of 
the high-risk conditions for CVD ranged from $9,694 - $13,490 per capita, which was 
significantly higher than their counterparts without these chronic conditions, and once 
again reflected the complex chronic disease burden among these diseased 
subpopulations.20 
 
Low-income populations with CVD or conditions placing them at high risk for 
CVD, such as acute myocardial infarction, congestive heart failure, coronary artery 
disease, peripheral and visceral atherosclerosis, stroke, hypertension, diabetes, 
hyperlipidemia, and chronic kidney disease, would face tremendous challenges in 
managing these complex chronic conditions. CVD and CVD-associated conditions 
require appropriate and uninhibited access to medical care, preventive care, prescription 
medications, and periodic primary and specialty care visits for prevention and treatment. 
Failure to appropriately manage these chronic conditions may exacerbate the symptoms 
and lead to worsening of health leading, resulting in unplanned hospitalizations and 
emergency room admissions. Insurance coverage is a critical component and an 
important factor in ensuring access to and utilization of needed medical care for 
appropriate disease management. Medicaid, as mentioned above is a critical safety-net 
health insurance program for low-income populations that provides these vulnerable 
populations the ability to seek needed medical care. Interruptions and discontinuity in 
Medicaid coverage may especially have a lead to significantly poor health outcomes 
among these vulnerable populations, and therefore policies to stabilize Medicaid 
coverage among low-income populations with CVD or high-risk conditions for CVD 
may be even more critical to ensuring continuity of care and appropriate disease 
management among these individuals. While need appropriate medical care, 
pharmacotherapy is also an important component of disease management for these 
individuals. Prescribed medicines not only need to be filled in a timely manner as 
directed, but adhering to the appropriate prescribed medication regimen is also critical to 
observe positive therapeutic effects of these medications. After reviewing the literature 
for the definitions for CVD and conditions which are high risk factors, and in 
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consultation with a cardiologist to restrict the number of these conditions to those 
requiring appropriate and prolonged disease management in the outpatient and 
community settings, the present study has considered the CVD and high-risk conditions 
for CVD listed above as the index chronic conditions.17,23-26 The rationale being that 
continuity of Medicaid coverage may be even more critical among this subpopulation of 
the non-elderly adult Medicaid population, and the adverse outcomes due to Medicaid 
discontinuity may be more detrimental among these individuals. 
 
 
RESEARCH AIMS 
 
Using nationally representative data on non-institutionalized, non-elderly adults 
diagnosed with one or more CVD or high-risk conditions for CVD who reported having 
Medicaid at any point of time during the year, this dissertation aims to investigate the 
associations between instability in Medicaid coverage within a year, and access to care, 
preventive care, prescription drug adherence and utilization, primary care visits, and 
inpatient and ER hospitalizations. 
 
 
Aim 1: To Examine the Individual Characteristics Associated with Medicaid 
Discontinuity 
 
1) Are the demographic, socioeconomic, Medicaid-, and health-related 
characteristics significantly different between those who have continuous 
Medicaid coverage and their counterparts with discontinuous Medicaid coverage 
during the year?  
2) Which characteristics are significantly associated with Medicaid discontinuity in 
this study population? 
 
 
Aim 2: To Examine the Associations between Medicaid Discontinuity, Medication 
Adherence and Medication Utilization 
 
? Hypothesis 2a: Medicaid discontinuity is associated with poor adherence to 
commonly prescribed therapeutic classes of medications used to treat CVD or 
high-risk conditions for CVD 
? Hypothesis 2b: Medicaid discontinuity is associated with lower all-cause and 
disease-specific prescription drug utilization 
 
 
Aim 3: To Examine the Associations between Medicaid Discontinuity, Access to 
Care, Preventive Services Use, and Utilization of Health Care Services 
 
? Hypothesis 3a: Medicaid discontinuity is associated with poor access to care 
? Hypothesis 3b: Medicaid discontinuity is associated with a lower likelihood of 
adequate preventive services use 
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? Hypothesis 3c: Medicaid discontinuity is associated with lower all-cause and 
disease-specific hospital outpatient visits, and office-based physician visits 
? Hypothesis 3d: Medicaid discontinuity is associated with higher all-cause and 
disease-specific inpatient hospitalizations and ER hospitalizations 
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CHAPTER 2.    CHARACTERISTICS ASSOCIATED WITH MEDICAID 
DISCONTINUITY IN ADULTS WITH CARDIOVASCULAR DISEASE OR 
ASSOCIATED HIGH-RISK CONDITIONS 
 
 
BACKGROUND 
 
Cardiovascular disease (CVD) and CVD associated conditions (e.g. hypertension, 
lipid disorders, and diabetes) exert substantial burden due to disability, morbidity, and 
mortality. CVD is the major cause of death in the U.S., accounting for 1 in 4 deaths being 
attributed to them.16 Economic burden due to these debilitating chronic conditions is 
estimated to exceed $300 billion annually.19 Continuity of care is essential to for 
appropriate management of these disease conditions, and having uninterrupted access to 
health insurance is critical to ensure this continuity of care.27,28 Medicaid, the nation’s 
primary public health insurance program for the low-income population, provides much-
needed health insurance coverage to an estimated 67 million individuals at any given 
point in time.7 Estimates indicate that over 28% of the Medicaid population at or below 
138 percent of the federal poverty level (FPL) are diagnosed with CVD or high-risk 
conditions for CVD.29,30 
 
Medicaid however, has been described as a leaky sieve.8 Inefficient administrative 
hurdles and ponderous periodic paperwork requirements, result in discontinuity in 
Medicaid coverage, characterized by wither loss of coverage or “churning” – frequent 
transitions into and out of various sources of coverage.8,9 Such instability often plagues 
Medicaid-eligible individuals, leading to both gaps in coverage and interruptions in the 
continuity of care. Families may have to find new providers or change their existing 
health treatments due to different provider networks or different services covered in their 
new health plans, or may end up forgoing needed care after becoming uninsured. 
 
The consequences of lack of insurance have been well-documented. Ayanian and 
colleagues reported that Americans who were uninsured for one year or more were more 
likely to have foregone routine clinical checkup in the past 2 years, and this pattern was 
observed among individuals diagnosed with several chronic conditions such as 
hypertension, hyperlipidemia, HIV/AIDS, among others. Long-term and short-term 
uninsured (uninsured for less than one year), also did not receive recommended cancer 
screening, and diabetes care among others.31 Recent estimates indicate that these trends 
have continued into the first decade of the 21st century. Fields and colleagues analyzed 
the Medical Expenditure Panel Survey (MEPS) data from 2006-2010 to examine the 
impact of insurance stability and residence on several health care utilization measures. 
They found that discontinuously insured individuals had more ED visits, fewer physician 
office visits, and fewer prescription drug fills among others, compared to those with 
continuous insurance coverage.32 Several other studies examining Medicaid data have 
also reported adverse impacts on access to care, and health outcomes due to gaps in 
Medicaid coverage.2,10-14 
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Medicaid discontinuity, due to either becoming ineligible or “drop-out” despite 
meeting the eligibility criteria, has been well documented in children.33-35 Some research 
has been conducted to examine Medicaid instability among adults, although this area of 
research is not exhaustive. For instance, estimates peg the rate of adult disenrollment 
from Medicaid to range from 21–33% annually.36-38 Sommers examined the predictors of 
loss of Medicaid and found that young age, male gender, and Hispanic ethnicity were 
significant risk factors for coverage discontinuity.38 However, there have been no 
estimates of Medicaid instability among non-elderly adults with CVD or high-risk 
conditions for CVD among whom, the impact of such coverage discontinuity could be 
detrimental. Including population groups diagnosed with and managing these chronic 
conditions in policy discussions to improve Medicaid retention among adults is 
important, as these groups could benefit the most from coverage stability and the 
resulting continuity in disease management. 
 
The present study aims to: 1) obtain national estimates of Medicaid coverage 
transitions and discontinuity among non-elderly adults with CVD or high-risk conditions 
for CVD, 2) characterize the population groups that have continuous and discontinuous 
Medicaid coverage within a year, and 3) examine the individual characteristics associated 
with Medicaid discontinuity in this study population. 
 
 
METHODS 
 
The present study is a retrospective cross-sectional analysis designed to compare 
the characteristics of non-elderly adults diagnosed with CVD or high-risk conditions for 
CVD with continuous full-year Medicaid coverage versus those with discontinuous 
Medicaid coverage. The study seeks to determine the individual characteristics associated 
with Medicaid discontinuity in this CVD population. Medicaid, being a means tested 
source of public health insurance, is not a permanent source of insurance coverage. As 
discussed earlier, the requirements of periodic reporting of income, assets, family status 
and residence, apart from changes in one or more of these circumstances are the major 
sources of instability in Medicaid coverage which may impact access to care and 
preventive services use for individuals with CVD or high-risk conditions for CVD. In 
order to capture this instability in the study population, we first describe the prevalence of 
these chronic conditions in this study population. We then examine in detail, the 
demographic, socioeconomic, Medicaid-, and health-related characteristics associated 
with Medicaid discontinuity in this study, and control for these covariates in the 
multivariate models to determine the individuals characteristics associated with Medicaid 
discontinuity in this CVD population. 
 
 
Data Source 
 
This study analyzed the Medical Expenditure Panel Survey (MEPS). MEPS is a 
set of large-scale surveys of families, individuals, their medical providers and employers 
across the United States. It is jointly sponsored by the Agency for Healthcare Research 
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and Quality (AHRQ) and the National Center for Health Statistics (NCHS), and has been 
conducted annually since 1996. It has two major components; the Household Component 
(HC), and the Insurance Component, with data on medical providers in the HC being 
supplemented by the Medical Provider Component. MEPS collects detailed information 
from a nationally representative sample of the civilian noninstitutionalized population of 
the U.S. on health services utilization and health expenditures, insurance coverage, and 
sources of payment.39 
 
When obtaining national estimates from surveys such as MEPS, appropriate 
sample size is critical to obtain reliable estimates, since estimates of some population 
subgroups may vary from year to year. AHRQ suggests a minimum of 100 unweighted 
participants per cell for producing reliable national estimates. The advantage of survey 
such as MEPS is that they allow for several years’ of data to be pooled together in order 
to increase the sample size and improve the precision of estimates. The pooling of the 
different years of data was conducted in accordance with the guidelines provided by 
MEPS, and data for the years 2002 – 2011 were pooled together to allow for a 
sufficiently large sample size to ensure reliable estimates.  
 
 
MEPS Sampling Plan 
 
MEPS has an overlapping panel design. Two separate panels of respondents are 
interviewed simultaneously during a calendar year. A new panel of sample households is 
selected each year, and data for each panel are collected for two calendar years. The two 
years of data for each panel are collected in five rounds of interviews that take place over 
a two and a half year period. This provides continuous and current estimates of health 
care expenditures at both the person and household level for two panels for each calendar 
year. Figure 2-1 illustrates this overlapping panel design in detail with an example of 
Panels 15 and 16. 
 
 
Study Population 
 
 The study population consisted of individuals diagnosed with CVD or high-risk 
conditions for CVD. CVD was defined as any diagnosis of acute myocardial infarction 
(Clinical Classification code (CCC): 100), coronary artery disease (CCC: 101), 
congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis (CCCs: 114, 
115, 116), stroke (CCCs: 109, 112). High-risk conditions for CVD were defined as 
hypertension (CCC: 098), lipid disorders (CCC: 053), diabetes (CCC: 049, 050), and 
chronic kidney disease (CCC: 158). CCC aggregates conditions and procedures into 
mutually exclusive and clinically homogeneous categories, using Clinical Classification 
Software.40 The study population included respondents who were: (1) aged 18 to 64 
years, (2) self-reported either being diagnosed with CVD or high-risk conditions for CVD 
in their first round of the MEPS survey, or reported having an event (an inpatient, 
emergency, outpatient, or office-based provider visits, or a prescription medication) 
associated with one or more of the aforementioned disease conditions at any point of time  
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Figure 2-1. MEPS Overlapping Panel Design 
 
Reprinted with permission. MEPS-HC Sample Design and Collection Process. Agency 
for Healthcare Research and Quality, Rockville, Md. 
http://www.meps.ahrq.gov/survey_comp/hc_data_collection.jsp. Accessed on April 6, 
2015.41 
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during the survey, (3) reported having had Medicaid coverage at any point of time during 
the survey year, and (4) had positive person weights, and were interviewed for all five 
rounds of the 2-year MEPS survey interviews. Events associated with any particular 
disease conditions were self-reported and coded by the MEPS data reviewers 
accordingly. A portion of the self-reported data were verified by contacting the health 
care providers associated with the events reported and coded accordingly.42 Selection of 
individuals in the study population on the basis of a medical event associated with the 
disease condition of interest is a valid approach to ensure that the study sample is not 
impacted by misreporting of chronic conditions diagnoses.43 Respondents who reported 
having Medicare, or pregnancy were excluded from this study.  
 
A major goal of this study was to characterize Medicaid discontinuity among 
individuals with CVD or high-risk conditions for CVD. Unlike previous studies, this 
study accounted for presence of other sources of health coverage among the 
discontinuous Medicaid coverage groups.15 This was done since individuals who do not 
report having continuous full-year Medicaid coverage and have no other health insurance 
during the year may be different from those with other sources of health insurance 
coverage, in terms of characteristics and health care utilization. Individuals in the study 
population who reported having Medicaid coverage during all 12 months of a survey year 
were classified as having continuous Medicaid coverage, which was the comparison 
group and designated as ‘Continuous Medicaid’ in this study. Individuals who reported 
having <12 months of Medicaid coverage during a survey year were divided into two 
groups: (1) individuals with <12 months of Medicaid coverage who did not report any 
other sources of health insurance during the survey year, designated in this study as 
‘Discontinuous–Uninsured’, and (2) individuals with <12 months of Medicaid coverage 
who also reported having other source(s) of health insurance during the survey year 
(either private, Tricare, or any hospital- or physician group-based health insurance), 
designated in this study as ‘Discontinuous–Insured’. 
 
 
Study Variables 
 
 Our primary outcomes of interest are an indicator for Medicaid discontinuity 
without other health insurance coverage (Discontinuous–Uninsured), and an indicator for 
Medicaid discontinuity with other sources of health insurance coverage (Discontinuous–
Insured). The measures of comparison between the three groups, which were also 
adjusted for in the regression models included the following covariates: 
 
1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity 
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital 
status (not married vs. married), family size (N), and geographic residence 
(Northeast vs. Midwest, South, and West). 
2) Socioeconomic covariates: education (less than high school vs. high school/GED, 
and Bachelor’s or higher), income as a percentage of the federal poverty level 
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always 
unemployed vs. intermittent employment, and always employed), binary indicator 
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for Metropolitan Statistical Area (MSA) residence. 
3) Medicaid-related covariates: binary indicator for Supplementary Security Income 
(SSI) for disability receipt or participation in the Temporary Assistance for Needy 
Families (TANF) program, and a binary indicator for Medicaid HMO/Managed 
Care participation. 
4) Health-related covariates: perceived health status (excellent/very good/good vs. 
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor), 
number of CVD or high-risk conditions for CVD (N), binary indicator for mental 
illness/substance abuse diagnosis, binary indicator for respiratory diseases 
diagnosis, binary indicator for arthritis/joint pain diagnosis, and Charlson 
Comorbidity Index (CCI) score. 
 
All regression models included the year fixed effects to capture any macro-level 
variations during the study period. 
 
 
Statistical Analysis 
 
 Survey-weighted proportions of prevalence of CVD or high-risk conditions for 
CVD were calculated. Chi-square tests and t-tests were conducted as part of the initial 
bivariate statistics to compare characteristics across the groups in the study population. 
Survey-weighted multivariate logistic regression analyses were then conducted to 
determine the predictors of Medicaid discontinuity in the study population. As denoted in 
Equation 2-1 and Equation 2-2,  
 
Pr[DU=1|x] = F-1(?? ?? ???
?
??? ??)  (Eq. 2-1) 
 
Pr[DI=1|x] = F-1(?? ?? ???
?
??? ??)  (Eq. 2-2) 
 
In the logistic regression analyses, both Discontinuous–Uninsured (denoted by 
DU) and Discontinuous–Insured (denoted by DI) were modeled as dichotomous outcome 
variables as a function of the demographic, socioeconomic, Medicaid eligibility and 
health-related covariates. F-1 denotes the inverse of the cumulative standard logistic 
distribution function that relates the outcome on the probability scale to the covariates. 
Pr[ ] denotes the population average probability of Medicaid discontinuity (for both with 
and without other sources of insurance coverage models) conditional on the covariates. X 
denotes the vector of aforementioned individual characteristics that predict Medicaid 
discontinuity in the two population groups of interest. The proportion of missing data was 
approximately 6% for the study. As a result, the listwise deletion approach was used to 
account for missing values. Multicollinearity was assessed for all the regression models, 
and the variance inflation factor was found to be less than 5, which was lower than the 
widely accepted threshold of 10 for existence of multicollinearity. The Hosmer-
Lemeshow tests for goodness-of-fit were highly insignificant for all the logistic 
regression models indicating no significant difference between the observed and 
predicted values of the response variables, and that the model fit the data. All data 
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analyses were conducted using SAS 9.3 and STATA 13 to account for the complex 
survey design of MEPS. 
 
 
RESULTS 
 
Figure 2-2 is a schematic representation of the process employed for deriving the 
unweighted, unadjusted study sample. Of the 344,933 individuals in the ten-year period 
between 2002 and 2011, 328,135 had positive MEPS person-level weights. After 
excluding individuals with Medicare (44,921), those who reported pregnancy (17), and 
those respondents who were not in-scope throughout the survey period (7,359), 275,838 
non-institutionalized study respondents remained. Of these, 231,675 respondents who did 
not report being diagnosed with CVD or high-risk conditions for CVD were excluded, 
resulting in a total of 41,163 individuals being selected who either reported being 
diagnosed with, or having an event (prescribed medicine, inpatient, ER, outpatient, or 
office-based provider visits) associated with CVD or high-risk conditions for CVD, 
which were the index chronic conditions considered in this study. Of these, a total of 
38,186 individuals were further excluded as they either did not have Medicaid coverage 
at any point of time during the study period, or they were less than 18 or more than 64 
years of age, resulting in a total overall sample of 5,977 individuals aged 18-64 years 
who had Medicaid at any given point in time during the study period.  
 
The overall study sample (5,977) was divided further into groups: the continuous 
Medicaid coverage group consisting of 3,926 individuals (65.7%) who had uninterrupted 
Medicaid coverage throughout the year (hereby referred to as Continuous Medicaid), and 
the discontinuous Medicaid coverage group consisting of 1,900 individuals (31.8%) who 
had less than 12 months of Medicaid coverage. There were 151 individuals (2.5%) who 
reported both full-year Medicaid coverage along with other sources of health insurance, 
which were excluded in the main analyses and included in the sensitivity analyses. In 
order to capture the heterogeneity in the discontinuous Medicaid subpopulation due to 
presence of other sources of health insurance coverage, this group was further divided 
into two groups: the Discontinuous–Uninsured, which consisted of 1,407 individuals 
(74.1% of the discontinuous Medicaid subpopulation, 23.5% of the total study sample) 
who did not report any other form of health insurance during the year, and the 
Discontinuous–Insured, consisting of 493 individuals (25.9% of the discontinuous 
Medicaid subpopulation, 8.3% of the total study sample) who reported some other form 
of health insurance during the year (either, private, Tricare, or other forms of hospital- or 
physician group-based health insurance). Thus, all outcome models were analyzed 
separately; comparing Continuous Medicaid and the Discontinuous–Uninsured 
populations, and separately comparing the Continuous Medicaid vs. the Discontinuous–
Insured population groups. This was done to capture the variability among the population 
group of interest, those with Discontinuous Medicaid. Individuals who do not report 
having continuous full-year Medicaid coverage and have no other health insurance during 
the year may have significant differences, not only in sociodemographic characteristics 
and health status, but may also have different health care utilization patterns and health 
behaviors. 
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Figure 2-2. Schematic Representation of the Study Sample Derivation Process
MEPS 2002-2011 
N = 344,933 
N = 328,135 
Exclusion: Non-positive person weights 
N = 16,798 
N = 283,214 
Exclusion: Medicare enrollees 
N = 44,921 
N = 283,197 
Exclusion: Pregnancy 
N = 17 
Individuals with CVD or high-
risk conditions 
N = 44,163 
Exclusion: Individuals without CVD or 
high-risk conditions 
N = 231,675 
N = 275,838 
Exclusion: Dropped out of survey 
N = 7,359 
Individuals aged 18-64 years, 
ever had Medicaid 
N = 5,977 
Exclusion: Age <18 or >64 years, 
never had Medicaid 
N = 38,186 
Exclusion for Main Analysis: Continuous 
Medicaid & Other insurance 
N = 151 
(Included in sensitivity analyses) 
Continuous Medicaid 
(12 months) 
N = 3,926 
Discontinuous Medicaid 
(<12 months) 
N = 1,900 
Discontinuous–Uninsured 
(<12 months & No other insurance) 
N = 1,407 
Discontinuous–Insured 
(<12 months & Other insurance) 
N = 493 
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Table 2-1 depicts the distribution of the various diagnosis and utilization 
components or criteria which were considered in this study for sample selection. From an 
overall sample of 5,997, 3,997 reported being diagnosed with one or more of the CVD or 
high-risk conditions for CVD examined in this study, 5,332 reported taking on or more 
prescription medicines associated with these index chronic conditions, and 3,713 had 
reported having one or more office-based provider visits for one or more of the index 
chronic conditions examined in this study. 
 
 
Prevalence of CVD or High-Risk Conditions for CVD 
 
 Table 2-2 shows the prevalence of CVD or high-risk conditions for CVD in the 
study population. The prevalence of the index disease conditions was fairly even between 
the Continuous and Discontinuous–Uninsured groups with hypertension being the most 
prevalent disease (49.9% vs. 52.7%, P=0.179), followed by lipid disorders (34.1% vs. 
31.3%, P=0.139), and diabetes (28.3% vs. 28.5%, P=0.918). The prevalence of coronary 
artery disease (8.1% vs. 7.3%, P=0.407), MI (4.3% vs. 4.0%, P=0.739), stroke (4.4% vs. 
3.8%, P=0.572), CHF (3.3% vs. 3.1%, P=0.856), peripheral and visceral atherosclerosis 
(1.6% vs. 0.9%, P=0.082), and chronic kidney disease (0.8% vs. 0.4%, P=0.293) had 
lower prevalence in these groups. Distribution of the index conditions when comparing 
the Continuous with the Discontinuous–Insured groups was similar. The mean number of 
index chronic conditions was higher among the Continuous Medicaid group compared to 
the Discontinuous–Uninsured (P=0.028), and the Discontinuous–Insured groups 
(P=0.008). When comparing the raw numbers of cardiovascular disease and associated 
comorbidities in this study population, this study found that 18.7% of individuals in the 
Continuous group had 3 or more chronic conditions, compared to 17.7% in the 
Discontinuous–Uninsured (P=0.792), and 13.6% in the Discontinuous–Insured groups 
(P=0.096). 
 
 Among individuals with MI, the most prevalent chronic comorbid index driving 
diagnosis was hypertension, followed by lipid disorders, coronary artery disease, 
diabetes, stroke, and congestive heart failure. In this subgroup, the prevalence of stroke 
was significantly different between the Continuous and Discontinuous–Insured groups 
(P=0.027). When examining individuals with CHF, the most prevalent chronic comorbid 
index driving diagnosis was found to be hypertension, followed by lipid disorders, 
diabetes, coronary artery disease, myocardial infarction, and stroke. Finally, among 
individuals with coronary artery disease, hypertension was again the most prevalent 
comorbidity, followed by lipid disorders, diabetes, myocardial infarction, and congestive 
heart failure (results not shown). 
 
 
Medicaid Enrollment among the Two Discontinuous Medicaid Groups 
 
 Table 2-3 shows the summary statistics for Medicaid enrollment among the 
discontinuous Medicaid insurance groups. The average duration of enrollment for the 
undivided discontinuous Medicaid population was 6.0 months. The Discontinuous– 
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Table 2-1. Diagnosis and Event Components Used to Select the Study Population 
 
Components Frequency (N) Weighted 
Frequency (N) 
     % (SE) 
CVD or High-Risk Conditions 
for CVD 
3,997 2,638,024 67.8 (0.9) 
    
Rx for CVD or High-Risk 
Conditions for CVD 
5,332 3,474,117 89.3 (0.6) 
    
Inpatient Visit for CVD or High-
Risk Conditions for CVD 
372 260,990 6.7 (0.4) 
    
ER Visit for CVD or High-Risk 
Conditions for CVD 
463 304,458 7.8 (0.5) 
    
Outpatient Visit for CVD or 
High-Risk Conditions for CVD 
480 324,800 8.3 (0.6) 
    
Office-Based Visit for CVD or 
High-Risk Conditions for CVD 
3,713 2,379,045 61.1 (0.9) 
    
Study Population 5,977 3,892,363 -- 
 
CVD: Cardiovascular disease; Rx: Prescription medication; ER: Emergency room.  
CVD include myocardial infarction, coronary artery disease, congestive heart failure, 
peripheral and visceral atherosclerosis, stroke. High-risk conditions for CVD include 
hypertension, lipid disorders, and diabetes, chronic kidney disease. 
Study Population includes individuals reporting one or more of at least one of the study 
components listed in the table. 
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Table 2-2. Prevalence of CVD or High-Risk Conditions for CVD in the Study Population 
 
  Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Prevalence Index 
Diseases 
           Weighted N 
or Mean 
% (SE) 
or SE 
  Weighted N 
or Mean 
% (SE) 
or SE 
  Weighted N 
or Mean 
% (SE) 
or SE 
 MI 109,746 4.3 (0.5)  36,811 4.0 (0.6)  10,903 2.6 (0.9) 
 CAD 207,594 8.1 (0.6)  66,361 7.3 (0.9)  25,846 6.1 (1.2) 
 CHF 83,275 3.3 (0.5)  28,341 3.1 (0.8)  5,709 1.4 (0.7) 
 PVA 40,962 1.6 (0.3)  8,511 0.9 (0.3)  7,810 1.8 (0.7) 
 Stroke 111,114 4.4 (0.5)  35,051 3.8 (0.8)  13,361 3.2 (1.1) 
 Hypertension 1,273,888 49.9 (1.2)  481,202 52.7 (1.8)  196,635 46.4 (2.7) 
 Lipid Disorders 870,818 34.1 (1.1)  285,706 31.3 (1.7)  133,370 31.4 (2.5) 
 Diabetes 723,694 28.3 (1.1)  260,672 28.5 (1.8)  113,299 26.7 (2.2) 
 CKD 19,144 0.8 (0.2)  4,046 0.4 (0.2)  1,323 0.3 (0.2) 
Mean Index 
Diseases (SE) 
             1.73 0.01        1.70 0.01*    1.56    0.06** 
No. of Index 
Diseases 
         
1  951,993 54.7 (1.4)  351,268 56.2 (2.2)  170,538 62.4 (3.2) 
2  462,928 26.6 (1.1)  163,062 26.1 (1.8)  65,581 24.0 (3.2) 
>3  325,033 18.7 (1.1)  110,621 17.7 (1.8)  37,000 13.6 (2.4) 
 
CVD: Cardiovascular disease; MI: myocardial infarction; CAD: coronary artery disease; CHF: congestive heart failure; PVA: peripheral vascular 
disease; CKD: chronic kidney disease; SE: standard error 
***P<0.001; **P<0.01; *P<0.05 for difference from the Continuous Medicaid group. Index diseases include the CVD or its associated risk factor 
comorbidities considered in this study. Sample consists of 3,003997 individuals or weighted sample of 2,638,024 who reported being diagnosed 
with one or more index diseases.
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Table 2-3. Medicaid Enrollment among the Discontinuous Medicaid Groups 
 
 Discontinuous–Uninsured  Discontinuous–Insured 
Coverage 
Components 
   Mean or 
Weighted N 
SE or % 
(SE) 
   Mean or 
Weighted N 
SE or % 
(SE) 
Mean Duration of 
Medicaid 
6.5 months 0.1      5.0 months***  0.2 
Mean Duration of 
No Insurance 
5.5 months 0.1      1.2 months***  0.1 
Insurance Status 
After 12 Months† 
     
Still in Medicaid   83,125 21.9 (2.2)   11,647***   8.0 (2.0) 
Uninsured 297,045 78.1 (2.2)   10,058***   6.0 (2.0) 
Other Insurance -- --           147,896 86.0 (2.0) 
Medicaid 
Coverage 
Transitions 
     
1 752,311 82.3 (1.4)           350,803 82.7 (2.0) 
>2 161,615 17.7 (1.4)             73,462 17.3 (2.0) 
 
Sample consisted of 380,171 individuals in the Discontinuous–Uninsured group and 169,600 
individuals in the Discontinuous–Insured group who either reported being diagnosed with or 
having an event (prescription medication, or inpatient, emergency, hospital outpatient, or office-
based provider visits) associated with CVD or high-risk conditions for CVD, and who reported 
having Medicaid at the beginning of the year. 
***P<0.001; **P<0.01; *P<0.05 for difference from the Discontinuous–Uninsured group.
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Uninsured group was enrolled in Medicaid for a longer period on average compared to 
the Discontinuous–Insured group (6.5 vs. 5.0 months, P<0.001). Additionally, this study 
examined the average duration of no insurance and found individuals in the 
Discontinuous–Insured group were uninsured for a little over a month (5.5 vs. 1.2 
months, P<0.001). This study also examined Medicaid enrollment status after 12 months 
of initial Medicaid enrollment. Overall, a total of 4,898 individuals were enrolled in the 
month of January of the survey year, of which 85.3% were still enrolled in Medicaid 
during the month of December in the survey year, 3.5% had some other form of 
insurance coverage, and 10.2% were uninsured (results not shown). Of the 621 
individuals in the Discontinuous–Uninsured group who had Medicaid in the beginning of 
the year, 78.1% were uninsured while 21.9% still had Medicaid coverage at the end of the 
year. Of the 200 individuals in the Discontinuous–Insured group who had Medicaid in the 
beginning of the survey year, only 8.0% still had Medicaid, 6.0% were uninsured, and the 
remaining 86% had some other source of health insurance coverage at the end of the year. 
Finally, when examining the number of transitions into and/or out of Medicaid coverage, 
this study found that overall 17.6% of individuals in this study population had more than 
one transitions, and the proportion of multiple transitions was similar between the two 
discontinuous Medicaid subgroups (17.7% vs. 17.3%, P=0.875). 
 
 
Characteristics of the Study Population 
 
 Table 2-4 displays the demographic, socioeconomic, eligibility, and health-
related characteristics of the study population. The mean age of the full sample was 46.5 
years (not displayed). In comparison to the Continuous Medicaid group, those in the 
Discontinuous–Uninsured group were less likely to belong to other races [5.5% 
(Discontinuous–Insured) vs. 9.5% (Continuous), P<0.001], were more likely to be 
married (37.7% vs. 29.9%, P<0.001), and were more likely to belong to the South (34.5% 
vs. 29.8%, P=0.035). When examining the socioeconomic characteristics, this study 
found that the Discontinuous–Uninsured were more likely to have completed high 
school/GED (54.9% vs. 50.4%, P=0.004) or college (12.2% vs. 9.4%, P=0.004), were 
more likely to have incomes >125% FPL (43.0% vs. 33.9%, P<0.001), and were more 
likely to have intermittent (25.0% vs. 12.4%, P<0.001), as well as continuous full-year 
employment (20.7% vs. 15.1%, P<0.001). Among the Medicaid eligibility variables, the 
Discontinuous–Uninsured were less likely to be eligible for SSI due to disability or 
participate in TANF (16.9% vs. 41.5%, P<0.001), and were less likely to report Medicaid 
HMO/managed care (50.6% vs. 61.3%, P<0.001). Finally, when examining the health-
related covariates, they were less likely to report having mental /substance abuse illnesses 
(24.9% vs. 30.8%, P=0.003), respiratory illnesses (12.9% vs. 19.7%, P<0.001), or 
arthritis/joint pain diagnosis (29.3% vs. 34.1%, P=0.015), and were less likely to report 
having fair or poor perceived mental health status (25.7% vs. 33.7%, P<0.001) when 
compared to the Continuous Medicaid group. The mean CCI score was not significantly 
different between the two groups (P=0.078). 
 
 When comparing the Discontinuous–Insured group to the Continuous Medicaid 
group (Table 2-4), this study found that when examining the demographic covariates, 
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Table 2-4. Characteristics of the Study Population 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE)    P-value† Weighted N % (SE) P-value†† 
DEMOGRAPHIC          
Age      0.621   0.027 
18 – 34 years 388,425 15.9 (1.0)  165,340 18.1 (1.3)  98,188 23.1 (2.3)  
35 – 49 years 875,809 35.9 (1.2)  324,653 35.5 (1.8)  141,109 33.3 (2.7)  
50 – 64 years 1,173,144 48.2 (1.3)  423,933 46.4 (2.0)  184,968 43.6 (3.0)  
Gender      0.359   0.223 
Female 1,632,006 67.0 (1.2)  624,410 68.3 (1.8)  267,502 63.1 (2.8)  
Race/Ethnicity      <0.001   <0.001 
Non-Hispanic White 1,094,002 44.9 (1.8)  442,534 48.4 (2.1)  256,231 60.4 (3.2)  
Non-Hispanic Black 666,358 27.3 (1.5)  219,033 24.0 (1.6)  799,36 18.8 (2.0)  
Hispanic 445,601 18.3 (1.2)  202,106 22.1 (1.5)  50,704 12.0 (1.6)  
Others 231,416 9.5 (0.9)  50,253 5.5 (0.9)  37,393 8.8 (1.7)  
Marital Status      <0.001   <0.001 
Married 727,457 29.9 (1.3)  344,150 37.7 (1.8)  184,414 43.5 (3.2)  
Region      0.035   0.034 
Northeast 608,070 25.0 (1.6)  187,785 20.5 (1.7)  104,394 24.6 (2.9)  
Midwest 477,401 19.6 (1.4)  184,710 20.2 (1.7)  115,146 27.2 (3.2)  
South 727,520 29.8 (1.6)  315,073 34.5 (1.8)  98,072 23.1 (2.3)  
West 624,386 25.6 (1.7)  226,358 24.8 (1.9)  106,652 25.1 (3.0)  
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Table 2-4.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted 
N 
% (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
Family Size Mean (SE) 2.8 (0.1)   2.9 (0.1)       0.481  2.8 (0.1)  0.900 
SOCIOECONOMIC           
Education      0.004    <0.001 
<High School 971,041 40.2 (1.4)  298,300 32.9 (1.8)   67,896 16.0 (1.9)  
High School/GED 1,215,968 50.4 (1.4)  498,289 54.9 (2.0)   232,334 54.9 (3.2)  
College Degree 227,668 9.4 (0.7)  111,300 12.2 (1.4)   123,109 29.1 (3.2)  
Income      <0.001    <0.001 
<100% FPL 1,384,551 56.8 (1.2)  428,540 46.9 (1.7)   104,719 24.7 (2.3)  
100 – <125% FPL 227,591 9.3 (0.6)  91,940 10.1 (1.1)   28,783 6.8 (1.3)  
>125% FPL 825,236 33.9 (1.1)  393,445 43.0 (1.8)   290,763 68.5 (2.6)  
Employment      <0.001    <0.001 
Always Unemployed 1,767,234 72.5 (1.2)  496,282 54.3 (1.8)   112,490 26.5 (2.2)  
Unstable Employment 301,597 12.4 (0.8)  228,246 25.0 (1.6)   129,583 30.6 (2.5)  
Always Employed 368,547 15.1 (0.9)  189,398 20.7 (1.4)   182,191 42.9 (2.9)  
MSA 1,931,797 79.3 (1.8)  721,532 78.9 (1.9) 0.854  344,287 81.1 (2.7) 0.503 
MEDICAID-RELATED           
SSI/TANF 1,012,240 41.5 (1.3)  154,157 16.9 (1.3) <0.001  41,212 9.7 (1.6) <0.001 
Medicaid HMO/MCO 1,424,726 61.3 (1.5)  459,330 50.5 (2.0) <0.001  233,429 55.0 (3.0) 0.064 
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Table 2-4.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
HEALTH-RELATED           
Perceived Health Status      0.144    <0.001 
Fair to Poor 1,314,794 53.9 (1.2)  467,555 51.2 (1.9)   170,598 40.2 (2.5)  
Perceived Mental Health      <0.001    <0.001 
Fair to Poor 821,318 33.7 (1.2)  234,931 25.7 (1.7)   84,716 20.0 (2.2)  
CVD or High-Risk 
Conditions for CVD 
     0.775    0.037 
<1 1,678,222 68.9 (1.1)  640,242 70.1 (1.8)   321,685 75.8 (2.3)  
2 444,995 18.2 (0.8)  163,062 17.8 (1.4)   65,581 15.5 (2.2)  
>3 314,160 12.9 (0.8)  110,621 12.1 (1.3)   37,000 8.7 (1.5)  
Mental/Substance Abuse 
Illnesses 
751,357 30.8 (1.2)  227,885 24.9 (1.6) 0.003  115,891 27.3 (2.4) 0.176 
Respiratory Illnesses 479,702 19.7 (1.1)  117,992 12.9 (1.1) <0.001  39,380 9.3 (1.5) <0.001 
Arthritis/Joint Pain 830,408 34.1 (1.3)  267,358 29.3 (1.7) 0.015  107,575 25.4 (2.4) 0.002 
CCI Score Mean (SE) 1.2 (0.0)   1.1 (0.1)     0.078  0.9 (0.1)  0.003 
Population Size 2,437,378 64.6 (1.0)  913,926 24.2 (0.8)   424,265 11.2 (0.7)  
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Table 2-4.  (Continued) 
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or 
reported having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or 
more cardiovascular disease or associated risk factor comorbidities considered in this study.  
†P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between 
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold 
value of P<0.05.  
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: 
Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health 
maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was 
calculated in this study using the 3-digit ICD-9-CM codes in MEPS). 
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individuals in the Discontinuous–Insured group were more likely to be younger (23.1% 
vs. 15.9% in the 18-34 years age group, P=0.027), less likely to be Non-Hispanic Black 
(18.8% vs. 27.3%, P<0.001) or Hispanic (12.0% vs. 18.3%, P<0.001), more likely to be 
married (43.5% vs. 30.4%, P<0.001), and more likely to reside in the Midwest (27.2% 
vs. 19.6%, P=0.034). Among the socioeconomic characteristics, the Discontinuous–
Insured were more likely to have a college degree (29.1% vs. 9.4%, P<0.001), were more 
likely to have family incomes >125% FPL (68.5% vs. 33.9%, P<0.001), were more likely 
to have intermittent (30.5% vs. 12.4%, P<0.001), or continuous full-year employment 
(42.9% vs. 15.1%, P<0.001). Among the Medicaid eligibility variables it was found that 
the Discontinuous–Insured were less likely to be eligible for SSI due to disability or 
participate in TANF (9.7% vs. 41.5%, P<0.001), however, Medicaid managed care 
enrollment was not statistically significant. When examining the health-related 
characteristics, the Discontinuous–Insured were less likely to report having fair to poor 
health status (40.2% vs. 53.9%, P<0.001), or fair to poor mental health status (20.0% vs. 
33.7%, P<0.001), more likely to have fewer CVD or high-risk conditions for CVD 
(P=0.037) less likely to have respiratory illnesses (9.3% vs. 19.7%, P<0.001), or 
arthritis/joint pain diagnosis (25.4% vs. 34.1%, P=0.002), and had a lower mean CCI 
score [Mean (SE): 0.9 (0.07) vs. 1.2 (0.04), P=0.003] in comparison to the Continuous 
Medicaid group. 
 
 
Characteristics Associated with Medicaid Discontinuity 
 
 The final study sample with non-missing values on all variables, after undergoing 
the listwise deletion process, was 5,738, comprising of 3,859 individuals in the 
Continuous Medicaid group, 1,388 individuals in the Discontinuous–Uninsured group, 
and 491 individuals in the Discontinuous–Insured group. Table 2-5 shows the results of 
the multivariate logistic regression analyses to determine the predictors of Medicaid 
discontinuity among non-elderly adults with CVD or high-risk conditions for CVD. 
 
Discontinuous–Uninsured 
 
When comparing individuals with discontinuous Medicaid coverage with no other 
sources of health coverage (Discontinuous–Uninsured) to those with continuous 
Medicaid coverage (Continuous) group, this study found that among the demographic 
predictors, male respondents had 18% lower odds than females [Odds Ratio (OR): 0.82; 
95% Confidence Interval (CI): 0.68 – 0.98], Non-Hispanic Blacks had a 21% lower odds 
(OR: 0.79, 95% CI: 0.64 – 0.98), and individuals belonging other races had a 43% lower 
odds compared to Non-Hispanic Whites (OR: 0.57, 95% CI: 0.40 – 0.81), married 
individuals had 26% higher odds than respondents who were not married (OR: 1.26, 95% 
CI: 1.03 – 1.55), and individuals living in the South had about 65% higher odds 
compared to the Northeast residents (OR: 1.65, 95% CI: 1.29 – 2.10), of experiencing 
Medicaid discontinuity with no subsequent (or concurrent) sources of health coverage. 
 
Among the socioeconomic predictors of Medicaid discontinuity, this study found 
that individuals with family income levels of >125% FPL had about 23% higher odds  
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Table 2-5. Characteristics Associated with Medicaid Discontinuity in the Study Population 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
DEMOGRAPHIC    
Age    
18 – 34 years 1.00 (Reference)  1.00 (Reference) 
35 – 49 years 1.10 (0.83 – 1.45)  1.12 (0.75 – 1.67) 
50 – 64 years 1.25 (0.92 – 1.69)  0.85 (0.62 – 1.16) 
Gender    
Female 1.00 (Reference)  1.00 (Reference) 
Male 0.82 (0.68 – 0.98)*  0.94 (0.73 – 1.21) 
Race/Ethnicity    
Non-Hispanic White 1.00 (Reference)  1.00 (Reference) 
Non-Hispanic Black 0.79 (0.64 – 0.98)*  0.59 (0.43 – 0.82)** 
Hispanic 1.09 (0.85 – 1.38)  0.65 (0.44 – 0.96)* 
Others 0.57 (0.40 – 0.81)**  1.01 (0.60 – 1.71) 
Marital Status    
Not Married 1.00 (Reference)  1.00 (Reference) 
Married 1.26 (1.03 – 1.55)*  1.50 (1.09 – 2.06)* 
Region    
Northeast 0.86 (0.66 – 1.11)  1.00 (Reference) 
Midwest 1.15 (0.87 – 1.52)  1.46 (0.97 – 2.18) 
South 1.40(1.09 – 1.80)**  1.13 (0.78 – 1.63) 
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Table 2-5.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
West 1.00 (Reference)  0.99 (0.67 – 1.48) 
Family Size  0.94 (0.89 – 1.00)*  0.86 (0.76 – 0.96)* 
SOCIOECONOMIC    
Education    
<High School 1.00 (Reference)  1.00 (Reference) 
High School/GED 1.22 (1.00 – 1.49)  1.77 (1.26 – 2.49)*** 
College Degree 1.05 (0.76 – 1.45)  3.13 (2.16 – 4.53)*** 
Income    
<100% FPL 1.00 (Reference)  1.00 (Reference) 
100 – <125% FPL 1.06 (0.80 – 1.41)  1.21 (0.77 – 1.92) 
>125% FPL 1.23 (1.01 – 1.50)*  2.52 (1.89 – 3.36)*** 
Employment    
Always Unemployed 1.00 (Reference)  1.00 (Reference) 
Unstable Employment 1.92 (1.49 – 2.47)***  3.97 (2.86 – 5.51)*** 
Always Employed 1.23 (0.96 – 1.56)  3.52 (2.47 – 5.01)*** 
MSA    
Non-MSA 1.00 (Reference)  1.00 (Reference) 
MSA 1.08 (0.85 – 1.37)  1.28 (0.85 – 1.92) 
    
    
 27 
Table 2-5.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
MEDICAID-RELATED    
SSI/TANF    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.33 (0.27 – 0.41)***  0.33 (0.21 – 0.51)*** 
Medicaid HMO/MCO    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.61 (0.52 – 0.73)***  0.70 (0.53 – 0.92)* 
HEALTH-RELATED    
Perceived Health Status    
Excellent/Very Good/Good 1.00 (Reference)  1.00 (Reference) 
Fair to Poor 1.25 (1.04 – 1.51)*  1.09 (0.83 – 1.42) 
Perceived Mental Health    
Excellent/Very Good/Good 1.00 (Reference)  1.00 (Reference) 
Fair to Poor 0.83 (0.67 – 1.02)  0.84 (0.60 - 1.17) 
CVD or High-Risk Conditions for 
CVD 
   
<1 1.00 (Reference)  1.00 (Reference) 
2 1.05 (0.84 – 1.32)  0.80 (0.54 – 1.17) 
>3 0.97 (0.69 – 1.36)  0.84 (0.50 – 1.41) 
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Table 2-5.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
Mental/Substance Abuse Illnesses    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.91 (0.73 – 1.15)  1.23 (0.90 – 2.18) 
Respiratory Illnesses    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.72 (0.56 – 0.91)**  0.66 (0.44 – 1.00)* 
Arthritis/Joint Pain    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.97 (0.79 – 1.19)  0.92 (0.67 – 1.27) 
CCI Score  0.99 (0.93 – 1.06)  1.07 (0.98 – 1.18) 
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or reported 
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or more 
cardiovascular disease or associated risk factor comorbidities considered in this study. 
***P-value<0.001, **P<0.01, *P<0.05 for the difference between Continuous Medicaid vs Discontinuous–Uninsured and Continuous Medicaid 
vs Discontinuous–Insured groups 
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: Supplementary 
Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health maintenance 
organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was calculated in this study 
using the 3-digit ICD-9-CM codes in MEPS). 
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(OR: 1.23, 95% CI: 1.01 – 1.50), and individuals with intermittent employment had 
almost two times higher odds compared to the unemployed (OR: 1.92, 95% CI: 1.49 – 
2.47) of belonging to the Discontinuous–Uninsured group. When examining the 
Medicaid-related variables, this study found that SSI due to disability or TANF 
participation was associated with about 67% lower odds (OR: 0.33, 95% CI: 0.27 – 0.41), 
and Medicaid HMO/managed care participation was associated with 39% lower odds 
(OR: 0.61, 95% CI: 0.52 – 0.73) of experiencing Medicaid discontinuity. When 
examining health-related variables, this study found that individuals with respiratory 
illnesses had about 28% lower odds (OR: 0.72, 95% CI: 0.56 – 0.91), and those reporting 
fair to poor health status had about 25% higher odds (OR: 1.25, 95% CI: 1.04 – 1.51) of 
belonging to the Discontinuous–Uninsured group. 
 
Discontinuous–Insured 
 
 When examining the predictors of discontinuous Medicaid coverage who also 
reported having other sources of health insurance coverage (Discontinuous–Insured), this 
study found that among the demographic characteristics, Non-Hispanic Blacks had 41% 
lower odds (OR: 0.59, 95% CI: 0.43 – 0.82), Hispanics had 35% higher odds (OR: 0.65, 
95% CI: 0.44 – 0.96), and married individuals had about 48% higher odds (OR: 1.48, 
95% CI: 1.07 – 2.05) of belonging of the Discontinuous–Insured group. In addition, as 
the number of family members increased by one, the odds of experiencing Medicaid 
discontinuity decreased by about 15% (OR: 0.85, 95% CI: 0.75 – 0.96). 
 
 Among the socioeconomic variables, this study found that individuals with higher 
education had higher odds compared to individuals with no high school education [OR 
(95% CI) for high school/GED: 1.75 (1.25 – 2.46), and OR (95% CI) for College degree: 
3.05 (2.10 – 4.44)], individuals with higher family income had higher odds compared to 
low-income group [OR (95% CI) for >125% FPL: 2.55 (1.91 – 3.41)], and those with 
partial or full-year employment had higher odds [OR (95% CI) for intermittent 
employment: 3.98 (2.87 – 5.54), and OR (95% CI) for always employed: 3.46 (2.42 – 
4.94)] compared to unemployed individuals of belonging to the Discontinuous–Insured 
group. Both the Medicaid-related variables were significant predictors with individuals 
who reported receiving SSI due to disability or TANF participation having 67% lower 
odds (OR: 0.33, 95% CI: 0.21 – 0.51), and those reporting Medicaid HMO/managed care 
participation having about 30% lower odds (OR: 0.70, 95% CI: 0.53 – 0.92) of 
experiencing Medicaid discontinuity. Finally, among the health-related variables, 
individuals who reported having respiratory illnesses had about 35% lower odds (OR: 
0.65, 95% CI: 0.43 – 0.98) of being in the Discontinuous–Insured group. 
 
 
DISCUSSION 
 
 The present study findings highlight the high prevalence of Medicaid 
discontinuity among non-elderly adults with CVD or high-risk conditions for CVD. 
National estimates indicate that of the roughly 4 million individuals who reported having 
CVD or an associated comorbidity in the first round of the MEPS survey and Medicaid at 
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any point in time during the year, a little over 1.3 million had less than full-year Medicaid 
coverage, over 900,000 (or 68.3%) of which did not have any other health insurance 
during the year. To our knowledge, no previous study has stratified the discontinuous 
Medicaid group based on presence (Discontinuous–Insured) or absence (Discontinuous–
Uninsured) other sources of health insurance coverage. On average, the Discontinuous–
Uninsured group in this study was enrolled for about 6.5 months in Medicaid during a 
year. The instability in Medicaid coverage is further highlighted by the finding that of the 
3.1 million individuals (Unweighted frequency = 4,898) who had Medicaid at the 
beginning of the year, a little over 300,000 (or 10%) of these individuals were uninsured 
at the end of the year. When this end-of-the-year insurance status was examined among 
individuals with family income level of <100% of FPL, this study found that of the 1.6 
million individuals who had Medicaid as the year began, over 130,000 (or 8%) of these 
individuals were uninsured as the year ended. Churning in Medicaid, or multiple 
transitions into and out of Medicaid coverage, especially to a state of having no health 
insurance, are a major concern among policymakers and health policy researchers.8,44 
Churning is especially concerning when it results in loss of health insurance. This study 
found that about 17% of the non-elderly adult population with CVD or high-risk 
conditions for CVD experienced more than one transition into or out of Medicaid 
coverage. 
 
 Hypertension, lipid disorders and diabetes, conditions considered significant risk 
factors for CVD, were the most prevalent chronic conditions in this population. Among 
the core CVD conditions, coronary artery disease, MI, and stroke – conditions that exert 
significant morbidity and mortality – were the most prevalent chronic conditions in this 
study.18,21 Hypertension has been well-established as a significant high-risk condition for 
CVD.17,21 This study found hypertension to be the most prevalent chronic condition 
among low-income individuals with CVD or high-risk conditions for CVD. Although 
estimates in the literature indicate the prevalence of CVD in the Medicaid population to 
be over 16 million as mentioned earlier, the lower numbers in this study may indicate 
differences in data source and inclusion criteria of first round-disease reporting to capture 
the chronicity of CVD and associated risk factors. The distribution of these index 
diseases was similar between the continuous Medicaid coverage, and both the 
discontinuous Medicaid groups indicating that Medicaid discontinuity, both with or 
without other sources of health insurance, may be predicted by factors other than 
differences in CVD burden.  
 
Of the two major public health insurance programs in the U.S., Medicaid 
enrollees are more likely to experience discontinuity in their health care coverage in 
comparison to Medicare enrollees, and the prevalence and duration of coverage 
discontinuity are as high as private employer-sponsored insurance among the low-income 
groups.45 Being the primary, means-tested health insurance program for the low-income 
population, small increases in family incomes and assets often render individuals and 
families ineligible for Medicaid based on their state’s Medicaid eligibility criteria. 
However, research has shown that several individuals and families lose Medicaid 
coverage despite being eligible, mainly due to the inability to periodically report changes 
in their income, assets, and residential status, among other information, and often not 
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being able to understand the state Medicaid reenrollment procedures.37,46,47 As shown in 
this study a significant proportion of the discontinuous Medicaid coverage group did not 
report having any other source of health insurance coverage. Overwhelmingly, empirical 
literature suggests uninsured individuals have poor access to care, utilization of health 
care services, unplanned inpatient admissions, and often have poor health outcomes 
compared to the insured populations.10-14,31,32 
 
Among the characteristics significantly associated with discontinuity, Non-
Hispanic Whites had a higher likelihood of experiencing discontinuity compared to 
minorities, which is similar to previous findings. This may be due to the fact that 
minorities are more likely to be eligible for Medicaid due to differential income and 
assets. This is further bolstered by additional findings in this study that those with higher 
education, income levels, and some form of employment during the year; indicators of 
better socioeconomic status; have a higher likelihood of experiencing Medicaid 
discontinuity, which may indicate that race/ethnicity may be impacting discontinuity in 
conjunction with socioeconomic characteristics. Individuals residing in the southern 
geographic region were more likely to report having discontinuous Medicaid coverage 
and no other form of health insurance, which may reflect regional differences in 
Medicaid eligibility criteria and reenrollment procedures.48 Respondents who reported 
having Medicaid through managed care organizations had significantly lower likelihood 
of experiencing discontinuity in their Medicaid coverage which may be due to better 
outreach efforts to ensure continued enrollment among their plan members compared to 
the traditional state fee-for-service Medicaid programs.38 
 
As of April 2015, thirty states, including the district of Columbia (D.C.) have 
moved forward to expand their state Medicaid programs in accordance with the 
regulations under the 2014 Patient Protection and Affordable Care Act (ACA), that 
stipulate States to provide Medicaid coverage to residents with incomes at or below 138 
percent of FPL, irrespective of marital or parenthood status.49 In addition, the health law 
stipulated the creation of health insurance marketplaces in each state, known as the health 
exchanges, as a one-stop shop for state residents and employers to purchase health 
insurance plans. Individuals with incomes between 138 – 400 percent of FPL, who do not 
meet the Medicaid eligibility criteria under the expansion provision (in states not 
expanding Medicaid, the range is 100 – 400 percent of FPL) would receive subsidies to 
purchase private plans from the health exchanges.50 These measures intended to expand 
coverage to hitherto uninsured and underinsured individuals and families may decrease 
the uninsured rate, but research suggests that the problems of Medicaid coverage 
transitions may continue to persist. Research suggests that among states not expanding 
Medicaid, the problems of losing Medicaid coverage to become uninsured will continue 
to exist, since upward income mobility would need to be significant for individuals to 
qualify for private insurance subsidies that will kick in above the 138 percent of FPL 
threshold. However, among states that do expand Medicaid, the problems of transitions 
from Medicaid to subsidized private insurance exchanges and/or back will also exist.51,52 
 
When individuals lose Medicaid coverage to become uninsured, and especially 
when they are eligible for Medicaid, it is considered a policy failure, and the resulting 
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lack of insurance may have significant adverse health outcomes.34 However, when 
individuals transition from one source of coverage to another, continuity of care may still 
be impacted, especially since different insurance plans have different network of 
providers, and differing benefit structures, and may cover different classes of medications 
and services. This study showed that over a quarter of the CVD population with 
discontinuous Medicaid coverage belonged to the Discontinuous–Insured group who 
reported having less than six months of Medicaid coverage, and were uninsured for a 
little over a month, on average. This may exert additional burden on individuals and 
families of taking out time and effort to sign up for other sources of health care coverage 
that includes providing the necessary documents for enrollment and may also temporarily 
disrupt continuity of care in this population. 
 
Policymakers debating measures to ensure continuity in Medicaid among non-
elderly adults should especially include populations with chronic and debilitating 
conditions such as CVD and associated risk factors in all such discussions, since the 
detrimental effects of coverage discontinuity and resultant disruptions in continuity of 
care may be amplified in such population groups. Moreover, outreach and reenrollment 
strategies employed by Medicaid managed care organizations can be adopted by 
traditional state Medicaid plans. In addition, expanding the penetration of managed care 
in Medicaid can also be an alternative to enable states to strike a balance between tight 
fiscal spending and increased and continued Medicaid enrollment. Health care providers 
and their staff in the meanwhile can play a major role by informing, encouraging, and if 
possible assisting, low-income patients with CVD, their risk factors, or disability, to sign-
up and maintain their enrollment in Medicaid through periodic reporting as per the state’s 
requirements. In a survey conducted for the Centers for Medicare and Medicaid Services 
(CMS), more than half of the respondents indicated that they would trust a doctor when 
making a decision to enroll in Medicaid or CHIP, and about 50 percent preferred getting 
Medicaid/CHIP-related information at the doctor’s office.53 
 
As with all observational research, this study is not without its limitations. State-
level Medicaid eligibility data was not available to explore the complex and dynamic 
patterns of discontinuity that may differ based on the state’s eligibility and reporting 
criteria. Nonetheless, the finding of individuals residing in the south having greater 
likelihood of discontinuity may have captured some of the regional variations in 
Medicaid policies, and future research with state-level data may better account for these 
differences. This study only explored associations between individual characteristics and 
Medicaid discontinuity, and not causality, and the findings only explore predictors of 
within-year discontinuous Medicaid coverage and may not capture risk factors for secular 
trends in Medicaid discontinuity. The regression analyses may not have adjusted for 
unobserved covariates that may have confounded the impact of certain risk factors on the 
likelihood of belonging to the Discontinuous–Uninsured or the Discontinuous–Insured 
groups.  
 
Limitations of small sample size due to the focus of this study on individuals with 
CVD or high-risk conditions for CVD, and not the entire Medicaid population, prevented 
us from imputing Medicaid eligibility and obtaining robust estimates of Medicaid 
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discontinuity predictors in this imputed subpopulation. Nonetheless, these findings have 
highlighted significant prevalence of overall discontinuous Medicaid coverage, and future 
studies with higher sample sizes of the CVD population can further explore predictors of 
Medicaid discontinuity separately among those losing eligibility due to upward income 
mobility, and those dropping out of Medicaid despite being eligible. Data in MEPS are 
self-reported, so the estimates may not exactly reflect the national estimates of Medicaid 
discontinuity. Researchers have speculated that most surveys underestimate the number 
of Medicaid enrollees due to a variety of reasons including stigma of public insurance. 
However, such misreporting is less of a problem for MEPS compared to other federal 
health surveys.54 Finally, findings from this study are representative of the non-
institutionalized civilian population and may not be applicable to individuals with 
prolonged hospitalizations or admitted to long-term care facilities. 
 
 
CONCLUSION 
 
 The present study highlights the prevalence of Medicaid discontinuity among 
non-elderly adults with CVD or high-risk conditions for CVD and finds that a high 
proportion of individuals with less than full-year Medicaid coverage do not have any 
other source of health insurance. Women, individuals with higher education and income, 
those residing in the South census region, and those perceiving their health to be fair or 
poor may be at higher risk for Medicaid discontinuity. Medicaid managed care enrollees 
may have lower risk for Medicaid discontinuity. Outreach and reenrollment strategies 
employed by such managed care organizations can be adopted by state Medicaid agencies 
to improve Medicaid uptake, continuity and reenrollment, especially for enrollees with 
chronic conditions such as CVD or high-risk conditions for CVD. Discussions regarding 
policies to improve retention of and continuity in Medicaid must include individuals 
suffering from these chronic and debilitating disease conditions whose continuity of care 
may be adversely impacted due to such coverage instability. Low-income adults 
managing chronic conditions, especially in regions with stringent Medicaid eligibility 
regulations, must be encouraged to ensure continuity of Medicaid coverage. 
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CHAPTER 3.    ASSOCIATIONS BETWEEN MEDICAID DISCONTINUITY, 
MEDICATION ADHERENCE AND MEDICATION UTILIZATION AMONG 
ADULTS WITH CARDIOVASCULAR DISEASE OR ASSOCIATED HIGH-RISK 
CONDITIONS 
 
 
BACKGROUND 
 
 Cardiovascular disease (CVD) along with conditions that are risk factors for 
CVD, such as diabetes and chronic kidney disease, are some of the most common causes 
of death, both regionally and globally.16,17,55 Randomized studies and guidelines have 
established the importance of lowering blood pressure, cholesterol, or blood sugar levels, 
along with lifestyle changes such as smoking cessation, in order to reduce morbidity and 
mortality associated with CVD or high-risk conditions for CVD.56,57 Nevertheless, 
management of the chronic risk factor conditions has been suboptimal.58-60 
Pharmacotherapy is essential to appropriately treat these chronic conditions and achieve 
and maintain the guidelines-recommended target levels for blood pressure, blood sugar, 
and cholesterol. Inability to obtain or consume medications necessary to avoid risk for 
chronic, debilitating conditions such as CVD may have detrimental outcomes among 
individuals who are at risk for these conditions. 
 
 Medicaid plays a pivotal role in providing access to care for individuals with low 
incomes, and disabilities. Among non-elderly adult Medicaid enrollees, the prevalence of 
chronic conditions is high and many have complex health care needs due to existing 
comorbid conditions, such as mental, and respiratory illnesses.30 Prevalence of CVD or 
high-risk conditions for CVD among Medicaid enrollees is high; an estimated 28% of 
enrollees are diagnosed with CVD, 24% with high blood pressure, 17% with high 
cholesterol, and 9-15% with diabetes.21,22 Due to this high chronic disease burden, adult 
Medicaid enrollees have high health care needs, and need the resources to effectively 
manage their chronic conditions.30 However, means-tested health insurance programs 
such as Medicaid have their own set of eligibility criteria and enrollment procedures, 
which vary from state to state,6 and it is critical for individuals and families to be 
cognizant of these policies and procedures to enroll in, and maintain eligibility, programs 
such as Medicaid. Small fluctuations in income levels for covered non-elderly adults due 
to increases in pay or work hours, would end up disqualifying individuals with incomes 
at or near eligibility thresholds. The rules and regulations for eligibility and enrollment 
between public and private health insurance are different, and therefore, individuals who 
have to transition between one system to another also experience gaps in insurance 
coverage, either due to failure to follow enrollment procedures, or being unaware of such 
an option, or even due to the stigma of enrolling for Medicaid or other low-income public 
programs. It is broadly due to these factors in this fragmented health insurance system, 
that individuals and families experience insurance instability and they continue to swing 
into and out of various types of health insurance coverage. 
 
 Instability in Medicaid coverage may not only impact utilization of prescription 
medications due to access issues, but may also affect adherence of these medications as 
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prescribed by health care providers. Adherence to evidence-based cardiovascular 
medications is essential for attaining therapeutic goals, in order to achieve favorable 
health outcomes.61-64 Suboptimal adherence may have detrimental consequences even 
among non-elderly adults with multiple chronic conditions and comorbidities, who often 
require multiple medications to manage their disease conditions.65,66 Policies to ensure 
higher retention of Medicaid-eligible needy individuals and continuity in Medicaid 
coverage, along with seamless transition from Medicaid to other insurance coverage 
sources must be a priority for policymakers and other stakeholders, including health care 
providers. Pharmacotherapy may become one of the first casualties of loss of Medicaid 
coverage, since out-of-pocket costs have been found to be one of the most significant 
barriers to medication adherence and utilization. 
 
 Empirical studies examining the impact of lack of insurance coverage continuity 
on medication adherence among individuals with CVD or high-risk conditions for CVD 
is lacking. Among the few studies examining impact of discontinuous Medicaid coverage 
on medication utilization in general, or focusing on other disease conditions, there is a 
general agreement that having instability in coverage has an adverse impact on obtaining 
needed medications to manage chronic diseases.15,32,67 In intending to strengthen the 
literature on Medicaid coverage discontinuity by highlighting the association between 
discontinuous Medicaid coverage and pharmacotherapy outcomes among the CVD 
population, this study has the following two objectives: (1) examine whether having 
discontinuous Medicaid coverage is associated with poor adherence to commonly 
prescribed therapeutic drug classes, and (2) examine whether discontinuous Medicaid 
coverage is associated with low prescription drug utilization. 
 
 
METHODS 
 
 
Data Source 
 
The present study is a retrospective cross-sectional comparative analysis of the 
Medical Expenditure Panel Survey (MEPS). MEPS is a set of large-scale surveys of 
families, individuals, their medical providers and employers across the United States. It is 
jointly sponsored by the Agency for Healthcare Research and Quality (AHRQ) and the 
National Center for Health Statistics (NCHS), and has been conducted annually since 
1996. It has two major components; the Household Component (HC), the Insurance 
Component, with data on medical providers in the HC being supplemented by the 
Medical Provider Component. MEPS collects detailed information from a nationally 
representative sample of the civilian noninstitutionalized population of the U.S. on health 
services utilization and health expenditures, insurance coverage, and sources of payment. 
 
MEPS has an overlapping panel design. Two separate panels of respondents are 
interviewed simultaneously during a calendar year. A new panel of sample households is 
selected each year, and data for each panel are collected for two calendar years. The two 
years of data for each panel are collected in five rounds of interviews that take place over 
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a two and a half year period. This provides continuous and current estimates of health 
care expenditures at both the person and household level for two panels for each calendar 
year. By combining data from the overlapping panels, these annual files provide nearly 
double the sample size of individual panels and cover the entire calendar year for each 
respondent. Although all MEPS data are reported by respondents during computer-
assisted personal interviewing, further detailed health service use data, including on 
prescription drugs, are collected from a sample of providers with respondents’ 
permission.39 
 
When obtaining national estimates from surveys such as MEPS, appropriate 
sample size is critical to obtain reliable estimates, since estimates of some population 
subgroups may vary from year to year. The advantage of survey such as MEPS is that 
they allow for several years’ of data to be pooled together in order to increase the sample 
size and improve the precision of estimates. The pooling of the different years of data 
was conducted in accordance with the guidelines provided by MEPS, and data for the 
years 2002 – 2011 were pooled together to allow for a sufficiently large sample size to 
ensure reliable estimates.  
 
 
Study Population 
 
The broad classification of “cardiovascular disease (CVD) and associated 
comorbidities” in this study consisted for the following disease conditions: acute 
myocardial infarction (Clinical Classification code (CCC): 100), coronary artery disease 
(CCC: 101), congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis 
(CCCs: 114, 115, 116), stroke (CCCs: 109, 112), hypertension (CCC: 098), lipid 
disorders (CCC: 053), and diabetes (CCC: 049, 050). CCC aggregates conditions and 
procedures into mutually exclusive and clinically homogeneous categories, using Clinical 
Classification Software.40 When examining utilization of prescription medications in the 
form of number of medication refills, the study population included respondents who 
were: (1) aged 18 to 64 years, (2) reported either being diagnosed with CVD or high-risk 
conditions for CVD for CVD in their first round of the MEPS survey, or reported having 
an event (an inpatient, emergency, outpatient, or office-based provider visits, or a 
prescription medication) associated with one or more of the aforementioned disease 
conditions at any point of time during the survey, (3) reported having had Medicaid 
coverage at any point of time during the survey year, and (4) had positive person weights, 
and were interviewed for all five rounds of the 2-year MEPS survey interviews. When 
examining adherence to commonly prescribed medication classes for managing the CVD 
and associated risk factor comorbidities listed above, an additional inclusion criteria was 
considered: (5) respondents who had one or more fills or refills for the following 
therapeutic drug classes – angiotensin converting enzymes inhibitors (ACEI), angiotensin 
II receptor blockers (ARB), beta blockers, calcium channel blockers, diuretics, anti-
hypertensive drug combinations, HMG-CoA reductase inhibitors (statins), sulfonylureas, 
and biguanides.  
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Respondents who reported having Medicare, or pregnancy were excluded from 
this study. Pregnant women with incomes at or below 133 percent of the federal poverty 
level are eligible for Medicaid coverage throughout the pregnancy; however, the 
coverage ceases 60 days postpartum.68 Low-income non-elderly adults with disabilities 
are also eligible for Medicare if they have received monthly social security disability 
income for two years. Most coverage benefits for prescription drugs for dual eligible 
beneficiaries are covered by Medicare Part D, instead of Medicaid. As a result, these two 
population groups were excluded from this study. 
 
Individuals who have less than a year of Medicaid coverage and experience 
within-year Medicaid discontinuity may not be a homogenous group, especially when 
they report having other forms of insurance coverage during the year. In order to account 
for these differences, individuals in the study population who reported having <12 
months of Medicaid coverage during a survey year were divided into two groups: (1) 
individuals with <12 months of Medicaid coverage who did not report any other sources 
of health insurance during the survey year, designated in this study as ‘Discontinuous–
Uninsured’, and (2) individuals with <12 months of Medicaid coverage who also reported 
having other source(s) of health insurance during the survey year (either private, Tricare, 
or any hospital- or physician group-based health insurance), designated in this study as 
‘Discontinuous–Insured’. Individuals in the study population who reported having 
Medicaid coverage during all 12 months of a survey year were classified as having 
continuous Medicaid coverage, which was the comparison group and designated as 
‘Continuous Medicaid’ in this study.  
 
 
Study Variables 
 
Our first objective was to examine whether Medicaid discontinuity was associated 
with adherence to commonly prescribed classes of medications among non-elderly adults 
with CVD or its associated risk factor comorbidities. The primary outcomes of interest 
was the binary indicator for medication adherence measured as the medication possession 
ratio (MPR), or the proportion of days during the survey year during which respondents 
had medications on hand. In the subsequent section, we describe how adherence was 
measured for this study. The second objective was to examine whether Medicaid 
discontinuity impacts medication utilization. The primary outcome of interest for this 
objective was the raw number of refills for all medications reported by the study 
respondents. We divided this utilization measure into all-cause, and disease-specific 
medication utilization, i.e. number of refills for all medications reported by the study 
respondents in the survey year (all-cause), and the number of refills for medications 
specifically prescribed for CVD or high-risk conditions for CVD for CVD that were 
examined in this study (disease-specific). 
 
All regression models included the following classes of covariates:-  
 
1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity 
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital 
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status (not married vs. married), family size (N), and geographic residence 
(Northeast vs. Midwest, South, and West). 
2) Socioeconomic covariates: education (less than high school vs. high school/GED, 
and Bachelor’s or higher), income as a percentage of the federal poverty level 
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always 
unemployed vs. intermittent employment, and always employed), binary indicator 
for Metropolitan Statistical Area (MSA) residence. 
3) Medicaid-related covariates: binary indicator for Supplementary Security Income 
(SSI) for disability receipt or participation in the Temporary Assistance for Needy 
Families program, and a binary indicator for Medicaid HMO/Managed Care 
participation. 
4) Health-related covariates: perceived health status (excellent/very good/good vs. 
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor) 
binary indicator for mental illness/substance abuse diagnosis, binary indicator for 
respiratory diseases diagnosis, binary indicator for arthritis/joint pain diagnosis, 
and Charlson Comorbidity Index (CCI) score. 
 
When examining medication adherence, the regression models included the 
following additional covariates: 
 
5) Medication-related covariates: number of unique prescription medications 
reported by the study respondents (N), and a binary indicator for whether 
individuals had a 90 days’ supply of medications. 
 
All regression models included the year fixed effects to capture any macro-level 
variations during the study period. SAS 9.3 and STATA 13 were used. 
 
 
Measurement of Adherence  
 
The measurement of adherence in this study involved several intermediate steps. 
From the Prescribed Medicines files in MEPS, this study used the drug refill records for 
each study respondent, to estimate adherence to each medication class during the year 
when the respondents had refills for any medication from that class of medication. Of the 
two most common measures of adherence, medication possession ratio (MPR) and 
proportion of days covered (PDC), this study used the MPR measure.69,70 Using an 
interval-based MPR measure approach, the denominator for this measure was the number 
of days between the index date, which was first day of the round in which the first fill or 
refill of a class of drug (e.g. beta blockers) was reported, and the last day of the survey 
year, i.e. December 31st. The numerator is the total number of days covered by drug fills 
during the denominator duration, i.e. the total days’ supply for that particular class of 
medication within the follow-up (denominator) period. Equation 3-1 displays the 
average MPR estimation: 
 
∑                       total Rx days of supplyn                        (Eq. 3-1) 
Intervaln (round date for first Rx during year – December 31)    n 
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As mentioned earlier, the proportion of the total days’ supply for a therapeutic 
class of medication was estimated within the follow-up interval reported by an individual. 
Depending on the number of therapeutic classes reported by each individual, the MPR 
was estimated for each class and summed, and then divided by the number of therapeutic 
classes reported by individuals (n) to obtain an average MPR measure for that individual. 
This enables capturing non-adherence, since any discontinuation in the drug refill will be 
captured in the calculation as it tracks adherence till the end of the duration and not the 
last drug refill during the measurement period, as is common with the standard measures 
of MPR.69 All MPR measures were expressed as a percentage and capped at 100% (or 
1.0). Drugs that were dispensed within a therapeutic class (e.g. switching from carvedilol 
to propranolol among beta blockers) were considered interchangeable.69 ACEI and ARBs 
were considered a single class for this study. 
 
More than 90% of index refills had occurred in the first two rounds of the 
calendar year. The drug class-specific MPRs that were obtained were summed, and an 
overall average MPR measure was calculated to summarize adherence to all drug classes 
an individual was taking. In order to make policy-relevant conclusions about the impact 
of insurance discontinuity on medication adherence, the continuous MPR measure was 
transformed into a binary MPR measure, with a cutoff of 80% (0.8) or more signifying 
adequate adherence to prescribed medications examined in this study. The main outcome 
variable was the overall binary MPR measure. Class-specific MPR adherence measures 
were examined in secondary analyses. 
 
Prior to 2010, MEPS did not report data on days’ supply for the prescription 
medications reported by the respondents during the survey year. Previous studies have 
overcome this shortcoming, by developing algorithms for days’ supply based on the 
quantity of drug dispensed using data from administrative claims, or other similar 
sources. A similar approach was applied; however, rather than using an external source of 
data, the 2010 and 2011 MEPS prescription medication data that had the days’ supply 
information was used to develop an algorithm that approximates days’ supply for 
previous years in MEPS based on their quantity prescribed/dispensed, which was 
available for all the 10 years in MEPS. The most frequent number of supply days 
furnished by each level of dispensed quantity was first identified, and found that 30, and 
90 days’ supply were the most common patterns observed for most quantities dispensed. 
After deriving a method to smoothly approximate the distribution of the days’ supply, the 
days of supply were categorized using different sets of categories. The third 
categorization algorithm was found to have the highest correlation with the actual MPR 
measures, both continuous and binary, which were calculated using the days’ supply 
variables from 2011 and 2010 years of MEPS data, separately as displayed in Table 3-1 
and Table 3-2. Finally, using this algorithm, the MPR adherence measures for all years 
prior to 2010 were calculated to obtain overall estimates of medication adherence. 
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Table 3-1. Refill Days of Supply Algorithms and MPR Validation in 2011 Sample (N= 5,475) 
 
    
Continuous MPR 
Measure 
Pearson’s 
Correlation 
 Binary MPR Measure 
Categorization Quantity 
Dispensed 
Corresponding 
Days’ Supply 
Algorithm 
 Observed 
Agreement (%) 
κ- Statistic 
Categorization 1 <75 30 0.868  0.925 0.841*** 
 >75 90     
       
Categorization 2 <50 30 0.881  0.931 0.854*** 
 >50 – <80 60     
 >80 90     
       
Categorization 3 <44 30 0.889  0.934 0.864*** 
 45 90     
 >45 – <75 30     
 >75 – <119 90     
 120 30     
 >120 90     
 
MPR: Medication Possession Ratio 
***P<0.001. The null hypothesis for estimating kappa statistic is that there is no agreement between the two discrete measures of 
MPR. 
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Table 3-2. Refill Days of Supply Algorithms and MPR Validation in 2010 Sample (N= 5,058) 
 
    
Continuous MPR 
Measure 
Pearson’s 
Correlation 
 Binary MPR Measure 
Categorization Quantity 
Dispensed 
Corresponding 
Days’ Supply 
Algorithm 
 Observed 
Agreement (%) 
κ- Statistic 
Categorization 1 <75 30 0.835  0.918 0.827*** 
 >75 90     
       
Categorization 2 <50 30 0.856  0.876 0.747*** 
 >50 – <80 60     
 >80 90     
       
Categorization 3 <44 30 0.868  0.924 0.841*** 
 45 90     
 >45 – <75 30     
 >75 – <119 90     
 120 30     
 >120 90     
 
MPR: Medication Possession Ratio 
***P<0.001. The null hypothesis for estimating kappa statistic is that there is no agreement between the two discrete measures of 
MPR. 
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Statistical Analysis 
 
Bivariate statistics were conducted when examining the characteristics of the 
study population. Survey-weighted proportions of the use of different classes of 
medications examined in this study were calculated. When examining medication 
adherence, Survey-weighted multivariate logistic regression analyses were conducted. 
Equation 3-2 and Equation 3-3 depict the logistic regression models to examine 
adherence among both the Discontinuous–Uninsured, and the Discontinuous–Insured 
groups relative to the Continuous Medicaid insurance group. 
 
Pr[MPR>0.8|x] = F-1(?? ? ???? ????????????? ? ????????? ?? ???
?
??? ??)   (Eq. 3-2) 
 
Pr[MPR>0.8|x] = F-1(?? ? ???? ????????????? ? ??????? ?? ???
?
??? ??)        (Eq. 3-3) 
 
 Medication adherence is modeled as a dichotomous outcome variable as a 
function of Medicaid discontinuity as well as the demographic, socioeconomic, 
eligibility, health-related, and medication-related covariates mentioned above. F-1 denotes 
the inverse of the cumulative standard logistic distribution function that relates the 
outcome on the probability scale to the covariates. Pr[ ] denotes the population average 
probability of adherence to medications conditional on the covariates denoted by x. 
Discontinuous–Uninsured and Discontinuous–Insured are binary indicator variables for 
the main independent variable of interest, that equals one for individuals having 
discontinuous annual Medicaid coverage without any other sources of insurance and with 
other sources of insurance during the year, respectively, and equals zero for the 
comparison group of individuals with continuous Medicaid coverage. X denotes the 
vector of aforementioned individual characteristics that predict Medicaid discontinuity in 
the two population groups of interest. 
 
 When examining all-cause and disease-specific medication utilization using the 
number of prescription drug fills as the outcome, the negative binomial regression model 
was utilized due to the skeweness in the distribution exhibited by the outcomes measures. 
Appendix A, Figures A-1 to A-4, display the distribution in the all-cause and disease-
specific prescription drug utilization outcome measures. It is a type of generalized linear 
model where the dependent variable Y is a count of the number of times an event occurs 
(in this case, the number of drug fills). A convenient parameterization of the negative 
binomial distribution is denoted by Equation 3-4.71  
 
???? ? ??? ? ?? ?
???????
???????????
? ?
????
?
???
? ??
????
?
?
 (Eq. 3-4) 
 
In Equation 3-4, μ>0 is the mean of Y, which is the count variable indicating the 
number of prescription drug fills (either all-cause, or disease-specific) and α>0 is the 
heterogeneity parameter. It can be derived as a Poisson-gamma mixture, or as the number 
of failures before the (1/α)th success. A simpler depiction of the traditional negative 
binomial regression model, the NB2 model is depicted is depicted in Equation 3-5 and 
Equation 3-6 as follows: 
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?? ?????????? ? ?? ? ??????????????? ? ?????????? ? ??? ?? ? ?? ??? ??  (Eq. 3-5)  
 
?? ????????????????? ? ?? ? ??????????????? ? ?????????? ? ??? ?? ? ?? ??? ??   
                 (Eq. 3-6) 
 
Apart from the main indicator variables for the Discontinuous–Uninsured group, 
the covariates ?? to ?? are known, and the population regression coefficients ?? to ?? are 
to be estimated. The two equations above depict the negative binomial regression models 
to estimate the differences in all-cause prescription drug utilization (Equation 3-5), and 
disease-specific prescription drug utilization (Equation 3-6) between the Continuous 
Medicaid, and Discontinuous–Uninsured groups. Similar regression models (not shown 
here) were run to estimate differences in prescription drug utilization between the 
Continuous Medicaid and Discontinuous–Insured groups. The coefficient of interest for 
the Discontinuous–Uninsured is the measure of differences in the utilization of overall, 
and disease-specific drug utilization. Because of the functional form of the negative 
binomial regression, the effect size of a factor is the antilog of its coefficient. This 
estimated coefficients are transformed to obtain the incidence rate ratio (IRR). An IRR of 
less than one for the discontinuous Medicaid groups would suggest lower medication 
utilization among them when compared to their counterparts with continuous Medicaid 
coverage. 
 
In addition to obtaining IRRs, this study further estimated the average marginal 
effect to determine the predicted difference in the number of all-cause and disease-
specific prescription drug fills between the continuous and discontinuous Medicaid 
groups. The marginal effects measure the discrete change in the outcome variable, i.e. for 
a binary independent variable, how do predicted probabilities change as the binary 
independent variable changes from 0 (Continuous Medicaid) to 1 (Discontinuous–
Uninsured, or Discontinuous–Insured).72 In order to obtain these marginal effects, after 
developing and running the multivariate negative binomial regression model, the 
estimated coefficients of the model were used to calculate two predicted prescription drug 
fills for all individuals in the study population. The first predicted utilization assumed all 
individuals had discontinuous Medicaid coverage (by setting the Medicaid discontinuity 
indicator variable to 1), and the second predicted utilization assumed all individual to 
have continuous full-year Medicaid coverage (by setting the Medicaid discontinuity 
indicator variable to 0). The average per-person difference in prescription drug fills 
attributable to Medicaid coverage was estimated by obtaining the difference in predicted 
drug utilization for each person and computing the weighted average of the difference 
across the entire study sample. All data analyses were conducted using SAS 9.3 and 
STATA 13 to account for the complex survey design of MEPS. 
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RESULTS 
 
 
Characteristics of the Study Populations 
 
 The characteristics of the study population when examining adherence to 
commonly prescribed medications to manage CVD or high-risk conditions for CVD, and 
when examining utilization of prescription medications, are displayed in Table 3-3 and 
Table 3-4, respectively. The study sample when examining overall medication adherence 
included 3,210 respondents in the Continuous Medicaid coverage group (nationally 
representative of about 2 million individuals), 1,088 individuals in the Discontinuous–
Uninsured group (nationally representative of over 700,000 individuals), and 388 
individuals in the Discontinuous–Insured group (nationally representative of over 
300,000 individuals). When examining utilization of prescription medications in the 
study population, the study sample included 3,926 respondents in the Continuous 
Medicaid coverage group (nationally representative of about 2.4 million individuals), 
1,407 individuals in the Discontinuous–Uninsured group (nationally representative of 
over 900,000 individuals), and 493 individuals in the Discontinuous–Insured group 
(nationally representative of over 400,000 individuals). The difference being, when 
examining medication adherence there was an additional inclusion criteria; the study 
population consisted of individuals who reported taking one or more of the eight classes 
of medications for which adherence was examined.  
 
When examining medication adherence (Table 3-3), in comparison to the 
Continuous Medicaid group, individuals in the Discontinuous–Uninsured group were less 
likely to belong to other race groups (P=0.016), and more likely to be married (P<0.001), 
and were more likely to belong to the South geographic region (P=0.010). Among the 
socioeconomic covariates, this study found that respondents were more likely to have 
completed high school/GED or college (P=0.006), were more likely to have family 
incomes >125% FPL (P<0.001), and more likely to have intermittent, as well as 
continuous full-year employment (P<0.001). Respondents were less likely to be eligible 
for SSI due to disability or participate in TANF (P<0.001), and less likely to report 
Medicaid HMO/managed care (P<0.001). Among the health-related variables, 
respondents were less likely to report having fair or poor perceived mental health status 
(P=0.001), less likely to report having mental /substance abuse illnesses (P=0.014), and 
less likely to report having respiratory illnesses (P<0.001). The mean CCI score was not 
significantly different between the two groups (P=0.181). When examining the 
medication-related variables, this study found that although the Discontinuous–Uninsured 
group on average were prescribed fewer medications than the Continuous Medicaid 
group (7.6 vs. 9.1 medications, P<0.001), and both groups had similar proportion of 90 
days’ supply for their medications (P=0.242). 
 
When comparing the Discontinuous–Insured group to the Continuous Medicaid 
group, this study found that among the demographic covariates, individuals in the 
Discontinuous–Insured group were more likely to be younger (P=0.034), were less likely 
to belong to minority race/ethnicity groups (P<0.001), more likely to be married 
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Table 3-3. Study Population Characteristics when Examining Medication Adherence 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
DEMOGRAPHIC           
Age      0.876    0.014 
18 – 34 years 248,650 12.5 (0.9)  93,295 13.1 (1.3)   65,519 19.6 (2.4)  
35 – 49 years 669,245 33.8 (1.3)  242,313 34.2 (2.1)   100,718 30.1 (3.0)  
50 – 64 years 1,065,905 53.7 (1.4)  373,450 52.7 (2.3)   168,190 50.3 (3.3)  
Gender      0.939    0.190 
Female 1,334,759 67.3 (1.3)  475,870 67.1 (2.0)   210,679 63.0 (3.2)  
Race/Ethnicity      0.016    <0.001 
Non-Hispanic White 894,528 45.1 (1.9)  336,390 47.4 (2.3)   211,937 63.4 (3.3)  
Non-Hispanic Black 562,325 28.3 (1.5)  183,702 25.9 (1.9)   64,835 19.4 (2.2)  
Hispanic 341,418 17.2 (1.2)  145,309 20.5 (1.6)   34,802 10.4 (1.6)  
Others 185,529 9.4 (0.9)  43,657 6.2 (1.0)   22,852 6.8 (1.5)  
Marital Status      <0.001    <0.001 
Married 602,503 30.4 (1.4)  271,354 38.3 (2.1)   154,101 46.1 (3.6)  
Region      0.064    0.040 
Northeast 481,061 24.3 (1.7)  141,392 19.9 (2.0)   82,125 24.5 (3.1)  
Midwest 393,671 19.8 (1.4)  139,468 19.7 (1.8)   92,872 27.8 (4.0)  
South 607,916 30.6 (1.7)  255,996 36.1 (2.0)   76,828 23.0 (2.7)  
West 501,152 25.3 (1.7)  172,201 24.3 (2.0)   82,602 24.7 (3.4)  
Family Size Mean (SE) 2.7 (0.1)   2.8 (0.1)   0.532     2.8 (0.1)        0.449 
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Table 3-3.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted 
N 
% (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
SOCIOECONOMIC           
Education      0.006    <0.001 
<High School 776,408 39.5 (1.5)  226,415 32.2 (1.9)   51,716 15.5 (2.1)  
High School/GED 997,819 50.7 (1.4)  392,411 55.7 (2.2)   176,153 52.8 (3.6)  
College Degree 193,484 9.8 (0.8)  85248 12.1 (1.6)   105,631 31.7 (3.6)  
Income      <0.001    <0.001 
<100% FPL 1,113,782 56.1 (1.3)  324,544 45.8 (2.0)   74,686 22.3 (2.3)  
100 – <125% FPL 185,942 9.4 (0.6)  69,730 9.8 (1.2)   24,692 7.4 (1.5)  
>125% FPL 684,076 34.5 (1.2)  314,784 44.4 (2.1)   235,048 70.3 (2.8)  
Employment      <0.001    <0.001 
Always Unemployed 1,468,299 74.0 (1.3)  399,549 56.3 (2.0)   91,161 27.3 (2.5)  
 Unstable Employment 231,945 11.7 (0.9)  165,706 23.4 (1.9)   102,142 30.5 (2.9)  
Always Employed 283,555 14.3 (1.0)  143,803 20.3 (1.5)   141,123 42.2 (3.2)  
MSA 1,564,442 78.9 (1.8)  552,171 77.9 (2.0) 0.651  267,784 80.1 (2.7) 0.696 
MEDICAID-RELATED           
SSI/TANF 852,158 43.0 (1.5)  127,179 17.9 (1.5) <0.001  30,671 9.2 (1.8) <0.001 
Medicaid HMO/MCO 1,139,857 60.4 (1.6)  354,416 50.3 (2.1) <0.001  180,662 54.0 (3.4) 0.077 
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Table 3-3.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
HEALTH-RELATED           
Perceived Health Status      0.050    <0.001 
Fair to Poor 1,112,169 56.1 (1.4)  366,568 51.7 (2.1)   140,242 41.9 (2.8)  
Perceived Mental Health      0.001    <0.001 
Fair to Poor 670,915 33.9 (1.4)  189,140 26.7 (1.9)   62,634 18.7 (2.4)  
CVD or high-risk 
conditions for CVD 
     0.998    0.066 
<1 1,281,387 64.6 (1.3)  457,590 64.5 (2.0)   240,536 71.9 (2.7)  
2 400,899 20.2 (0.9)  144,019 20.3 (1.6)   58,036 17.4 (2.5)  
>3 301,513 15.2 (1.0)  107,449 15.2 (1.5)   35,854 10.7 (1.5)  
Mental/Substance Abuse 
Illnesses 
606,104 30.6 (1.4)  177,733 25.1 (1.8) 0.014  94,737 28.3 (2.8) 0.463 
Respiratory Illnesses 394,992 19.9 (1.2)  87,482 12.3 (1.2) <0.001  32,380 9.7 (1.8) <0.001 
Arthritis/Joint Pain 693,646 35.0 (1.4)  221,951 31.3 (1.9) 0.073  97,019 29.0 (3.0) 0.073 
CCI Score Mean (SE) 1.2 (0.0)   1.1 (0.1)  0.181  1.1 (0.1)  0.058 
Population Size 1,983,799 65.5 (1.1)  709,058 23.4 (0.9)   334,426 11.1 (0.8)  
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Table 3-3.  (Continued) 
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or 
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-
risk conditions for CVD, had <1 month of Medicaid coverage during the survey year, and who consumed one or more medications from the 
following therapeutic drug classes: ACEI/ARB, beta blockers, calcium channel blockers, diuretics, anti-HTN combinations, statins, 
sulfonylureas, and biguanides. 
†P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between 
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold 
value of P<0.05. 
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: 
Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health 
maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was 
calculated in this study using the 3-digit ICD-9-CM codes in MEPS). 
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Table 3-4. Study Population Characteristics when Examining Medication Utilization 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
DEMOGRAPHIC           
Age      0.385    0.013 
18 – 34 years 388,425 15.9 (1.0)  165,340 18.1 (1.3)   98,188 23.1 (2.3)  
35 – 49 years 875,809 35.9 (1.2)  324,653 35.5 (1.8)   141,109 33.3 (2.7)  
50 – 64 years 1,173,144 48.2 (1.3)  423,933 46.4 (2.0)   184,968 43.6 (3.0)  
Gender      0.491    0.169 
Female 1,632,006 67.0 (1.2)  624,410 68.3 (1.8)   267,502 63.1 (2.8)  
Race/Ethnicity      <0.001    <0.001 
Non-Hispanic White 1,094,002 44.9 (1.8)  442,534 48.4 (2.1)   256,231 60.4 (3.2)  
Non-Hispanic Black 666,358 27.3 (1.5)  219,033 24.0 (1.6)   79,936 18.8 (2.0)  
Hispanic 445,601 18.3 (1.2)  202,106 22.1 (1.5)   50,704 12.0 (1.6)  
Others 231,416 9.5 (0.9)  50,253 5.5 (0.9)   37,393 8.8 (1.7)  
Marital Status      <0.001    <0.001 
Married 727,457 29.9 (1.3)  344,150 37.7 (1.8)   184,414 43.5 (3.2)  
Region      0.049    0.023 
Northeast 608,070 25.0 (1.6)  187,785 20.5 (1.7)   104,394 24.6 (2.9)  
Midwest 477,401 19.6 (1.4)  184,710 20.2 (1.7)   115,146 27.2 (3.2)  
South 727,520 29.8 (1.6)  315,073 34.5 (1.8)   98,072 23.1 (2.3)  
West 624,386 25.6 (1.7)  226,358 24.8 (1.9)   106,652 25.1 (3.0)  
Family Size Mean (SE) 2.8 (0.1)  2.9 (0.1) 0.409           2.8 (0.1)                      0.976 
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Table 3-4.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
SOCIOECONOMIC           
Education      0.001    <0.001 
<High School 971,041 40.2 (1.4)  298,300 32.9 (1.8)   67,896 16.0 (1.9)  
High School/GED 1,215,968 50.4 (1.4)  498,289 54.9 (2.0)   232,334 54.9 (3.2)  
College Degree 227,668 9.4 (0.7)  111,300 12.2 (1.4)   123,109 29.1 (3.2)  
Income      <0.001    <0.001 
<100% FPL 1,384,551 56.8 (1.2)  428,540 46.9 (1.7)   104,719 24.7 (2.3)  
100 – <125% FPL 227,591 9.3 (0.6)  91,940 10.1 (1.1)   28,783 6.8 (1.3)  
>125% FPL 825,236 33.9 (1.1)  393,445 43.0 (1.8)   290,763 68.5 (2.6)  
Employment      <0.001    <0.001 
Always Unemployed 1,767,234 72.5 (1.2)  496,282 54.3 (1.8)   112,490 26.5 (2.2)  
 Unstable Employment 301,597 12.4 (0.8)  228,246 25.0 (1.6)   129,583 30.6 (2.5)  
Always Employed 368,547 15.1 (0.9)  189,398 20.7 (1.4)   182,191 42.9 (2.9)  
MSA 1,931,797 79.3 (1.8)  721,532 78.9 (1.9) 0.880  344,287 81.1 (2.7) 0.494 
MEDICAID-RELATED           
SSI/TANF 1,012,240 41.5 (1.3)  154,157 16.9 (1.3) <0.001  41,212 9.7 (1.6) <0.001 
Medicaid HMO/MCO 1,424,726 61.3 (1.5)  459,330 50.5 (2.0) <0.001  233,429 55.0 (3.0) 0.048 
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Table 3-4.  (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
HEALTH-RELATED           
Perceived Health Status      0.162    <0.001 
Fair to Poor 1,314,794 53.9 (1.2)  467,555 51.2 (1.9)   170,598 40.2 (2.5)  
Perceived Mental Health      <0.001    <0.001 
Fair to Poor 821,318 33.7 (1.2)  234,931 25.7 (1.7)   84,716 20.0 (2.2)  
CVD or high-risk 
conditions for CVD 
     0.775    0.037 
<1 1,678,222 68.9 (1.1)  640,242 70.1 (1.8)   321,685 75.8 (2.3)  
2 444,995 18.2 (0.8)  163,062 17.8 (1.4)   65,581 15.5 (2.2)  
>3 314,160 12.9 (0.8)  110,621 12.1 (1.3)   37,000 8.7 (1.5)  
Mental/Substance Abuse 
Illnesses 
751,357 30.8 (1.2)  227,885 24.9 (1.6) 0.003  115,891 27.3 (2.4) 0.176 
Respiratory Illnesses 479,702 19.7 (1.1)  117,992 12.9 (1.1) <0.001  39,380 9.3 (1.5) <0.001 
Arthritis/Joint Pain 830,408 34.1 (1.3)  267,358 29.3 (1.7) 0.009  107,575 25.4 (2.4) 0.002 
CCI Score Mean (SE)        1.2 (0.0)         1.1 (0.1) 0.079          0.9 (0.1) 0.003 
Population Size 2,437,378 64.6 (1.0)  913,926 24.2 (0.8)   424,265 11.2 (0.7)  
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Table 3-4.  (Continued) 
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or 
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-
risk conditions for CVD, had <1 month of Medicaid coverage during the survey year. 
†P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between 
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold 
value of P<0.05. SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical 
Area; SSI: Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: 
Health maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score 
was calculated in this study using the 3-digit ICD-9-CM codes in MEPS).
 53 
(P<0.001). Among the socioeconomic covariates, this study found that individuals in the 
Discontinuous–Insured group were more likely to complete high school/GED or college 
(P<0.001), more likely to have higher family income levels (P<0.001), and were more 
likely to have some form of employment during the year (P<0.001). The Discontinuous–
Insured group was also to be eligible for SSI due to disability or participate in TANF 
(P<0.001), however, there was no significant difference between having Medicaid 
through an HMO/MCO (P=0.087). Among the health-related covariates, this study found 
that the Discontinuous–Insured group was less likely to have respiratory illnesses 
(P<0.001), less likely to report having fair to poor health status (P<0.001), or fair to poor 
mental health status (P<0.001), and was similar to the Continuous Medicaid coverage 
group in terms of having mental/substance abuse illnesses (P=0.428), arthritis/joint pain 
(P=0.086), and mean CCI score or burden of disease (P=0.078). Finally, when examining 
the medication-related variables, the Discontinuous–Insured group was found to be 
prescribed lower number of unique medications on average (P<0.001), and more likely to 
have a 90-day supply of medications (P<0.001) than the Continuous Medicaid group. 
 
 For the second aim of examining medication utilization, the patterns in the 
demographic, socioeconomic, Medicaid -, and health-related characteristics of the study 
population were found to be similar to the patterns described above, with some 
exceptions. When examining geographic census region, individuals in the Discontinuous 
– Uninsured group were found to be more likely to reside in the South, compared to their 
counterparts in the Continuous Medicaid group. However, the magnitude the statistical 
significance in difference was small (P=0.049). They were also less likely to have 
mental/substance abuse illnesses, and arthritis/joint pain. Among the Discontinuous – 
Uninsured group, individuals were less likely to participate in Medicaid administered by 
an HMO/MCO (P=0.048), less likely to have 2 or more CVD or high-risk conditions for 
CVD (P=0.037), less likely to have arthritis/joint pain (P=0.002), and had a lower 
disease burden or mean Charlson score (P=0.003), when compared to those with 
continuous Medicaid coverage. 
 
 
Prescription Medication Use in the Study Population 
 
 Table 3-5 displays the summary statistics for prescription medication use in the 
study population. The distribution of the classes of medications prescribed was similar 
among all three groups; the Continuous Medicaid, Discontinuous–Uninsured, and the 
Discontinuous–Insured. Statins and thiazolidinediones were the most commonly 
prescribed classes of medications, followed by diuretics and anti-hypertensive 
combination medications. On average, the Continuous Medicaid group reported higher 
number of all-cause prescription fills annually than the Discontinuous–Uninsured (46.0 
vs. 30.0 fills, P<0.001), and the Discontinuous–Insured groups (46.0 vs. 30.0 fills, 
P<0.001). Similarly, the Continuous Medicaid group reported higher mean disease-
specific (CVD or high-risk conditions for CVD for CVD) prescription fills annually than 
the Discontinuous–Uninsured (16.6 vs. 13.5 fills, P<0.001), and the Discontinuous–
Insured groups (16.6 vs. 12.8 fills, P<0.001). The proportion of days during which  
 54 
Table 3-5. Summary Statistics for Prescription Medication Use in the Study Population 
  
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or having an 
event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-risk conditions 
for CVD, and who reported having Medicaid anytime during the year. 
Estimates in bold indicate statistical significance at P<0.05. 
ACEI: Angiotensin converting enzyme inhibitors, ARB: Angiotensin II converting enzyme receptor blockers, Calcium channel blockers, HTN: 
Hypertension; SE: Standard Error. *P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and discontinuous Medicaid groups.
  Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Measures Therapeutic 
Drug Classes 
  Weighted N 
or Mean 
   % (SE) 
or SE 
 Weighted N 
or Mean 
    % (SE) 
or SE 
   Weighted N 
or Mean 
   % (SE) 
or SE 
 ACEI/ARB 136,818 6.9 (0.7)  47,265 6.7 (1.0)  28,419 8.5 (1.8)  
 Beta blockers 147,001 7.4 (0.7)  57,759 8.1 (1.2)  37,979 11.4 (2.3)  
 CCB 125,709 6.3 (0.6)  57,759 6.3 (0.9)  13,328 4.0 (1.1) 
 Diuretics 288,166 14.5 (1.0)  105,673 14.9 (1.5)  39,934 11.9 (2.2) 
 Anti-HTN 
combinations 
197,107 9.9 (0.7)  72,220 10.2 (1.0)  42,047 12.6 (2.0) 
 Statins 538,014 27.1 (1.1)  167,148 23.6 (1.8)  85,635 25.6 (2.9) 
 Sulfonylureas 114,938 5.9 (0.6)  43,755 6.2 (1.0)  16,097 4.8 (1.6) 
 Biguanides 436,045 22.0 (1.1)  170,483 24.0 (2.0)  70,987 21.2 (2.7) 
Mean No. of Drug 
Classes 
 2.4 0.02  2.0        0.02  1.6*              0.1 
Mean No. of All-
Cause Drug Fills 
 46.0 1.1  30.0***           1.3  30.0***           1.5 
Mean No. of 
Disease-Specific 
Drug Fills 
 16.6 0.5  13.5***           0.6  12.8*** 0.8 
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respondents had possession of medications was significantly higher among the 
Continuous Medicaid group when compared to the Discontinuous–Uninsured (67.8% vs. 
64.9%, P<0.001), but was not significantly different from the Discontinuous–Insured 
group (67.8% vs. 68.4%, P=0.710) (results not shown). 
 
 The results for medication adherence outcomes, both overall and therapeutic 
drugclass-specific, are displayed in Table 3-6. When examining overall adherence using 
the average MPR measure, this study found that although the Discontinuous–Uninsured 
group had about 17% lower odds of being adherent to their medications than the 
Continuous Medicaid group, this difference was not statistically significant [Odds Ratio 
(OR): 0.83; 95% Confidence Interval (CI): 0.69 – 1.00]. Difference in overall adherence 
was found to be highly insignificant when comparing Discontinuous–Insured and 
Continuous Medicaid groups (P=0.775). Appendix Table A-1 displays the full model 
coefficients exponentiated as odds ratios for the comparisons between Continuous 
Medicaid, Discontinuous–Uninsured, and the Discontinuous–Insured Among the 
covariates, having fair or poor perceived health status, arthritis/joint pain, and a 90 days’ 
supply of prescription drugs were associated with higher odds of being adherent to 
commonly prescribed medications that are essential for managing CVD or high-risk 
conditions for CVD. When examining class-specific medication adherence, this study 
found that the Discontinuous–Uninsured group were 41% less likely to be adherent to 
sulfonylureas when compared to the Continuous Medicaid group (OR: 0.59; 95% CI: 
0.38 – 0.92). Adherence to the remaining classes of medications examined was not 
significantly different between these two groups. When examining class-specific 
adherence among the Discontinuous–Insured, this study found that this group was 43% 
less likely to be adherent to diuretics (OR: 0.57; 95% CI: 0.33 – 0.98), and had almost 3 
times higher odds of being adherent to calcium channel blockers (OR: 2.86; 95% CI: 1.44 
– 5.69).  
 
 Table 3-7 displays the results for the multivariate negative binomial regression 
analyses to examine medication utilization. This study found that the incidence of overall 
prescription fills (all-cause) was 27% lower among the Discontinuous–Uninsured group 
compared to the Continuous Medicaid group, or in other words, the expected number of 
all-cause prescription fills among the Discontinuous–Uninsured group were 27% less 
when compared to the Continuous Medicaid group [Incidence Rate Ratio (IRR): 0.73; 
95% CI: 0.68 – 0.79]. The average incremental difference in overall prescription 
medication fills between the Discontinuous–Uninsured and Continuous Medicaid group 
was found to be -12.0 fills (Standard Error (SE): 1.4 fills; P<0.001). In other words, 
individuals in the Discontinuous–Uninsured group were predicted to have 12 fewer 
prescription drug fills per person annually, compared to the Continuous Medicaid group. 
Further, it was found that the Discontinuous–Uninsured group had about 12% lower 
prescription drug fills annually specific to the CVD or high-risk conditions for CVD for 
CVD considered in this study (disease-specific), when compared to the Continuous 
Medicaid group (IRR: 0.88; 95% CI: 0.80 – 0.97). When estimating the average marginal 
effect of Medicaid discontinuity, the Discontinuous–Uninsured group was predicted to 
have about 2.0 fewer disease-specific prescription drug fills per person annually (SE: 
0.76 fills; P=0.009), compared to the Continuous Medicaid group. 
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Table 3-6. Association between Medicaid Discontinuity and Prescription 
Medication Adherence in the Study Population 
 
Outcome Medicaid Coverage  Odds Ratio  
(95% Confidence 
Interval) 
Average Adherence Continuous  1.00 (Reference) 
(MPR: <0.8 v >0.8) Discontinuous–Uninsured  0.83 (0.69 – 1.00) 
 Discontinuous–Insured  1.04 (0.79 – 1.36) 
    
Therapeutic Class-Specific 
Adherence (MPR: <0.8 v 
>0.8) 
   
ACEI/ARB Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.97 (0.74 – 1.28) 
 Discontinuous–Insured  1.56 (1.02 – 2.39)* 
    
Beta Blockers Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.74 (0.53 – 1.04) 
 Discontinuous–Insured  0.84 (0.51 – 1.36) 
    
Calcium Channel Blockers Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  1.20 (0.86 – 1.66) 
 Discontinuous–Insured  3.06 (1.56 – 6.01)** 
    
Diuretics Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.80 (0.60 – 1.08) 
 Discontinuous–Insured  0.50 (0.29 – 0.87)* 
    
Anti-HTN Combinations  Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.98 (0.65 – 1.50) 
 Discontinuous–Insured  1.60 (0.82 – 3.15) 
    
Statins Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.85 (0.63 – 1.16) 
 Discontinuous–Insured  1.02 (0.63 – 1.66) 
    
Sulfonylureas Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.60 (0.38 – 0.94)* 
 Discontinuous–Insured  0.63 (0.28 – 1.43) 
    
Biguanides Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  1.02 (0.69 – 1.50) 
 Discontinuous–Insured  1.30 (0.63 – 2.67) 
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Table 3-6.  (Continued) 
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 
years, who either reported being diagnosed with or having an event (prescription 
medication, or inpatient, emergency, outpatient, or office-based provider visits) associated 
with CVD or high-risk conditions for CVD, and who reported having Medicaid anytime 
during the year. Estimates in bold indicate statistical significance at P<0.05. *P<0.05, 
**P<0.01, ***P<0.001. MPR: Medication Possession Ratio. All models were adjusted for 
age, gender race/ethnicity, marital status, family size, census region, education, income, 
employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance abuse illnesses, 
arthritis/joint pain, no. of CVD conditions, perceived health status, perceived mental health 
status, Charlson Comorbidity Index score, and survey year. 
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Table 3-7. Association between Medicaid Discontinuity and Prescription 
Medication Utilization in the Study Population 
 
Outcome Medicaid Coverage  Incidence Rate 
Ratio  
(95% CI) 
Predicted 
Difference in 
Events 
Prescription 
Drug Fills 
    
All-Cause Continuous  1.00 (Reference)  
 Discontinuous–
Uninsured 
 0.73 (0.68 – 0.79)*** – 12.1 fills*** 
 Discontinuous–Insured  0.86 (0.76 – 0.97)* – 6.5 fills** 
     
Disease-
Specific 
Continuous  1.00 (Reference)  
 Discontinuous–
Uninsured 
 0.86 (0.79 – 0.95)** – 2.3 fills** 
 Discontinuous–Insured  0.84 (0.73 – 0.96)* – 2.8 fills** 
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 
years, who either reported being diagnosed with or having an event (prescription 
medication, or inpatient, emergency, outpatient, or office-based provider visits) 
associated with CVD or high-risk conditions for CVD, and who reported having 
Medicaid anytime during the year. 
Two separate covariates-adjusted regression models for each outcome comparing 
Continuous to Discontinuous–Uninsured, and to Discontinuous–Insured, respectively.  
Estimates in bold indicate statistical significance at P<0.05. 
MPR: Medication Possession Ratio 
All models were adjusted for age, gender race/ethnicity, marital status, family size, 
census region, education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO, 
mental/substance abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived 
health status, perceived mental health status, Charlson Comorbidity Index score, and 
survey year. 
*P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and 
discontinuous Medicaid groups. 
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 Medication utilization was similarly lower among the Discontinuous–Insured 
group. When examining all-cause medication utilization, this study found that the 
Discontinuous–Insured had approximately 14% lower prescription drug fills annually 
(IRR: 0.86; 95% CI: 0.76 – 0.97), with a predicted marginal difference of 6.5 fewer 
medication fills per person (SE: 2.4; P=0.007), compared to the Continuous Medicaid 
group. Similarly, the Discontinuous–Insured had an approximately 14% lower fills of 
overall prescription medications annually (IRR: 0.86; 95% CI: 0.74 – 0.99), and a 
predicted marginal difference of 2.4 fewer drug fills on average per person annually (SE: 
1.1; P=0.023), when compared to the Continuous Medicaid coverage population. 
 
 
DISCUSSION 
 
 Discontinuous Medicaid coverage among adults with CVD or high-risk 
conditions for CVD was found to have a negative association with prescription drug 
utilization. The effects were more pronounced among individuals with less than full-year 
Medicaid coverage and having no other insurance during the year. This Discontinuous–
Uninsured group was predicted to have 12 fewer fills per person on average for all 
prescription medications, and about 2 fewer fills per person on average for prescription 
drugs specific to CVD or high-risk conditions for CVD, compared to the Continuous 
Medicaid group. Similarly, the Discontinuous–Insured group, or individuals with less 
than full-year coverage who reported having other sources of insurance coverage during 
the year, were found to have an average of about 6 fewer drug fills per person overall, 
and about 3 fewer fills per person for disease-specific medications. Adherence to 
commonly prescribed medications to manage CVD or high-risk conditions for CVD, 
measured as average MPR to determine overall concurrent medication adherence, was 
not found to be significantly different between the continuous and discontinuous 
Medicaid coverage groups in this study. However, when examining adherence specific to 
individual therapeutic drug classes, this study found lower adherence among the 
discontinuous Medicaid groups to sulfonylureas and diuretics. Adherence to ACEI/ARB 
and calcium channel blockers was found to be higher among the Discontinuous–Insured 
groups, and was not significantly different between the Discontinuous–Uninsured and the 
Continuous Medicaid groups as well. Being among the first line therapies to treat high 
blood pressure that are commonly prescribed, access to these medication classes may not 
have been impacted by changes in Medicaid coverage during the year in these population 
groups. 
 
 Medication adherence is a highly complex phenomena and barriers to adherence 
are multifactorial. The World Health Organization (WHO) has done a phenomenal job in 
classifying the barriers of adherence that capture a wide range of factors that contribute to 
non-adherence.73 As per the WHO classification, barriers to adherence result from: 1) 
factors associated with the health care team and system in place, 2) disease-related 
factors, 3) patient-related factors, 4) therapy-related factors, and 5) socio-economic 
factors. Health system- and health care team-related factors can include lack of access to 
health care and prescribed medications, and lack of continuity of care due to changes in 
insurance status, among others. Complex chronic debilitating conditions, such as heart 
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failure or stroke, or asymptomatic disorders such as hypertension and diabetes may 
prevent taking therapies as prescribed or seeking needed medical care. Patient factors 
such as younger age, minority race or ethnicity, presence of physical or cognitive 
impairments can also be barriers to medication adherence. Complexity of medication 
therapy regimen, and side effects of therapies previously undetected in clinical trials can 
also hinder appropriate management of conditions through pharmacotherapy.74 Finally, 
socioeconomic factors such as low incomes, high medication costs, low literacy, and poor 
social support may hinder effective use of medications to manage disease conditions.62  
 
The present study examined the impact of a health system-related barrier of not 
having continuous full-year Medicaid coverage on medication adherence after accounting 
for several other factors that may hinder or confound medication adherence. Given that 
this study found Medicaid discontinuity to be significantly associated with lower 
prescription fills, we have strong reasons to believe that having discontinuous Medicaid 
coverage has a negative impact on prescription medication utilization, and by estimating 
adherence within a limited time frame of one year using an imputed MPR measure due to 
absence of complete days’ supply information, this study may have underestimated the 
impact of Medicaid discontinuity on adherence. Adherence to certain classes of 
antidiabetic and antihypertensive medications was found to be lower among the 
discontinuous Medicaid groups which further highlights the negative impact that 
discontinuity and disruptions in Medicaid coverage may have on managing high-risk 
conditions for CVD. 
 
To our knowledge, there have been no previous studies which have examined the 
association between discontinuous Medicaid coverage and prescription medication 
adherence, and the paucity of empirical evidence establishing an association between 
Medicaid discontinuity and prescription drug utilization, especially among 
subpopulations with chronic diseases, warranted an in-depth examination of these 
outcomes. Our findings on prescription drug fills are in line with the findings of Banerjee 
and colleagues, who examined the impact transitions into and/or out of Medicaid 
coverage on prescription drug fills, among other outcome measures.15 They found that 
individuals experiencing discontinuity in their Medicaid coverage had lower incidence of 
prescription drug refills compared to those without any disruptions in their Medicaid 
coverage. Among studies that investigated disease-specific prescription drug utilization, 
Smith and Kirking found that individuals with Medicaid coverage disruptions were 
associated with significantly lower acquisition of medications for HIV/AIDS (human 
immunodeficiency virus infection and acquired immune deficiency syndrome), such as 
antiretrovirals.67 Fields and colleagues examined the impact of insurance stability and 
residence on several health care utilization measures and found that discontinuously 
insured individuals had fewer prescription drug fills, physician office visits, among other 
outcome measures, compared to those with continuous insurance coverage.32 Baicker and 
colleagues utilized the random assignment of individuals embedded in the Oregon 
Medicaid lottery to examine the impact of Medicaid coverage on several outcome 
measures, dubbed the Oregon Experiment. They found that although the use of diabetes 
medications increased 2 years after the Medicaid lottery to expand Medicaid coverage, 
the utilization of medications for hypertension or high cholesterol were not significantly 
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different.75 Differences in sampling, study design (observational vs. random assignment), 
and duration, besides differences in the study sample may have contributed to the 
discrepancies between some of these findings and findings from the present study. 
 
Medicaid, the nation’s primary public health insurance program for the low-
income population, provides much-needed health insurance coverage to an estimated 67 
million individuals who meet the eligibility criteria, which include having incomes and 
assets below a certain threshold level determined by each State.7 Medicaid enrollees have 
very little copays, with most states requiring about $1 – 3 per drug as copay, although 
most of them have limits of up to 5 concurrent prescription medications that can be filled 
per month.76 Although seemingly restrictive, studies have found Medicaid enrollees to be 
more likely to be prescribed medications for certain chronic conditions. Rice and 
Colleagues in their analysis of the 2001 California Health Interview Survey found that 
California Medicaid enrollees had higher odds of reporting taking medications for heart 
disease, high blood pressure, and asthma.77 Nonetheless, continuity of insurance 
coverage, especially for low-income populations, is as critical as gaining insurance 
coverage, and the findings from this study reinforce the conclusions made by previous 
studies that discontinuous Medicaid coverage may have an adverse impact on enrollees’ 
prescription drug utilization.15,32,67 
 
The literature examining the impact of lack of insurance on health care outcomes 
in general, and disease-specific outcomes in particular is exhaustive with studies 
highlighting the adverse impact of lacking health insurance. However, there is a lack of 
studies examining the impact of discontinuous health insurance on medication outcomes, 
especially for certain disease conditions such as cardiovascular diseases that require 
prolonged disease management. And although medication adherence as an area of 
research has been thoroughly examined with several high-quality robust analyses of 
adherence and its impact on health care utilization, research examining the impact of 
churning in insurance in general and Medicaid on medication adherence in particular is 
limited.  
 
Adherence to medications for CVD or high-risk conditions for CVD varies 
significantly depending on the study population, and therapeutic classes examined. 
Studies have shown adherence to several therapeutic classes of medications such as 
statins, beta blockers, and antiplatelet agents declined following hospitalizations for AMI, 
CAD, and stroke, and that the trend in decreased adherence continued over periods of 
more than a year after discharge.66,78-80 Using medication event monitoring data, Vrijens 
and colleagues found medication annual nonadherence rate of 50% among patients 
prescribed antihypertensive drugs, whereas Bramley and colleagues in their examination 
of association between adherence and blood pressure control found 75% of patients to be 
adherent to antihypertensives.81,82 Bailey and colleagues analyzed Tennessee’s Medicaid 
claims data to examine association between antihypertensive medication adherence and 
ambulatory visits to hazards of stroke and mortality, and found the mean adherence rate 
to antihypertensive medications to be 67%.65 Examinations of medication adherence 
among heath failure patients have also found differing estimates of adherence.83,84 
Adherence to sulfonylureas was found to be lower among the Discontinuous–Uninsured 
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compared to the Continuous Medicaid population. Estimates have found adherence to 
oral hypoglycemic agents to be low among Medicaid enrollees, and range from 35 to 
about 50%.85,86 Discontinuous Medicaid coverage with no other coverage during the year 
may exacerbate the already low levels of adherence to this therapeutic class, which may 
have been reflected in these findings. Although nonadherence to cardiovascular 
medications is prevalent, the varying methodologies to estimate adherence, data sources, 
and study designs, make it difficult to compare results across studies focused on 
cardiovascular conditions.  
 
This study is not without limitations. Adherence was calculated using an imputed 
MPR measure that approximated days’ supply for medications based on an algorithm 
created using quantity of medications dispensed. However, unlike previous empirical 
analyses, this study utilized MEPS data itself to impute MPR, using a plausible 
assumption that over the 10-year period from 2002, there have not been major changes in 
the strengths and dosage frequencies of cardiovascular medications. The quality of the 
prescription drug data in MEPS has been found to be comparable to Medicare claims data, 
and combined with the high degree of correlation between the imputed and actual days’ 
supply variables, we believe benchmarking our analysis solely to MEPS data is a credible 
approach.87 Additionally, each state establishes their own Medicaid eligibility and 
procedures for reenrollment, which were not available in MEPS to explore the complex 
and dynamic patterns of discontinuity that may differ based on the state’s eligibility and 
reporting criteria. Further, this study only explored associations between individual 
characteristics and Medicaid discontinuity, and not causality, and the findings only 
explore predictors of within-year discontinuous Medicaid coverage and may not capture 
risk factors for secular trends in Medicaid discontinuity. Regression models may not have 
adjusted for certain covariates that may confound the relationship between Medicaid 
insurance and medication adherence and utilization, or account for unobserved 
differences between the study population groups. Finally, MEPS data are self-reported, so 
the estimates may not exactly reflect the national estimates of Medicaid discontinuity. 
Researchers have speculated that most surveys underestimate the number of Medicaid 
enrollees due to a variety of reasons including stigma of public insurance. However, such 
misreporting is less of a problem for MEPS compared to other federal health surveys.54 
Finally, findings from this study are representative of the non-institutionalized civilian 
population and may not be applicable to individuals with prolonged hospitalizations or 
admitted to long-term care facilities. 
 
 
CONCLUSION 
 
 The findings from this study suggest that continuous Medicaid coverage is critical 
for non-elderly adults with CVD or high-risk conditions for CVD, and having 
discontinuous Medicaid coverage was associated with lower prescription drug utilization, 
and lower adherence to certain therapeutic classes of medications, which are essential 
components of appropriate disease management. Losing Medicaid coverage may increase 
the cost sharing burden for former enrollees who have a majority of their maintenance 
medications covered with nominal copays, resulting in forgoing needed 
pharmacotherapy, and exacerbating already low levels of adherence to medication 
 63 
regimens. Further research with more complete prescription drug data to analyze the 
impact of Medicaid discontinuity on adherence to important therapeutic classes may 
better inform policymakers on the determinants of nonadherence, and optimize the 
delivery of interventions to improve adherence to these vulnerable populations. 
Discussions on policies to improve retention of and continuity in Medicaid must include 
individuals suffering from these chronic and debilitating conditions whose 
pharmacotherapy may be adversely impacted due to such coverage instability. 
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CHAPTER 4.    ASSOCIATIONS BETWEEN MEDICAID DISCONTINUITY, 
ACCESS TO CARE, PREVENTIVE CARE, AND HEALTH SERVICES 
UTILIZATION AMONG ADULTS WITH CARDIOVASCULAR DISEASE OR 
ASSOCIATED HIGH-RISK CONDITIONS 
 
 
BACKGROUND 
 
Medicaid provides much-needed health insurance coverage to an estimated 67-70 
million low-income and disabled children, adults, and elderly at any given point in time, 
who meet the eligibility criteria, which include having incomes and assets below a certain 
threshold level determined by each State.7,88 Recent estimates indicate that over 28% of 
non-elderly adult Medicaid enrollees with family incomes at or below 138 percent of the 
federal poverty level (FPL) are diagnosed with cardiovascular disease (CVD), including 
heart disease and stroke.20 Conditions such as hypertension, hypercholesterolemia, and 
diabetes, among others, are significant risk factors for CVD; however, these conditions 
are preventable and manageable. For low-income vulnerable populations having CVD or 
high-risk conditions for CVD, accessing needed medical care, prescription drugs, routine 
preventive care, and periodic primary care visits are extremely critical to manage their 
complex chronic conditions. Failure to do so may exacerbate their cardiovascular 
symptoms leading to prolonged morbidity and result in avoidable hospitalizations that 
may exert a substantial financial stress on the health care system. 
 
Overwhelming evidence suggests that access to medical care, routine preventive 
services, and having a usual source of care for primary care visits are critical in managing 
disease conditions, and maintaining good health.89-92 Having stable, continuous health 
insurance coverage has been shown to be critical in ensuring that individuals do not have 
to forego medical care or have high financial burden, ensure appropriate preventive care 
services are accessed on a timely basis, and have regular access to primary care providers 
to obtain the medical care necessary for preventing and treating their chronic diseases.2,93-
95 Poor disease management, resulting from inadequate access to care, lack of adherence 
to pharmacotherapy, or lack of sufficient access to primary care physicians may result in 
increased risk of hospitalizations that could have been avoided.91,96-98 
 
Low family incomes, assessed as a percentage of the federal poverty level, family 
status, residence, and assets test, are some of the criteria used to determine eligibility for 
Medicaid coverage, which are specific to each states. Although most states have moved 
towards a 12 month coverage renewal for non-elderly adults in recent years, they may 
still require certain individuals to periodically report their income and/or other criteria in 
order to maintain eligibility. Upward income mobility would render individuals ineligible 
for their state’s Medicaid coverage if their incomes cross the eligibility threshold; 
however, research has shown that individuals may passively end up not reenrolling into 
Medicaid due to a variety of reasons, ranging from lack of awareness to various barriers 
faced in reenrollment.99 This results in individuals and families losing Medicaid coverage 
within 12 months of enrollment. Instability in Medicaid, characterized by dropouts and 
moving back and forth into various sources of coverage or a state of being uninsured, has 
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been a long-standing issue that has impacted non-elderly adult Medicaid enrollees due to 
stringent administrative regulations governing coverage for this population.9,100 Previous 
estimates have shown that about 43% of individuals who are newly enrolled in Medicaid, 
end up losing their Medicaid coverage within twelve months.38 Transitions into and out 
of Medicaid coverage may adversely impact the ability for low-income populations with 
CVD or high-risk conditions for CVD to seek, and maintain continuity in, medical care. 
Losing Medicaid coverage to become uninsured would be detrimental, as there is strong 
consensus regarding the negative outcomes associated with lack of insurance.10-12,31,32 
However, transitioning between Medicaid and other sources of insurance coverage may 
also prove to be problematic, as this may lead to moving between different provider 
networks, and coverage with different benefit structures that may limit use of previously 
covered health care resources. 
 
Estimates of the impact of discontinuous Medicaid coverage on access to care and 
utilization of health care services among individuals with CVD or high-risk conditions 
for CVD are very few and dated. Findings from state-specific Medicaid data have found 
Medicaid coverage discontinuity to be associated with higher inpatient and ER 
hospitalizations associated, especially for individuals with heart disease, diabetes, among 
other ambulatory care sensitive conditions.14,101 Newer, more comprehensive national 
estimates of the impact of discontinuous Medicaid coverage on access to care, preventive 
services use, and health care services utilization among individuals with CVD or its risk 
factor chronic conditions are critical to determine the outcomes among vulnerable 
diseased populations for whom insurance coverage continuity may be even more critical. 
The present study aims to obtain national estimates among adults with CVD or high-risk 
conditions for CVD of associations between Medicaid discontinuity and (1) access to 
care, (2) preventive services use, and (3) utilization of overall (all-cause) and disease-
specific health care services, such as hospital inpatient visits, emergency room (ER) 
visits, hospital outpatient visits, and physician office visits. We hypothesized that having 
discontinuous Medicaid coverage, relative to full-year continuous Medicaid coverage, 
would be associated with significantly poor access to care, lower preventive services use, 
lower primary care utilization, and higher hospitalizations in this study population. 
 
 
METHODS 
 
The present study is a retrospective cross-sectional analysis comparing adult 
populations with CVD or high-risk conditions for CVD, with and without continuous 
full-year Medicaid coverage. Instability and disruptions in Medicaid coverage may 
especially have a detrimental impact on the continuity of care among low-income adults 
with CVD or any of its risk factor conditions. We hypothesized that Medicaid 
discontinuity would be associated with poor access to care, decreased primary care – 
characterized by lower preventive services use and physician visits – and increased 
hospitalizations, both overall (all-cause), and those specific to CVD or high-risk 
conditions for CVD (disease-specific). 
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Data Source 
 
The present study analyzed data from the Medical Expenditure Panel Survey 
(MEPS). MEPS is a set of large-scale surveys of families, individuals, their medical 
providers and employers across the United States. It is jointly sponsored by the Agency 
for Healthcare Research and Quality (AHRQ) and the National Center for Health 
Statistics (NCHS), and has been conducted annually since 1996. It has two major 
components; the Household Component (HC), the Insurance Component, with data on 
medical providers in the HC being supplemented by the Medical Provider Component. 
MEPS collects detailed information from a nationally representative sample of the 
civilian noninstitutionalized population of the U.S. on health services utilization and 
health expenditures, insurance coverage, and sources of payment. 
 
MEPS has an overlapping panel design. Two separate panels of respondents are 
interviewed simultaneously during a calendar year. A new panel of sample households is 
selected each year, and data for each panel are collected for two calendar years. The two 
years of data for each panel are collected in five rounds of interviews that take place over 
a two and a half year period. This provides continuous and current estimates of health 
care expenditures at both the person and household level for two panels for each calendar 
year. By combining data from the overlapping panels, these annual files provide nearly 
double the sample size of individual panels and cover the entire calendar year for each 
respondent. Although all MEPS data are reported by respondents during computer-
assisted personal interviewing, further detailed health service use data, including on 
prescription drugs, are collected from a sample of providers with respondents’ 
permission.39 
 
When obtaining national estimates from surveys such as MEPS, appropriate 
sample size is critical to obtain reliable estimates, since estimates of some population 
subgroups may vary from year to year. The advantage of survey such as MEPS is that 
they allow for several years’ of data to be pooled together in order to increase the sample 
size and improve the precision of estimates. The pooling of the different years of data 
was conducted in accordance with the guidelines provided by MEPS, and data for the 
years 2002 – 2011 were pooled together to allow for a sufficiently large sample size to 
ensure reliable estimates.  
 
 
Study Population 
 
The broad classification of “cardiovascular disease (CVD) and associated 
comorbidities” in this study consisted for the following disease conditions: acute 
myocardial infarction (Clinical Classification code (CCC): 100), coronary artery disease 
(CCC: 101), congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis 
(CCCs: 114, 115, 116), stroke (CCCs: 109, 112), hypertension (CCC: 098), lipid 
disorders (CCC: 053), and diabetes (CCC: 049, 050). CCC aggregates conditions and 
procedures into mutually exclusive and clinically homogeneous categories, using Clinical 
Classification Software.40 The study population included respondents who were: (1) aged 
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18 to 64 years, (2) reported either being diagnosed with CVD or high-risk conditions for 
CVD for CVD in their first round of the MEPS survey, or reported having an event (an 
inpatient, emergency, outpatient, or office-based provider visits, or a prescription 
medication) associated with one or more of the aforementioned disease conditions at any 
point of time during the survey, (3) reported having had Medicaid coverage at any point 
of time during the survey year, and (4) had positive person weights, and were interviewed 
for all five rounds of the 2-year MEPS survey interviews. Respondents who reported 
having Medicare, or pregnancy were excluded from this study.  
 
Respondents who reported having Medicare, or pregnancy were excluded from 
this study. Pregnant women with incomes at or below 133 percent of the federal poverty 
level are eligible for Medicaid coverage throughout the pregnancy; however, the 
coverage ceases 60 days postpartum.68 Low-income non-elderly adults with disabilities 
are also eligible for Medicare if they have received monthly social security disability 
income for two years. Most coverage benefits for prescription drugs for dual eligible 
beneficiaries are covered by Medicare Part D, instead of Medicaid. As a result, these two 
population groups were excluded from this study. 
 
Individuals with less than a year of Medicaid coverage who experience within-
year Medicaid discontinuity may not be a homogenous group, especially when they 
report having other forms of insurance coverage during the year. In order to account for 
these differences, individuals in the study population who reported having <12 months of 
Medicaid coverage during a survey year were divided into two groups: (1) individuals 
with <12 months of Medicaid coverage who did not report any other sources of health 
insurance during the survey year, designated in this study as ‘Discontinuous–Uninsured’, 
and (2) individuals with <12 months of Medicaid coverage who also reported having 
other source(s) of health insurance during the survey year (either private, Tricare, or any 
hospital- or physician group-based health insurance), designated in this study as 
‘Discontinuous–Insured’. Individuals in the study population who reported having 
Medicaid coverage during all 12 months of a survey year were classified as having 
continuous Medicaid coverage, which was the comparison group and designated as 
‘Continuous Medicaid’ in this study.  
 
 
Study Variables 
 
Our first objective was to examine whether Medicaid discontinuity was associated 
with poor access to care among non-elderly adults with CVD or high-risk conditions for 
CVD. The outcomes of interest for this objective were the following three binary 
indicators for: (1) having a usual source of care, (2) having difficulty in obtaining 
medical care, and (3) having difficulty obtaining prescription medications. When 
examining association between Medicaid discontinuity and preventive services use, the 
following three binary outcomes were examined: (1) having blood pressure checkup 
within the past year, (2) having cholesterol checkup within the past year, and (3) having 
routine medical checkup within the past year. For the final objective of examining 
associations between Medicaid discontinuity, primary care visits, and hospitalizations, we 
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divided the utilization outcome measures into all-cause, i.e. overall utilization during the 
survey year irrespective of diagnosis, and disease-specific utilization, i.e. utilization 
specific to CVD or high-risk conditions for CVD considered in this study. Specifically, 
the total number of inpatient visits, ER visits, hospital outpatient visits, and physician 
office visits, were examined, resulting in eight outcome measures (one all-cause, and one 
disease-specific for each) that were characterized as discrete counts of the events 
 
All regression models included the following classes of covariates:-  
 
1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity 
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital 
status (not married vs. married), family size (N), and geographic residence 
(Northeast vs. Midwest, South, and West). 
2) Socioeconomic covariates: education (less than high school vs. high school/GED, 
and Bachelor’s or higher), income as a percentage of the federal poverty level 
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always 
unemployed vs. intermittent employment, and always employed), binary indicator 
for Metropolitan Statistical Area (MSA) residence. 
3) Medicaid-related covariates: binary indicator for Supplementary Security Income 
(SSI) for disability receipt or participation in the Temporary Assistance for Needy 
Families program, and a binary indicator for Medicaid HMO/Managed Care 
participation. 
4) Health-related covariates: perceived health status (excellent/very good/good vs. 
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor) 
binary indicator for mental illness/substance abuse diagnosis, binary indicator for 
respiratory diseases diagnosis, binary indicator for arthritis/joint pain diagnosis, 
and Charlson Comorbidity Index (CCI) score. 
 
Additionally, all of the multivariate models included the year fixed effects to 
capture any macro-level variations during the study period. 
 
 
Statistical Analysis 
 
 Bivariate statistics were conducted to examine the characteristics of the study 
population. When examining the binary outcomes for access to care and preventive 
services use, adjusted multivariate logistic regression analyses were conducted. As an 
example, Equation 4-1 and Equation 4-2 depict the logistic regression models usual 
source of care, as part of the access to care measures, among both the Discontinuous–
Uninsured, and the Discontinuous–Insured groups relative to the Continuous Medicaid 
insurance group. 
 
Pr[USC=1|x] = F-1(?? ? ???? ????????????? ? ????????? ?? ???
?
??? ??)   (Eq. 4-1) 
 
Pr[USC=1|x] = F-1(?? ? ???? ????????????? ? ??????? ?? ???
?
??? ??)        (Eq. 4-2) 
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 Usual source of care is modeled as a dichotomous outcome variable as a function 
of Medicaid discontinuity as well as the demographic, socioeconomic, Medicaid-related, 
and health-related covariates mentioned above. F-1 denotes the inverse of the cumulative 
standard logistic distribution function that relates the outcome on the probability scale to 
the covariates. Pr[ ] denotes the population average probability of having a usual source 
of care (denoted by 1) that is conditional on the covariates denoted by x. Discontinuous–
Uninsured and Discontinuous–Insured are binary indicator variables for the main 
independent variable of interest, that equals one for individuals having discontinuous 
annual Medicaid coverage without any other sources of insurance and with other sources 
of insurance during the year, respectively, and equals zero for the comparison group of 
individuals with continuous Medicaid coverage. X denotes the vector of the 
aforementioned individual characteristics that predict Medicaid discontinuity in the two 
population groups of interest. 
 
 The number of physician office visits data (both all-cause and disease-specific) 
displayed overdispersion, however, this count outcome measure did not have excess 
zeros. Thus, an adjusted negative binomial regression was utilized. It is a type of 
generalized linear model where the dependent variable Y is a count of the number of 
times an event occurs (in this case, the number of physician office visits). A convenient 
parameterization of the negative binomial distribution is denoted by Equation 4-3.71  
 
???? ? ??? ? ?? ?
???????
???????????
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????
?
???
? ??
????
?
?
 (Eq. 4-3) 
 
In Equation 4-3, μ>0 is the mean of Y, which is the count variable indicating the 
number of prescription drug fills (either all-cause, or disease-specific) and α>0 is the 
heterogeneity parameter. It can be derived as a Poisson-gamma mixture, or as the number 
of failures before the (1/α)th success. A simpler depiction of the traditional negative 
binomial regression model, the NB2 model is depicted is depicted in Equation 4-4 and 
Equation 4-5 as follows, 
 
?? ?????????? ? ?? ? ??????????????? ? ?????????? ? ??? ?? ? ?? ??? ??  (Eq. 4-4)  
 
?? ????????????????? ? ?? ? ??????????????? ? ?????????? ? ??? ?? ? ?? ??? ??   
                 (Eq. 4-5) 
 
where, apart from the main indicator variables for the Discontinuous–Uninsured 
group, the covariates ?? to ?? are known, and the population regression coefficients ?? to 
?? are to be estimated. The two equations above depict the negative binomial regression 
models to estimate the differences in overall (Equation 4-4), and disease-specific 
physician office visits (Equation 4-5) between the Continuous Medicaid, and 
Discontinuous–Uninsured groups. Similar regression models (not shown here) were run 
to estimate differences in the number of physician office visits between the Continuous 
Medicaid and Discontinuous–Insured groups.  
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When analyzing the discrete count data for the number of all-cause and disease-
specific inpatient visits, ER visits, and hospital outpatient visits, it was important to 
account for the overdispersion in the data characterized by the presence of an excessive 
number of zeros, a problem that is commonly known as zero inflation (ZI). Appendix B, 
Figures B-1 to B-16, display the distribution of the all-cause and disease-specific 
outcome variables examined in this study. The distribution of the ZI data is often right-
skewed, with a huge peak at zero, representing the individuals with zero health care 
consumption, and a skewed tail representing the rest of the study population with varying 
amounts of non-zero consumption. ZI data are often analyzed using a two-part mixture 
models combining a point mass at zero with a proper count distribution. These models 
assume an initial process to determine membership into one of two latent groups, 
generally referred to the ‘susceptible’ and ‘non-susceptible’ population groups.102 The 
approach for ZI models uses two regression models, one is usually a logit regression (or 
probit) modeling the susceptible probability, and the other is either a Poisson or negative 
binomial model, modeling the mean for the susceptible population (Equation 4-6). 
Explanatory variables are allowed to have a different impact for the two processes, and 
the two models are fit simultaneously using maximum likelihood estimation.102 The 
outcomes measures with excess zeros were therefore analyzed using zero inflated 
negative binomial regression models, mathematically represented as follows: 
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             (Eq. 4-6) 
 
Having a mean E(Y) = (1 – p)μ, and a variance Var(Y) = (1 – p)μ(1 + pμ + αμ). 
Research has shown zero-inflated negative binomial models to provide superior fit when 
compared to zero-inflated Poisson regression.103 For the binary model estimating the 
susceptible probability, the following variables were included 
 
The coefficient of interest for the Discontinuous–Uninsured is the measure of 
differences in the utilization of overall, and disease-specific drug utilization. Because of 
the functional form of the negative binomial regression, the effect size of a factor is the 
antilog of its coefficient. This estimated coefficients are transformed to obtain the 
incidence rate ratio (IRR). An IRR of less than one for the discontinuous Medicaid 
groups would suggest lower hospital outpatient utilization for instance, among them 
when compared to their counterparts with continuous Medicaid coverage. 
 
In addition to obtaining IRRs, this study further estimated the average marginal 
effect to determine the predicted difference in the number of all-cause and disease-
specific prescription drug fills between the continuous and discontinuous Medicaid 
groups. The marginal effects measure the discrete change in the outcome variable, i.e. for 
a binary independent variable, how do predicted probabilities change as the binary 
independent variable changes from 0 (Continuous Medicaid) to 1 (Discontinuous–
Uninsured, or Discontinuous–Insured).72 In order to obtain these marginal effects, after 
developing and running the multivariate negative binomial regression model, the 
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estimated coefficients of the model were used to calculate two predicted event visits for 
all individuals in the study population. The first predicted utilization assumed all 
individuals had discontinuous Medicaid coverage (by setting the Medicaid discontinuity 
indicator variable to 1), and the second predicted utilization assumed all individual to 
have continuous full-year Medicaid coverage (by setting the Medicaid discontinuity 
indicator variable to 0). The average per-person difference in the event visits attributable 
to Medicaid coverage was estimated by obtaining the difference in predicted drug 
utilization for each person and computing the weighted average of the difference across 
the entire study sample.  
 
The proportion of missing data was around 6% in this study, as a result, the 
listwise deletion approach was used to account for missing values. Multicollinearity was 
assessed for all the regression models, and the variance inflation factor was found to be 
less than 5, which was lower than the widely accepted threshold of 10 for existence of 
multicollinearity. The Hosmer-Lemeshow tests for goodness-of-fit were highly 
insignificant for all the logistic regression models indicating that the model fit the data. 
All data analyses were conducted using SAS 9.3 and STATA 13 to account for the 
complex survey design of MEPS. 
 
 
RESULTS 
 
 
Characteristics of the Study Populations 
 
 Table 4-1 displays the characteristics of the study population. The study sample 
included 3,926 respondents in the Continuous Medicaid coverage group (nationally 
representative of about 2.4 million individuals), 1,407 individuals in the Discontinuous–
Uninsured group (nationally representative of over 900,000 individuals), and 493 
individuals in the Discontinuous–Insured group (nationally representative of over 
400,000 individuals). 
 
When compared to the Continuous Medicaid group, individuals in the 
Discontinuous–Uninsured group were less likely to belong to other race groups 
(P<0.001), more likely to be married (P<0.001), and were more likely to reside in the 
South region (P=0.049). Among the socioeconomic covariates, this study found that 
respondents were more likely to have completed high school/GED or college (P=0.001), 
were more likely to have family incomes >125% FPL (P<0.001), and more likely to have 
intermittent, as well as continuous full-year employment (P<0.001). Respondents were 
less likely to be eligible for SSI due to disability or participate in TANF (P<0.001), and 
less likely to report being Medicaid managed care enrollees (P<0.001). Among the 
health-related variables, respondents were less likely to report having fair or poor 
perceived mental health status (P<0.001), less likely to report having mental/substance 
abuse illnesses (P=0.003), less likely to report having respiratory illnesses (P<0.001), and 
less likely to report having arthritis/joint pain (P=0.009). The mean CCI score was not 
significantly different between the two groups (P=0.181). 
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Table 4-1. Characteristics of the Study Population (2002 – 2011) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
DEMOGRAPHIC           
Age      0.385    0.013 
18 – 34 years 388,425 15.9 (1.0)  165,340 18.1 (1.3)   98,188 23.1 (2.3)  
35 – 49 years 875,809 35.9 (1.2)  324,653 35.5 (1.8)   141,109 33.3 (2.7)  
50 – 64 years 1,173,144 48.2 (1.3)  423,933 46.4 (2.0)   184,968 43.6 (3.0)  
Gender      0.491    0.169 
Female 1,632,006 67.0 (1.2)  624,410 68.3 (1.8)   267,502 63.1 (2.8)  
Race/Ethnicity      <0.001    <0.001 
Non-Hispanic White 1,094,002 44.9 (1.8)  442,534 48.4 (2.1)   256,231 60.4 (3.2)  
Non-Hispanic Black 666,358 27.3 (1.5)  219,033 24.0 (1.6)   79,936 18.8 (2.0)  
Hispanic 445,601 18.3 (1.2)  202,106 22.1 (1.5)   50,704 12.0 (1.6)  
Others 231,416 9.5 (0.9)  50,253 5.5 (0.9)   37,393 8.8 (1.7)  
Marital Status      <0.001    <0.001 
Married 727,457 29.9 (1.3)  344,150 37.7 (1.8)   184,414 43.5 (3.2)  
Region      0.049    0.023 
Northeast 608,070 25.0 (1.6)  187,785 20.5 (1.7)   104,394 24.6 (2.9)  
Midwest 477,401 19.6 (1.4)  184,710 20.2 (1.7)   115,146 27.2 (3.2)  
South 727,520 29.8 (1.6)  315,073 34.5 (1.8)   98,072 23.1 (2.3)  
West 624,386 25.6 (1.7)  226,358 24.8 (1.9)   106,652 25.1 (3.0)  
Family Size Mean (SE) 2.8 (0.1)   2.9 (0.1)  0.409  2.8 (0.1)  0.976 
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Table 4-1. (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted 
N 
% (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
SOCIOECONOMIC           
Education      0.001    <0.001 
<High School 971,041 40.2 (1.4)  298,300 32.9 (1.8)   67,896 16.0 (1.9)  
High School/GED 1,215,968 50.4 (1.4)  498,289 54.9 (2.0)   232,334 54.9 (3.2)  
College Degree 227,668 9.4 (0.7)  111,300 12.2 (1.4)   123,109 29.1 (3.2)  
Income      <0.001    <0.001 
<100% FPL 1,384,551 56.8 (1.2)  428,540 46.9 (1.7)   104,719 24.7 (2.3)  
100 – <125% FPL 227,591 9.3 (0.6)  91,940 10.1 (1.1)   28,783 6.8 (1.3)  
>125% FPL 825,236 33.9 (1.1)  393,445 43.0 (1.8)   290,763 68.5 (2.6)  
Employment      <0.001    <0.001 
Always Unemployed 1,767,234 72.5 (1.2)  496,282 54.3 (1.8)   112,490 26.5 (2.2)  
 Unstable Employment 301,597 12.4 (0.8)  228,246 25.0 (1.6)   129,583 30.6 (2.5)  
Always Employed 368,547 15.1 (0.9)  189,398 20.7 (1.4)   182,191 42.9 (2.9)  
MSA 1,931,797 79.3 (1.8)  721,532 78.9 (1.9) 0.880  344,287 81.1 (2.7) 0.494 
MEDICAID-RELATED           
SSI/TANF 1,012,240 41.5 (1.3)  154,157 16.9 (1.3) <0.001  41,212 9.7 (1.6) <0.001 
Medicaid HMO/MCO 1,424,726 61.3 (1.5)  459,330 50.5 (2.0) <0.001  233,429 55.0 (3.0) 0.048 
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Table 4-1. (Continued) 
 
 Continuous Medicaid  Discontinuous–Uninsured  Discontinuous–Insured 
Characteristics Weighted N % (SE)  Weighted N % (SE) P-value†  Weighted N % (SE) P-value†† 
HEALTH-RELATED           
Perceived Health Status      0.162    <0.001 
Fair to Poor 1,314,794 53.9 (1.2)  467,555 51.2 (1.9)   170,598 40.2 (2.5)  
Perceived Mental Health      <0.001    <0.001 
Fair to Poor 821,318 33.7 (1.2)  234,931 25.7 (1.7)   84,716 20.0 (2.2)  
CVD or high-risk 
conditions for CVD 
         0.775      0.037 
<1 1,678,222 68.9 (1.1)  640,242 70.1 (1.8)   321,685 75.8 (2.3)  
2 444,995 18.2 (0.8)  163,062 17.8 (1.4)   65,581 15.5 (2.2)  
>3 314,160 12.9 (0.8)  110,621 12.1 (1.3)   37,000 8.7 (1.5)  
Mental/Substance Abuse 
Illnesses 
751,357 30.8 (1.2)  227,885 24.9 (1.6) 0.003  115,891 27.3 (2.4) 0.176 
Respiratory Illnesses 479,702 19.7 (1.1)  117,992 12.9 (1.1) <0.001  39,380 9.3 (1.5) <0.001 
Arthritis/Joint Pain 830,408 34.1 (1.3)  267,358 29.3 (1.7) 0.009  107,575 25.4 (2.4) 0.002 
CCI Score Mean (SE) 1.2 (0.0)   1.1 (0.1)      0.079  0.9 (0.1)    0.003 
Population Size 2,437,378 64.6 (1.0)  913,926 24.2 (0.8)   424,265 11.2 (0.7)  
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or having an 
event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-risk conditions 
for CVD, had <1 month of Medicaid coverage during the survey year. †P-value for the difference between Discontinuous–Uninsured and 
Continuous Medicaid groups. ††P-value for the difference between Discontinuous–Insured and Continuous Medicaid groups. P-values in bold 
indicate statistically significant difference at P<0.05. SE: Standard error; GED: General educational development; FPL: Federal poverty level; 
MSA: Metropolitan Statistical Area; SSI: Supplementary Security Income. 
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When comparing the Discontinuous–Insured group to the Continuous Medicaid 
group in the above table, this study found that among the demographic covariates, 
individuals in the Discontinuous–Insured group were more likely to be younger 
(P=0.013), were less likely to belong to minority race/ethnicity groups (P<0.001), more 
likely to be married (P<0.001), and were more likely to reside in the Midwest (P=0.023). 
Among the socioeconomic covariates, this study found that individuals in the 
Discontinuous–Insured group were more likely to complete high school/GED or college 
(P<0.001), more likely to have higher family income levels (P<0.001), and were more 
likely to have some form of employment during the year (P<0.001). The Discontinuous–
Insured group was also less likely to be eligible for SSI due to disability or participate in 
TANF (P<0.001), and less likely to report having Medicaid through an HMO/MCO 
(P=0.048). Among the health-related covariates, this study found that the Discontinuous–
Insured group was less likely to report having self-perceived health status (P<0.001), and 
self-perceived mental health status (P<0.001), more likely to report fewer CVD or high-
risk conditions for CVD (P=0.037), were less likely to report having respiratory illnesses 
(P<0.001), less likely to report having arthritis/joint pain (P=0.002), and lower chronic 
disease burden (P=0.003). 
 
 
Medicaid Enrollment among the Discontinuous Medicaid Coverage Groups 
 
 Table 4-2 shows the summary statistics for Medicaid enrollment among the 
discontinuous Medicaid insurance groups. The average duration of enrollment for the 
undivided discontinuous Medicaid population was 6.0 months. The Discontinuous–
Uninsured group was enrolled in Medicaid for a longer period on average compared to 
the Discontinuous–Insured group (6.5 vs. 5.0 months, P<0.001). Additionally, this study 
examined the average duration of no insurance and found individuals in the 
Discontinuous–Insured group were uninsured for a little over a month (5.5 vs. 1.2 
months, P<0.001). This study also examined Medicaid enrollment status after 12 months 
of initial Medicaid enrollment. Overall, a total of 4,898 individuals were enrolled in the 
month of January of the survey year, of which 85.3% were still enrolled in Medicaid 
during the month of December in the survey year, 3.5% had some other form of 
insurance coverage, and 10.2% were uninsured (results not shown). Of the 621 
individuals in the Discontinuous–Uninsured group who had Medicaid in the beginning of 
the year, 78.1% were uninsured while 21.9% still had Medicaid coverage at the end of the 
year. Of the 200 individuals in the Discontinuous–Insured group who had Medicaid in the 
beginning of the survey year, only 8.0% still had Medicaid, 6.0% were uninsured, and the 
remaining 86% had some other source of health insurance coverage at the end of the year. 
Finally, when examining the number of transitions into and/or out of Medicaid coverage, 
this study found that overall 17.6% of individuals in this study population had more than 
one transitions, and the proportion of multiple transitions was similar between the two 
discontinuous Medicaid subgroups (17.7% vs. 17.3%, P=0.875). 
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Table 4-2. Patterns of Medicaid Coverage among Discontinuous Medicaid 
Groups 
 
 Discontinuous–Uninsured  Discontinuous–Insured 
Coverage 
Components 
   Mean or 
Weighted N 
SE or % 
(SE) 
   Mean or 
Weighted N 
SE or % 
(SE) 
Mean Duration of 
Medicaid 
6.5 months 0.1      5.0 months*** 0.2 
Mean Duration of No 
Insurance 
5.5 months 0.1      1.2 months*** 0.1 
Insurance Status 
After 12 Months† 
     
Still in Medicaid 83,125 21.9 (2.2)   11,647***   8.0 (2.0) 
Uninsured 297,045 78.1 (2.2)   10,058***   6.0 (2.0) 
Other Insurance -- --           147,896 86.0 (2.0) 
Medicaid Coverage 
Transitions 
     
1 752,311 82.3 (1.4)           350,803 82.7 (2.0) 
>2 161,615 17.7 (1.4)             73,462 17.3 (2.0) 
 
Sample consisted of 380,171 individuals in the Discontinuous–Uninsured group and 169,600 
individuals in the Discontinuous–Insured group who either reported being diagnosed with or 
having an event (prescription medication, or inpatient, emergency, hospital outpatient, or 
office-based provider visits) associated with CVD or high-risk conditions for CVD, and who 
reported having Medicaid at the beginning of the year. 
***P<0.001; **P<0.01; *P<0.05 for difference from the Discontinuous–Uninsured group.
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Access to Care 
 
 In comparison to the Continuous Medicaid group, individuals in the 
Discontinuous–Uninsured group were less likely to report having a usual source of care 
(93.6% vs. 84.5%; P<0.001), and more likely to report having difficulties in obtaining 
medical care (5.6% vs. 19.1%; P<0.001), and prescription medications (5.8% vs. 15.8%; 
P<0.001). When compared to the Continuous Medicaid group, those in the 
Discontinuous–Insured group were less likely to report having a usual source of care 
(93.6% vs. 88.6%; P=0.002), and more likely to report having difficulty in obtaining 
prescription medications (5.8% vs. 11.3%; P<0.001); however, there were no differences 
between the two groups in facing difficulty in obtaining medical care (P=0.094). Results 
of these bivariate analyses are not displayed. Table 4-3 displays the results of the 
multivariate logistic regression examining association between Medicaid discontinuity 
and access to care, among adults with CVD or high-risk conditions for CVD. In 
comparison to the Continuous Medicaid group, the Discontinuous–Uninsured group were 
found to have almost 60% lower odds of having a usual source of care [Odds Ratio (OR): 
0.41; 95% Confidence Interval (CI): 0.32 – 0.52]. Additionally, the odds were a 
staggering 4 times higher of reporting having difficulty in obtaining in obtaining medical 
care (OR: 4.20; 95% CI: 3.14 – 5.62), and were more than 3 times higher of reporting 
having difficulty in obtaining prescription medications (OR: 3.32; 95% CI: 2.50 – 4.40) 
when compared to those with continuous Medicaid coverage. Among the Discontinuous–
Insured group, the odds of having a usual source of care were 43% lower when compared 
to the Continuous Medicaid group (0.57; 95% CI: 0.37 – 0.88). The odds of reporting 
having difficulty in obtaining medical care were 74% higher (OR: 1.74; 95% CI: 1.02 – 
2.98), and the odds of reporting having difficulty in obtaining prescription medications 
were more than twice, when compared to the Continuous Medicaid group (OR: 2.16; 
95% CI: 1.42 – 3.27). 
 
 
Preventive Services Use 
 
 When examining the bivariate statistics between the Continuous Medicaid and 
Discontinuous–Uninsured groups, this study found no significant differences between the 
two when reporting about the routine BP checkup (P=0.073) and routine cholesterol 
checkup (P=0.140); however, the Discontinuous–Uninsured group was less likely to 
report having had a medical checkup within the past year (P=0.004). When comparing 
the Continuous Medicaid and Discontinuous–Insured groups, this study found that those 
in the Discontinuous–Insured group were less likely to report having routine BP checkup 
(96.9% vs. 94.5%; P=0.023), whereas differences in routine cholesterol checkup (P= 
0.897) and medical checkup (P= 0.146) were insignificant (results not displayed). Table 
4-4 displays the results of the multivariate logistic regression examining association 
between Medicaid discontinuity and preventive services use, among adults with CVD or 
high-risk conditions for CVD. When examining routine blood pressure checkup and 
routine blood cholesterol checkup, there were no significant differences between the 
continuous and discontinuous Medicaid populations. However, the Discontinuous–
Uninsured were found to have 22% lower odds of having had a medical checkup within 
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Table 4-3. Association between Medicaid Discontinuity and Access to Care in the 
Study Population 
 
Outcome Medicaid Coverage  Odds Ratio  
(95% Confidence Interval) 
Have Usual Source of Care Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.41 (0.32 – 0.52)*** 
 Discontinuous–Insured  0.57 (0.37 – 0.88)* 
 
Difficulty in Obtaining  Continuous  1.00 (Reference) 
Necessary Medical Care Discontinuous–Uninsured  4.20 (3.14 – 5.62)*** 
 Discontinuous–Insured  1.74 (1.02 – 2.98)* 
    
Difficulty in Obtaining  Continuous  1.00 (Reference) 
Prescription Medications Discontinuous–Uninsured  3.32 (2.50 – 4.40)*** 
 Discontinuous–Insured  2.16 (1.42 – 3.27)*** 
    
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who 
either reported being diagnosed with or having an event (prescription medication, or inpatient, 
emergency, outpatient, or office-based provider visits) associated with CVD or high-risk 
conditions for CVD, and who reported having Medicaid anytime during the year. 
Two separate covariates-adjusted regression models for each outcome comparing Continuous to 
Discontinuous–Uninsured, and to Discontinuous–Insured, respectively.  Estimates in bold 
indicate statistical significance at P<0.05. *P<0.05, **P<0.01, ***P<0.001 for comparison 
between the continuous and discontinuous Medicaid groups. 
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region, 
education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance 
abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived health status, perceived 
mental health status, Charlson Comorbidity Index score, and survey year. 
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Table 4-4. Associations between Medicaid Discontinuity and Preventive Services 
Use in the Study Population 
 
Outcome Medicaid Coverage  Odds Ratio  
(95% Confidence Interval) 
Routine BP Checkup Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.90 (0.61 – 1.31) 
 Discontinuous–Insured  0.75 (0.42 – 1.33) 
    
Routine Cholesterol Checkup Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.85 (0.64 – 1.13) 
 Discontinuous–Insured  1.06 (0.68 – 1.64) 
    
Routine Medical Checkup Continuous  1.00 (Reference) 
 Discontinuous–Uninsured  0.78 (0.63 – 0.96)* 
 Discontinuous–Insured  0.80 (0.56 – 1.13) 
    
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who 
either reported being diagnosed with or having an event (prescription medication, or inpatient, 
emergency, outpatient, or office-based provider visits) associated with CVD or high-risk 
conditions for CVD, and who reported having Medicaid anytime during the year. 
Two separate covariates-adjusted regression models for each outcome comparing Continuous to 
Discontinuous–Uninsured, and to Discontinuous–Insured, respectively.  Estimates in bold 
indicate statistical significance at P<0.05. *P<0.05, **P<0.01, ***P<0.001 for comparison 
between the continuous and discontinuous Medicaid groups. 
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region, 
education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance 
abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived health status, perceived 
mental health status, Charlson Comorbidity Index score, and survey year. 
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the past year when compared to the Continuous Medicaid population (OR: 0.78; 95% CI: 
0.63 – 0.96). 
 
 
Utilization of Health Care Services 
 
 The results of the final objective of examining associations between Medicaid 
discontinuity and heath care services utilization are displayed in Table 4-5. Overall 
inpatient visits were not significantly different between the continuous and discontinuous 
Medicaid groups. However, when examining disease-specific inpatient visits, this study 
found that the Discontinuous–Uninsured group had about 62% higher inpatient visits 
compared to the Continuous Medicaid group [Incidence Rate Ratio (IRR): 1.62; 95% CI: 
1.19 – 2.22]. The marginal predicted difference in the number of inpatient visits was 
found to be 0.05 visits (P=0.007); in other words, individuals in the Discontinuous–
Uninsured group were predicted to have 0.05 higher inpatient visits per person annually, 
compared to the Continuous Medicaid group. Similarly, the incidence of disease-specific 
inpatient visits was found to be 95% higher among the Discontinuous–Insured population 
(IRR: 1.95; 95% CI: 1.23 – 3.10), which at the margins was predicted to be 0.08 higher 
inpatient visits per person (P=0.029) when compared to the Continuous Medicaid group. 
When examining ER visits, this study did not find significant associations between 
Medicaid discontinuity and all-cause ER visits. When examining disease-specific ER 
visits, this study found that the incidence of these visits were 52% higher among the 
Discontinuous–Uninsured population, and the predicted marginal difference from the 
Continuous Medicaid group was found to be 0.05 additional visits per person (P=0.008). 
The Discontinuous–Insured too had a 79% higher incidence of disease-specific ER visits 
compared to the Continuous Medicaid population, with a predicted difference of 0.07 
greater ER visits per person (P=0.034). 
 
 Among the primary care utilization outcomes, this study found the 
Discontinuous–Uninsured group to have an 86% higher incidence of disease-specific 
hospital outpatient visits compared to the Continuous Medicaid insurance group (IRR: 
1.86; 95% CI: 1.32 – 2.63), and a predicted marginal difference of 0.21 additional visits 
(P=0.007). Finally, the Discontinuous–Uninsured group was found to have 
approximately 29% lower incidence of all-cause physician office visits (IRR: 0.71; 95% 
CI: 0.64 – 0.80), and were predicted to have 3.4 fewer overall physician office visits per 
person annually, when compared to their counterparts with continuous Medicaid 
coverage (P<0.001). 
 
 
DISCUSSION 
 
 Adults with CVD or high-risk conditions for CVD who did not have continuous 
full-year Medicaid coverage, due to either loss of coverage, or disruptions/gaps, reported 
significantly worse health care and medication access, and routine healthcare checkup 
visits. Additionally, those in with discontinuous Medicaid coverage reported lower 
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Table 4-5.  Associations between Medicaid Discontinuity and Health Care Resources Utilization in the Study Population 
 
Outcome Medicaid Coverage  Incidence Rate Ratio 
(95% Confidence Interval) 
Predicted 
Difference in Visits 
Inpatient Visits     
All-Cause Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  1.14 (0.95 – 1.37) 0.05 visits 
 Discontinuous–Insured  1.24 (0.97 – 1.58) 0.08 visits 
     
Disease-Specific Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  1.62 (1.19 – 2.22)** 0.05 visits** 
 Discontinuous–Insured  1.95 (1.23 – 3.10)** 0.08 visits* 
     
Emergency Room Visits     
All-Cause Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  0.96 (0.79 – 1.17) -0.02 visits 
 Discontinuous–Insured  1.00 (0.73 – 1.38) 0.00 visits 
     
Disease-Specific Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  1.52 (1.14 – 2.03)** 0.05 visits** 
 Discontinuous–Insured  1.79 (1.16 – 2.77)** 0.07 visits* 
     
Hospital Outpatient Visits     
All-Cause Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  0.77 (0.55 – 1.06) -0.33 visits 
 Discontinuous–Insured  1.20 (0.71 – 2.04) 0.28 visits 
     
Disease-Specific Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  1.86 (1.32 – 2.63)*** 0.21 visits** 
 Discontinuous–Insured  0.86 (0.47 – 1.60) -0.04 visits 
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Table 4-5.  (Continued) 
 
Outcome Medicaid Coverage  Incidence Rate Ratio 
(95% Confidence Interval) 
Predicted 
Difference in Visits 
Physician Office Visits     
All-Cause Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  0.71 (0.62 – 0.81)*** -3.37 visits*** 
 Discontinuous–Insured  0.89 (0.77 – 1.11) -1.27 visits 
     
Disease-Specific Continuous  1.00 (Reference)  
 Discontinuous–Uninsured  0.90 (0.80 – 1.02)* -0.30 visits 
 Discontinuous–Insured  0.86 (0.71 – 1.06) -0.43 visits 
 
Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being 
diagnosed with or having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider 
visits) associated with CVD or high-risk conditions for CVD, and who reported having Medicaid anytime during the year. 
Estimates in bold indicate statistical significance at P<0.05. 
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region, education, income, 
employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance abuse illnesses, arthritis/joint pain, no. of CVD 
conditions, perceived health status, perceived mental health status, Charlson Comorbidity Index score, and survey year. 
*P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and discontinuous Medicaid groups 
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physician office visits, and higher inpatient, and ER hospitalizations. In examining these 
associations, this study further classified individuals with discontinuous Medicaid 
coverage into those who did not report any other coverage (the Discontinuous–
Uninsured), and those who reported having other sources of insurance coverage during 
the year (the Discontinuous–Insured), in order to capture the heterogeneity of the 
discontinuous Medicaid group. In doing so, we found that the outcomes of Medicaid 
discontinuity were not always similar, either in magnitude, directionality, or statistical 
significance. For instance, in comparison to the Continuous Medicaid group, among both 
the Discontinuous–Uninsured and Discontinuous–Insured groups, the access to care 
outcomes were significantly poor; however, the odds of reporting difficulty in obtaining 
medical care were over 4 times, and almost 2 times higher, respectively. Similarly, the 
Discontinuous–Uninsured population in this study had significantly lower odds of 
reporting routine medical checkup within the past year, whereas no significant difference 
in this outcome was observed between the Discontinuous–Insured and the Continuous 
Medicaid populations. 
 
 Nearly three-quarters (74.1%) of the individuals who did not have continuous 
full-year Medicaid coverage in this CVD population belonged to the Discontinuous–
Uninsured group. On average, this group was uninsured for over 5 months during the 
year, and around 18% of individuals experienced multiple transitions in their Medicaid 
coverage, indicating significant churning, and relapses into the state of being uninsured. 
Of the roughly 400,000 individuals who had Medicaid at the beginning of the year, a 
whopping 78% were found to be uninsured by the end of the year. These individuals 
collectively had worse outcomes associated with Medicaid discontinuity when compared 
to those who reported other sources of insurance coverage during the year, the 
Discontinuous–Insured, with significantly fewer physician office visits and higher 
incidences of inpatient and ER hospitalizations, when compared to those with continuous 
Medicaid coverage. Although preventive services use, and primary care visit outcomes 
were not significantly poor among the Discontinuous–Insured, these individuals did 
collectively have poor access to medical care and pharmacotherapy, and higher 
incidences of hospitalizations when compared to those with continuous Medicaid 
coverage. Our study findings indicate that for individuals with CVD or some of its risk 
factor conditions that require continuous, prolonged disease management, lacking 
continuous Medicaid coverage may adversely impact access to care, and primary care, 
and have a strong association with increased incidences of hospitalizations, irrespective 
of whether or not they have other sources of coverage during the year. And these 
outcomes may worsen among individuals and families for whom Medicaid is the only 
source of health insurance coverage. 
 
 The increased hospitalizations, both inpatient and ER, were The results of this 
study, are in line with previous estimates, however, very few have examined Medicaid 
discontinuity outcomes among adults with CVD or high-risk conditions for CVD. Among 
the earliest studies, Lurie and colleagues examined access to care among a cohort of 
California Medicaid enrollees within a 6-month period after loss of coverage. A 
significantly higher proportion of individuals in the lost coverage group (62%) reported 
poor access to needed medical care, compared to those still on Medicaid (7%), with the 
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discontinuous Medicaid group being more likely to have uncontrolled hypertension.104 In 
a follow-up study conducted at one year found no improvements in access to care 
between the discontinuous and continuous Medicaid groups.105 Carlson and colleagues 
examined the impact of disrupted or lost Medicaid coverage within a year of benefit 
structure changes among the Oregon Medicaid program, on unmet medical care or 
pharmacotherapy needs, utilization, and medical debt.106 They found that enrollees with 
discontinuous Medicaid coverage were more likely to report unmet medical care, 
prescription medication needs (lost Medicaid coverage group), and were less likely to 
report having primary care visits, when compared to those enrolled continuously in the 
program.  
 
Harman and colleagues examined associations between interruptions in a state 
Medicaid program coverage and inpatient psychiatric services among persons with 
schizophrenia.10 They found an 86% increase in the incidence of hospitalizations, 
representing 0.63 more psychiatric hospitalizations per beneficiary, and longer hospital 
stays to be associated with discontinuous Medicaid coverage. Hall and colleagues 
examined the impact of gaps in Florida’s Medicaid coverage on health care utilization 
and expenditures among individuals with diabetes.101 That study found that gaps in 
coverage were associated with higher inpatient and ER utilization, and higher 
expenditures, especially in the period after lapse in Medicaid coverage. Banerjee and 
colleagues analyzed the MEPS data for the years 2000 – 2004 to examine association 
between Medicaid discontinuity and health resource utilization among all Medicaid 
enrollees.15 They defined discontinuity as having one or more than one transitions into or 
out of Medicaid coverage, which was different from the present study. The 
aforementioned study found Medicaid discontinuity to be associated with higher 
inpatient, ER, and higher outpatient physician visits. It is unclear whether they examined 
hospital outpatient visits and physician office visits separately, or combined the two 
outcomes together. Nonetheless, the results from this study are broadly in agreement with 
the study of Banerjee and colleagues, indicating that Medicaid discontinuity, either due to 
coverage loss or disruptions in coverage continuity have detrimental outcomes, both 
overall, and among individuals with chronic conditions. Alternatively, it may be possible 
that the results obtained in the analyses of Medicaid enrollees in general, may in 
particular be contributed by individuals with chronic, debilitating conditions, such as 
CVD or conditions that are high risk factors for CVD, as this study has shown. 
 
Medicaid provides much-needed health care coverage to the poor and disabled 
vulnerable populations who often are unable to afford private health insurance. Medicaid 
is often referred to as a “Cadillac” health insurance program, which provides a rich 
benefits package at very little or even no cost to the enrollees.107 A substantial body of 
research has shown that low-income Medicaid enrollees have comparable access to 
physician care, preventive services, and unmet medical care needs when compared to 
their counterparts with private health insurance.107 Even low-income mothers on 
Medicaid report similar preventive services use and access to care compared to those 
with private insurance.108 Together, these and other estimates shown the importance of 
Medicaid coverage for low-income populations, and dispel the notion that Medicaid is a 
costly, low-quality health coverage program.109,110 Loss of Medicaid coverage may 
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deprive these vulnerable populations suffering from chronic conditions of the ability to 
afford and seek much-needed medical care and pharmacotherapy. Such disruptions in 
continuity of care may be responsible for respondents reporting lack of usual source of 
care and difficulties in obtaining medical care and prescription drugs. The 
Discontinuous–Uninsured group also reported lower incidence of physician office visits 
overall, which may be precipitated by the lack of usual source of care, and inability of 
afford physician visit reimbursements following loss of coverage. This group reported 
higher rates of hospital outpatient visits compared to those with continuous Medicaid 
coverage, a finding that was puzzling. It may be that these individuals may be more 
inclined to seek care in the outpatient setting following loss of Medicaid coverage, and 
subsequent inability to afford physician office visits as highlighted earlier. The higher 
incidences of disease-specific hospitalizations observed in this study could have been 
precipitated by poor access to care, lower likelihood of getting routine medical checkups, 
lower primary care office visits, and the disruptions in continuity of care resulting from 
loss of Medicaid coverage. A follow-up evaluation of the Oregon Health Experiment, 
found higher ER utilization among individuals who gained Medicaid coverage, relative to 
those who remained uninsured.111 The present study found increases in CVD or high-risk 
conditions for CVD-specific ER visits among the discontinuous Medicaid groups 
compared to the Continuous Medicaid group, which may have been precipitated by poor 
access to care as observed in our findings, and also due to disruptions in disease 
management caused by loss or gaps in Medicaid coverage. Differences in the study 
population (diseased vs. general population, and national vs. state-specific) and 
estimation techniques may have contributed to the differences in our findings from the 
Oregon analysis of ER utilization. 
 
This study has several limitations. State-level Medicaid eligibility data was not 
available to explore the complex and dynamic patterns of discontinuity that may differ 
based on the state’s eligibility and reporting criteria. This study found strong associations 
between Medicaid discontinuity and poor access to care, lower odds of routine medical 
checkup, higher disease-specific hospitalizations, and lower all-cause physician office 
visits. Nonetheless, temporality between discontinuity and the various outcomes, and the 
resulting causality could not be established due to data limitations. The regression 
analyses may not have adjusted for unobserved covariates that may have confounded the 
impact of certain risk factors on the likelihood of belonging to the Discontinuous–
Uninsured or the Discontinuous–Insured groups. Data in MEPS are self-reported, and the 
reasons for discontinuity of Medicaid coverage were not captured, resulting in estimates 
that may not exactly reflect the national estimates of the impact of Medicaid discontinuity 
on access to care, preventive services use, and health care services utilization. 
Researchers have speculated that most surveys underestimate the number of Medicaid 
enrollees due to a variety of reasons including stigma of public insurance. However, such 
misreporting is less of a problem for MEPS compared to other federal health surveys.54 
Finally, findings from this study are representative of the non-institutionalized civilian 
population and may not be applicable to individuals with prolonged hospitalizations or 
admitted to long-term care facilities. 
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Loss of Medicaid coverage has an adverse impact on individuals’ ability to seek 
medical care which may in turn lead to poor health outcomes and increased burden on the 
health care system resulting from providing care to uninsured individuals. Individuals 
eligible for Medicaid may also lose coverage due to the inefficient administrative hurdles 
and burdensome paperwork requirements, and may be considered a policy failure.34 
However, when individuals transition from one source of coverage to another, continuity 
of care may still be impacted, especially since different insurance plans have different 
network of providers, and differing benefit structures, and may cover different classes of 
medications and services. The present study highlighted the adverse impact that Medicaid 
discontinuity may have on ability to access needed medical care, and the increased 
hospitalizations for CVD or high-risk conditions for CVD associated with coverage 
instability. Enabling continuity in Medicaid coverage for low-income populations with 
chronic and debilitating conditions would ensure increased effectiveness of the care they 
receive to manage these disease, and may prove cost-effective in the long run. 
 
Discontinuity in Medicaid and the Children’s Health Insurance Program (CHIP) 
coverage among low-income children is an issue that has gained considerable scrutiny 
previously, and the detrimental effects of such a policy failure have been well 
established.35,112 Apart from simplification of administrative regulations governing policy 
renewals, a policy initiative adopted by most states is the 12 months continuous eligibility 
provision. Under this policy, children continue to be enrolled under Medicaid/CHIP 
irrespective for 12 months after gaining or renewing coverage, irrespective of any income 
or other eligibility midway. Researchers and advocacy groups, such as the Medicaid and 
CHIP Payment Access Commission, have advocated for extending such a measure for 
non-elderly adults to ensure continuity of Medicaid coverage in this population.8,44 Our 
study findings indicate that individuals with chronic conditions requiring prolonged and 
continuous disease management, such as CVD or its high-risk conditions, may be 
especially adversely impacted by instability in their Medicaid coverage. States can 
choose to have a straight-forward option of establishing a minimum guaranteed eligibility 
period, such as the 12 month continuous eligibility provision, for subpopulations of non-
elderly adults with chronic conditions, such as CVD, or other such as cancers, respiratory 
illnesses, mental illnesses, HIV/AIDS, among others, which require prolonged 
management of disease symptoms and risk factors. By using annual eligibility 
redetermination periods, and guaranteeing enrollment for the period in between, states 
can ensure that loss of coverage or churning midway during enrollment can be reduced in 
these vulnerable populations. 
 
 
CONCLUSION 
 
The present study highlighted the significantly worse access to care, preventive 
medical checkups, lower primary care office visits, and higher hospitalizations for CVD 
or high-risk conditions for CVD, associated with having discontinuous Medicaid 
coverage. Policy initiatives to stabilize Medicaid coverage among non-elderly adults may 
provide the most benefit for individuals with chronic conditions requiring continuous 
long-term medical care interventions, and appropriate disease management. Low-income 
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adults managing chronic conditions, especially in regions with stringent Medicaid 
eligibility regulations, must be encouraged to ensure continuity of Medicaid coverage. 
States may adopt annual eligibility reassessment policies, with continuous eligibility for 
the intermittent period, for non-elderly adults with certain chronic conditions among 
whom continuous Medicaid coverage would ensure greater effectiveness of disease 
management. 
 
 
 
 
 
 
 
  
 88 
CHAPTER 5.    CONCLUSION 
 
 
SUMMARY 
 
 The present study was aimed at conducting a detailed examination of the impact 
of having discontinuous Medicaid coverage on various health care utilization outcomes 
and medication consumption behaviors, which are extremely crucial in effectively 
preventing and treating chronic diseases of the cardiovascular system along with many of 
its risk factor disease conditions. Although previous estimates have characterized general 
populations that experience discontinuous Medicaid coverage, and compared them with 
their counterparts with continuous Medicaid insurance, none have focused on national 
estimates of subpopulations diagnosed with complex chronic conditions requiring 
prolonged disease management, such as CVD or chronic conditions which are high risk 
factors for CVD. The first aim of this dissertation intended to characterize the populations 
of non-elderly adults with CVD or high-risk conditions for CVD who have discontinuous 
Medicaid coverage, and compare them to their counterparts with continuous Medicaid 
coverage. Another difference between this analyses and previous ones is the classification 
of the subpopulations with less than full-year Medicaid coverage. Individuals with 
discontinuous Medicaid coverage are not a homogenous population, since although many 
individuals may not have any other source of insurance coverage during the year, the 
Discontinuous–Uninsured group in this study, this population would also comprise of 
individuals with other sources of coverage, ranging from private insurance, Tricare, or 
other hospital-, or physician group-based health insurance. Interestingly, this study found 
about three-fourths of this population to belong to the Discontinuous–Uninsured group, 
and a little over a fourth to belong to the Discontinuous–Insured group. 
 
 Hypertension, lipid disorders, and diabetes, significant risk factors for CVD, were 
found to be the most prevalent chronic conditions in this study population. These are 
diseases that require prolonged, and sometimes lifelong treatment, which includes 
adequate preventive care to monitor health or disease progression, getting regular medical 
checkups and making regular primary care visits to diagnose and treat these conditions 
early, and filling prescription medications regularly and consuming them as prescribed by 
health care providers. This finding, coupled with the fact that insurance is a major source 
that enables individuals, especially low-income sick populations, to seek needed medical 
care and pharmacotherapy, further strengthens our justification for examining the impact 
of Medicaid discontinuity among low-income populations with CVD or high-risk 
conditions for CVD. 
 
When examining Medicaid coverage patterns among the two discontinuous 
Medicaid coverage groups, this study found that on average, the Discontinuous–
Uninsured were uninsured for over 5 months during the year, and the Discontinuous–
Insured too were uninsured on average for a little over a month, despite reporting other 
insurance sources. Further, a subsample of individuals who had coverage at the beginning 
of the year were examined to determine their coverage patterns by the year end. It was 
observed that among the Discontinuous–Uninsured who had Medicaid coverage at the 
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start of the year, 78% were uninsured by the year end. Among the Discontinuous- 
Insured, only 8% had Medicaid, 86% had other insurance, and around 6% were uninsured 
by the end of the year. Finally, this study found that almost 18% of both the 
discontinuous Medicaid groups had more than one transitions, indicating a decent amount 
of churning taking place in these groups, i.e. going back-and-forth from Medicaid to 
either a state of being uninsured, or enrolling in another source of insurance coverage, or 
vice versa (uninsured – Medicaid – uninsured, or other insurance – Medicaid – other 
insurance). These findings highlight the instability in Medicaid coverage encountered by 
low-income, chronically diseased, non-elderly adult population, and the disruptions in 
continuity of care associated with transitioning from Medicaid to other sources of 
coverage, or vice versa, not to mention the difficulties involved with adjusting to 
differences in provider networks, services covered, services and resources covered, and 
benefit structures. 
 
When examining the population characteristics associated with Medicaid 
discontinuity among the Discontinuous–Uninsured relative to the Continuous Medicaid 
group, this study found that those who were married, resided in the South, had 
intermittent unstable employment, and had fair to poor perceived health status, had higher 
odds of having discontinuous Medicaid coverage, whereas men, minorities, those with 
higher incomes, SSI/TANF beneficiaries, Medicaid managed care enrollees, and those 
with respiratory illnesses had lower odds of experiencing discontinuity in their Medicaid 
coverage during the year. Among the Discontinuous–Insured group, married individuals, 
those with higher education, higher incomes, and having some form of employment 
during the year were the characteristics associated with higher odds of Medicaid 
discontinuity, whereas minorities, those who were married, SSI/TANF beneficiaries, 
Medicaid managed care enrollees, and those with respiratory illnesses were associated 
with lower odds of Medicaid discontinuity. These findings may have highlighted racial 
and ethnic differences in Medicaid continuity; for instance, low-income minorities have 
been known to have lower incomes and education, and may be more likely to be 
unemployed, resulting in greater continuity in their Medicaid coverage compared to their 
Caucasian counterparts. An interesting finding was the lower odds of Medicaid 
discontinuity among Medicaid managed care enrollees, which may be the result of better 
outreach efforts by managed care organizations, although they may be incentivized to do 
so given they are paid on a per-member basis by Medicaid.34 
 
When examining the associations between Medicaid discontinuity, medication 
adherence, and medication utilization, as part of the second aim of this dissertation, it was 
found that although the point estimate for overall average adherence to frequently 
prescribed medications was lower for the Discontinuous–Uninsured, the estimate was not 
statistically significantly different from the Continuous Medicaid group. This study found 
lower adherence to sulfonylureas among the Discontinuous–Uninsured compared to the 
Continuous Medicaid, which may result in higher health care costs in this 
subpopulation.113 The Discontinuous–Insured were found to have higher odds of 
adherence to ACEI/ARB and calcium channel blockers, which could have been 
contributed by better access to these medications through other insurance programs. The 
odds of clinically adequate adherence to diuretics, however, was found to be significantly 
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lower among the Discontinuous–Insured, which is traditionally used as a first-line 
antihypertensive therapy. Medication utilization on the other hand, both all-cause and 
disease-specific, was found to be significantly lower among both the discontinuous 
Medicaid groups compared to the Continuous Medicaid. On average, the Discontinuous–
Uninsured had 12 fewer drug fills per person for all medications, and 2.3 fewer fills per 
person for CVD-specific medications. Even the Discontinuous–Insured had 6.5 fewer 
fills, and 2.8 fewer fills per person, for all-cause and disease-specific medications, 
respectively. Given the significantly lower prescription drug fills among the 
discontinuous Medicaid groups, this study may have overestimated adherence to 
medications, which may also be lower among populations lacking continuous Medicaid 
coverage. 
 
Finally, as part of the third aim, this study examined associations between 
Medicaid discontinuity, access to care, preventive services use, and health care 
utilization. Access to care was poor among the discontinuous Medicaid populations, with 
these groups having lower odds of having usual source of care, and higher odds for 
experiencing difficulties in obtaining needed medical care and medications. The odds of 
routine medical checkups were also found to be lower among the Discontinuous–
Uninsured, indicating inadequate medical checkups which are critical for early detection 
and management of chronic conditions. Incidences of disease-specific hospitalizations, 
both inpatient and ER visits, were found to be significantly higher among the 
discontinuous Medicaid populations compared to those with continuous Medicaid. 
Although ER use has been found to be higher among individuals who gain Medicaid 
coverage, as ER may be a usual source of care for certain vulnerable populations even for 
conditions that can be managed in outpatient setting, the increased hospitalizations are 
more likely due to poor management of CVD or high-risk conditions for CVD resulting 
from poor access to care and inadequate pharmacotherapy. The reason being, when 
individuals are asked about whether or not they have a usual source of care, the options 
include ER as well, apart from provider offices, outpatient and other clinic settings. 
Moreover, all-cause office-based provider visits were lower, whereas all-cause hospital 
outpatient visits were higher among the Discontinuous–Uninsured, which may indicate 
inability to seek care and build patient-provider relationships with a usual source of 
primary care physician, and overreliance on the hospital clinical care setting. It may also 
be a result of lower acceptance of Medicaid patients by private practice physicians, 
however, the comparison group is those with continuous Medicaid coverage, which 
would have had worse primary care office visits if lack of acceptance were predominant 
and prevalent. These findings indicate that Medicaid discontinuity among low-income 
CVD or high risk chronic condition patients is associated with poor access to care, 
inadequate medical checkups, lower prescription drug utilization and poor adherence to 
certain commonly prescribed therapeutic drug classes, higher CVD-related 
hospitalizations and ER visits, lower overall physician office visits to seek primary care, 
and a greater reliance on hospital outpatient setting. 
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IMPLICATIONS FOR POLICY 
 
 Gaps in Medicaid coverage may have deleterious health consequences for low-
income enrollees, and this study found that the health care access, and utilization 
outcomes, and medication consumption behaviors among adults with CVD or high-risk 
conditions for CVD may be adversely impacted due to instability in Medicaid coverage. 
Continuity of Medicaid, especially for those who continue to be eligible for coverage, 
represents a cost-effective policy solution, and lead to greater effectiveness of the 
prevention and treatment services and resources, especially among low-income diseased 
populations. State Medicaid agencies have a policy option of guaranteeing enrollment for 
adults in Medicaid until the next reenrollment and eligibility determination cycle, and 
have the duration of these cycles to be six months or annual. This would significantly 
reduce within enrollment period churning and ensure better continuity of Medicaid 
coverage, and in turn the continuity of care afforded by it. On a long term basis, cost 
reductions may be realized due to providing better continuity in Medicaid coverage to 
non-elderly adults, especially if the administrative costs associated with frequent 
reenrollment are higher. The immediate impact of prolonged continuity of Medicaid may 
however, result in a higher financial burden on the states, which may be a reason for the 
stringent administrative regulations governing Medicaid coverage for none-elderly adults. 
If that may be the case, then rather than a blanket policy that provides guaranteed 
Medicaid enrollment to all non-elderly adults, state Medicaid agencies may focus on 
specific subpopulations suffering from chronic, debilitating disease conditions, who often 
require prolonged medical care to manage their conditions and comorbidities, and for 
whom having continuous Medicaid coverage may prove to be more effective, and cost-
effective. Indeed, the present study showed that adults with CVD or high-risk conditions 
for CVD had greater access to care problems, substandard medication adherence, 
inadequate preventive care and primary care, and higher incidences of hospitalizations 
associated Medicaid discontinuity, after adjusting for a host of demographic, 
socioeconomic, health-related and Medicaid eligibility-related covariates in order to 
obtain robust estimates. And although this study did not examine individuals with other 
disease conditions such as respiratory illnesses, HIV/AIDS, mental illnesses, these 
subpopulations too may experience similar negative outcomes of poor access to and use 
of health care resources. Therefore, policies to stabilize Medicaid coverage among the 
low-income population with chronic, debilitating disease conditions, may provide more 
bang for the buck. 
 
Instability in insurance, both public and private, have negative impact on health 
and well-being of individuals as has been established by studies above. Although there 
has not been any positive impact of this loss of and gaps in coverage investigated on 
patients and society, there are some aspects or reasons of that contribute to churning in 
insurance or Medicaid that are needed for the benefit of the society. One is the need for 
deductibles and co-payments for insurance programs. Studies have shown that inability to 
afford paying for deductibles and co-payments is one of the reasons that people opt out of 
insurance plans, or do not enroll for public health plans. Although high deductibles and 
co-pays have a negative effect on individuals’ utilization of needed care, complete 
elimination of these payment structures might also be detrimental. This is because with 
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“no skin in the game”, there will the likelihood of what economists call “moral hazard”, 
that is individuals will consume more health care than what they need resulting in 
inefficient allocation and spending of resources and excessive health care burden on the 
society. In order to promote rational utilization of health care resources such contribution 
from health plan enrollees is needed; the challenge to determining the “sweet spot” or the 
right balance that would ensure that it does not exert a tremendous financial burden. 
Another aspect is the requirement for sufficient documentation to ensure that means-
tested insurance plans enroll individuals who truly qualify for the health plans, and 
prevent any fraud which may divert needed health care resources to individuals who may 
not need them. Once again, rather than getting rid of documentation requirements, the 
process should be made less burdensome, with greater choices or avenues given to 
patients, such as online enrollment, and longer time periods, and note having short 
periodic reporting requirements to report eligibility. Also, provisions that enable smooth 
transitions from public to private health insurance, or vice versa, especially for low-
income population, can also minimize churning and gaps, while still ensuring that 
minimum checks and balances of determining eligibility are in place to prevent wastage 
of much needed health care resources. 
 
As part of the 2010 PPACA provisions of Medicaid expansion, states have the 
option for expanding Medicaid coverage to their non-elderly adult residents with incomes 
at or below 138% FPL. As of May 2015, however, 18 states have chosen status quo over 
adopting these provisions and expanding Medicaid coverage, which would result in 
continuation of these issues of instability of Medicaid in none-elderly adults and the 
resulting adverse impact on continuity and quality of care and disease management.49 
Even under PPACA provisions, states will be required to have 12 month recertification 
periods, meaning individuals will have to reenroll in Medicaid annually; however, even 
within this enrolled period, individuals and families may lose coverage midway if their 
incomes and other criteria change. For these states, ensuring continuous Medicaid 
coverage, at least for the diseased vulnerable populations could be a policy initiative that 
can be adopted to ensure better health outcomes among these populations, and possibly 
lower financial burden on the health care system due to providing high cost care resulting 
from avoidable hospitalizations. Due to competing priorities, and even among the health 
care sector, competing health priorities, resources available for management of these 
conditions may be limited and policy initiatives to ensure continuity of insurance 
coverage among low-income adult populations may be lacking. Failure to address issues 
of Medicaid coverage continuity among adults with complex chronic conditions such as 
CVD, may lead to large increases in prevalence of avoidable chronic conditions, which 
may exert a tremendous burden on the health care system and the economy.  
 
 
IMPLICATIONS FOR FUTURE RESEARCH 
 
 The present study found strong associations between Medicaid discontinuity and 
the negative access to care and health care resource utilization outcomes among the low-
income CVD adult population. However, due to data limitations, we were unable to 
establish temporality between Medicaid discontinuity and various outcomes under 
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investigation. Moreover, the reasons for losing or gaps in Medicaid coverage were not 
known. Future research may incorporate these shortcomings to obtain a holistic view of 
the outcomes associated, and possibly caused by disruptions in Medicaid coverage. Using 
state-specific eligibility would also be able to better control for state-level differences in 
observed and unobserved characteristics that may not have been adequately controlled by 
geographic region. 
 
 Costs associated with Medicaid discontinuity are an important outcome, and may 
be of more interest to policymakers. The obvious follow-up to this study would examine 
the costs, including total costs and costs specific to each health care services, to provide a 
comprehensive picture of the impact of Medicaid discontinuity on health care resources 
and costs, from the health care system perspective or payer perspective. Disruptions in 
care continuity associated with poor access to care, lack of preventive care and primary 
care, and the resulting increased hospitalizations and ER visits may lead to significant 
increases in health care costs. And with a significant increase ER use by the uninsured to 
obtain their usual care, or due hospitalizations resulting from chronic disease 
exacerbations, the financial burden may increase tremendously on the health care 
providers and hospitals due to provision of uncompensated care. The insured may end up 
subsidizing a significant portion of the uncompensated care costs through their insurance 
plans, and related out-of-pocket expenditures due to cost shifting. This vicious cycle may 
not only exert a financial strain on providers and payers, but on patients as well. 
Examinations of cost implications due to Medicaid discontinuity from not just payer or 
provider perspective, but patient perspective may also provide meaningful information of 
the impact of Medicaid discontinuity, and produce a complete and comprehensive picture 
of the implications of Medicaid discontinuity among the non-elderly adult population, or 
subpopulations of these with chronic conditions such as CVD or several of its high-risk 
conditions. 
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APPENDIX A. SUPPLEMENTAL MATERIALS FOR CHAPTER 3 
 
 
 
 
 
Figure A-1. Distribution of All-Cause Prescription Drug Fills among Continuous 
Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure A-2. Distribution of All-Cause Prescription Drug Fills among Continuous 
Medicaid and Discontinuous–Insured 
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Figure A-3. Distribution of Disease-Specific Prescription Drug Fills among 
Continuous Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure A-4. Distribution of Disease-Specific Prescription Drug Fills among 
Continuous Medicaid and Discontinuous–Insured
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Table A-1. Characteristics Associated with Medication Adherence 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
DEMOGRAPHIC    
Age    
18 – 34 years 1.00 (Reference)  1.00 (Reference) 
35 – 49 years 1.25 (0.97 – 1.61)  1.16 (0.90 – 1.49) 
50 – 64 years 1.26 (0.97 – 1.63)  1.22 (0.93 – 1.59) 
Gender    
Female 1.00 (Reference)  1.00 (Reference) 
Male 1.11 (0.91 – 1.35)  1.09 (0.88 – 1.35) 
Race/Ethnicity    
Non-Hispanic White 1.00 (Reference)  1.00 (Reference) 
Non-Hispanic Black 0.83 (0.67 – 1.04)  0.81 (0.65 – 1.01) 
Hispanic 0.86 (0.68 – 1.09)  0.79 (0.61 – 1.02) 
Others 0.74 (0.53 – 1.02)  0.74 (0.54 – 1.01) 
Marital Status    
Not Married 1.00 (Reference)  1.00 (Reference) 
Married 0.96 (0.79 – 1.17)  1.05 (0.86 – 1.30) 
Region    
Northeast 1.00 (Reference)  1.00 (Reference) 
Midwest 1.12 (0.84 – 1.49)  1.01 (0.76 – 1.37) 
South 1.05 (0.83 – 1.34)  1.00 (0.78 – 1.29) 
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Table A-1.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
West 1.02 (0.79 – 1.31)  1.02 (0.79 – 1.32) 
Family Size  0.97 (0.93 – 1.02)  0.95 (0.90 – 1.00) 
SOCIOECONOMIC    
Education    
<High School 1.00 (Reference)  1.00 (Reference) 
High School/GED 0.99 (0.84 – 1.18)  0.97 (0.81 – 1.71) 
College Degree 0.85 (0.61 – 1.19)  0.85 (0.62 – 1.17) 
Income    
<100% FPL 1.00 (Reference)  1.00 (Reference) 
100 – <125% FPL 0.87 (0.66 – 1.19)  0.84 (0.61 – 1.15) 
>125% FPL 1.11 (0.93 – 1.33)  1.04 (0.85 – 1.27) 
Employment    
Always Unemployed 1.00 (Reference)  1.00 (Reference) 
Unstable Employment 1.01 (0.72 – 1.40)  1.00 (0.73 – 1.38) 
Always Employed 0.97 (0.75 – 1.25)  1.01 (0.79 – 1.30) 
MSA    
Non-MSA 1.00 (Reference)  1.00 (Reference) 
MSA 1.00 (0.80 – 1.25)  0.97 (0.77 – 1.22) 
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Table A-1.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
MEDICAID-RELATED    
SSI/TANF    
No 1.00 (Reference)  1.00 (Reference) 
Yes 1.02 (0.87 – 1.20)  1.01 (0.84 – 1.21) 
Medicaid HMO/MCO    
No 1.00 (Reference)  1.00 (Reference) 
Yes 1.15 (0.97 – 1.36)  1.10 (0.92 – 1.31) 
HEALTH-RELATED    
Perceived Health Status    
Excellent/Very Good/Good 1.00 (Reference)  1.00 (Reference) 
Fair to Poor 1.22 (1.01 – 1.48)  1.10 (0.90 – 1.34) 
Perceived Mental Health    
Excellent/Very Good/Good 1.00 (Reference)  1.00 (Reference) 
Fair to Poor 1.07 (0.89 – 1.30)  1.11 (0.92 - 1.35) 
CVD or High-Risk Conditions for 
CVD 
   
<1 1.00 (Reference)  1.00 (Reference) 
2 0.82 (0.63 – 1.06)  0.93 (0.70 – 1.22) 
>3 1.01 (0.76 – 1.34)  1.00 (0.72 – 1.38) 
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Table A-1.  (Continued) 
 
Characteristics Discontinuous–Uninsured  Discontinuous–Insured 
 Odds Ratio (95% Confidence Interval)  Odds Ratio (95% Confidence Interval) 
Mental/Substance Abuse Illnesses    
No 1.00 (Reference)  1.00 (Reference) 
Yes 1.12 (0.91 – 1.38)  0.91 (0.73 – 1.13) 
Respiratory Illnesses    
No 1.00 (Reference)  1.00 (Reference) 
Yes 0.88 (0.70 – 1.10)  0.81 (0.63 – 1.04) 
Arthritis/Joint Pain    
No 1.00 (Reference)  1.00 (Reference) 
Yes 1.13 (0.93 – 1.37)  1.30 (1.04 – 1.62)* 
CCI Score  1.00 (0.94 – 1.07)  1.03 (0.97 – 1.11) 
 
Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or reported 
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or more 
cardiovascular disease or associated risk factor comorbidities considered in this study. 
***P-value<0.001, **P<0.01, *P<0.05 for the difference between Continuous Medicaid vs Discontinuous–Uninsured and Continuous Medicaid 
vs Discontinuous–Insured groups 
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: Supplementary 
Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health maintenance 
organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was calculated in this study 
using the 3-digit ICD-9-CM codes in MEPS). 
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APPENDIX B. SUPPLEMENTAL MATERIALS FOR CHAPTER 4 
 
 
 
 
 
Figure B-1. Distribution of All-Cause Inpatient Visits among Continuous 
Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-2. Distribution of All-Cause Inpatient Visits among Continuous 
Medicaid and Discontinuous–Insured 
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Figure B-3. Distribution of Disease-Specific Inpatient Visits among Continuous 
Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-4. Distribution of Disease-Specific Inpatient Visits among Continuous 
Medicaid and Discontinuous–Insured 
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Figure B-5. Distribution of All-Cause Emergency Room Visits among Continuous 
Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-6. Distribution of All-Cause Emergency Room Visits among Continuous 
Medicaid and Discontinuous–Insured 
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Figure B-7. Distribution of Disease-Specific Emergency Room Visits among 
Continuous Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-8. Distribution of Disease-Specific Emergency Room Visits among 
Continuous Medicaid and Discontinuous–Insured 
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Figure B-9. Distribution of All-Cause Hospital Outpatient Visits among 
Continuous Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-10. Distribution of All-Cause Hospital Outpatient Visits among 
Continuous Medicaid and Discontinuous–Insured 
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Figure B-11. Distribution of Disease-Specific Hospital Outpatient Visits among 
Continuous Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-12. Distribution of Disease-Specific Hospital Outpatient Visits among 
Continuous Medicaid and Discontinuous–Insured 
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Figure B-13. Distribution of All-Cause Physician Office Visits among Continuous 
Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-14. Distribution of All-Cause Physician Office Visits among Continuous 
Medicaid and Discontinuous–Insured 
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Figure B-15. Distribution of Disease-Specific Physician Office Visits among 
Continuous Medicaid and Discontinuous–Uninsured 
 
 
 
 
 
 
Figure B-16. Distribution of Disease-Specific Physician Office Visits among 
Continuous Medicaid and Discontinuous–Insured 
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